Textbook of Aging Skin
Miranda A. Farage, Kenneth W. Miller and Howard I. Maibach Editors
Textbook of Aging Skin With 366 Figures and 156 Tables
Editors: Miranda A. Farage, Ph.D. Principal Scientist The Procter & Gamble Company 6110 Center Hill Avenue Cincinnati, OH 45224 USA Kenneth W. Miller, Ph.D. Associate Director The Procter & Gamble Company 6110 Center Hill Avenue Cincinnati, OH 45224 USA Howard I. Maibach, M.D. Professor Department of Dermatology University of California, School of Medicine San Francisco, CA 94122 USA
Library of Congress Control Number: 2009938632 ISBN 978-3-540-89655-5 This publication is available also as: Electronic publication under ISBN 978-3-540-89656-2 Print and electronic bundle under ISBN 978-3-540-89935-8 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. ß Springer-Verlag Berlin Heidelberg 2010 The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature. Springer is part of Springer Science+Business Media www.springer.com Publishing Editor: Tobias Kemme MRW Editor: Sandra Fabiani Printed on acid‐free paper
Dedicated to those on a forgotten and sometimes lonely and scary aging journey—much more dignity and respect are deserved for all of you. – MAF, KWM and HIM
When things go wrong as they sometimes will, When the road you’re trudging seems all uphill, When the funds are low and the debts are high, And you want to smile but you have to sigh, When care is pressing you down a bit Rest if you must, but don’t you quit. Success is failure turned inside out, The silver tint on the clouds of doubt, And you can never tell how close you are, It may be near when it seems afar. So, stick to the fight when you’re hardest hit It’s when things go wrong that you mustn’t quit. —Unknown
Acknowledgments
Deep appreciation and grateful thank-yous are extended to the significant efforts of many people who contributed both knowingly and indirectly to this book, by dedicating their valuable time in preparing their chapters. This book represents the fruits of a jointly conceived and executed venture, and has also benefited from global and diverse partners. A special thank-you to Dr. Mark Dato and Mr. Ron Visscher for generously offering their time and expertise in peerreviewing the relevant chapters and extending their immense support to this book. No praise is excessive for their efforts, and our heartfelt gratitude goes to them. We would like to single out Mr. Anil Joseph Chandy (Springer Reference Editorial Office) for a special recognition of his great effort, time, discipline, and dedication in moving this book forward in a timely and organized manner. We extend our appreciation to Ms. Marion Philipp and Ms. Ellen Blasig (Springer Heidelberg) too for the same. Last but not least, we acknowledge the assistance provided by Dr. Deborah A. Hutchins, Ms. Zeinab Schwen, Ms. Wendy Wippel, Ms. Gayle Entrup, Ms. Jan Tremaine, Ms. Peggy Firth, and Dr. T. L. Nusair for this book. Their collective recommendations and input have vastly improved the texts assembled here. Above all, we extend our everlasting gratitude and love to our parents, who inspired us and to our families and children, who supported and encouraged us all the way with their incredible patience. Only their continuous care, unconditional love, and incomparable sacrifice made all this possible, and easy to achieve. Miranda A. Farage Kenneth W. Miller Howard I. Maibach
Cincinnati and San Francisco October 2009
Foreword
The population is aging rapidly. Centenarians are no longer a rarity. The fastest growing segment of the population in the United States is people over 80. In the next 25 years, half of the population in the United States will be aged over 50. These shifts will have a tremendous impact on the delivery of healthcare to the elderly and will require a new awareness of how cutaneous disorders affect the quality of life, comprising a heavy burden on health and wellbeing. Physicians and healthcare workers are woefully ignorant of the distress, discomfort, and anxieties of people afflicted by disorders of the skin. There exists a widespread misconception that skin disorders are simply cosmetic nuisances that can be self-treated by a great assortment of anti-aging creams and lotions available at the local drug store. Most of these include high-sounding ingredients such as antioxidants, vitamins, nutrients, botanicals, and ancient folkloristic remedies, the efficacy and safety of which have never been tested. They offer little more than hope in a bottle. The fact is that common skin diseases may not often be lethal but can ruin enjoyment of life. Chronic itchy rashes can be maddening, lowering one’s self-esteem, embarrassing, interfering with sleep, and often accompanied by depression, social isolation, and deterioration of appearance; they can also be uncomfortable, and, not least, costly to treat. The elderly commonly take 15–20 oral supplements daily to fight the ailments of old age. These are generally useless and may be harmful, often interacting adversely with prescription drugs. The elderly often resort to alternative medicines instead of seeing their doctor to obtain FDA-approved drugs, and also often skip their daily doses to save money. Noncompliance is common. Misdiagnosis and mistreatment of the elderly by health-care workers are common. National surveys show that skin diseases increase steadily throughout our lifespan. Old people may have as many as 5–10 coexistent cutaneous problems that are worthy of medical attention. Moreover, the clinical manifestations of skin diseases in the aged often have different appearances than in the young, confounding diagnosis. Importantly, healing of chronic lesions, especially ulcers, is impaired in the elderly. Immunity is weakened, increasing susceptibility to infections. Response to treatment is slower, leading to noncompliance. Adverse drug reactions are common and too commonly not suspected. Management of chronic conditions is difficult and frustrating. The above litany of problems makes this textbook edited by Farage, Miller, and Maibach a welcome addition to the literature. It is invaluable as a reference resource covering exhaustively an enormous number of clinical conditions. No topic is neglected including cosmetic treatments. The numerous contributions are by highly qualified experts who have a published record of expertise. This comprehensive volume is also practical and relevant to the everyday world of clinical practice. The information will be useful to physicians, manufacturers of drugs and skincare products, educators, investigators, nursing home personnel, estheticians, and federal regulators. This first edition is up-to-date, including much new material that belongs to the shelves of every library, which deals with geriatric problems. Dermatologists especially will be remiss if they do not put this volume within easy reach for consultation as they encounter a swelling clientele of aging patients. Albert M. Kligman M.D., Ph.D. Professor Emeritus University of Pennsylvania Philadelphia, PA USA
Preface
The skin is a portal of knowledge on aging. From its softness and smoothness in infancy, through its suppleness in youth, to its wrinkled texture in elders, the skin displays the most visible and accessible manifestations of aging. Due to falling birth rates and rising life expectancies in industrialized countries, the average age of the population is increasing. Research interest in the process of aging has grown and people are becoming obsessed with looking and “staying” young. Although excellent compendia exist on the subject of aging skin, the body of knowledge is burgeoning. Consequently, this handbook compiles information into one comprehensive reference. It covers a range of topics, from the basics of skin structure and function, to the cellular and molecular mechanisms of aging, to the latest bioengineering instruments used to assess age-related changes in the skin. The Nobel Prize in Physiology and Medicine awarded in 2009 to Drs. E. H. Blackburn, C. W. Greider and J. W. Szostak will stimulate research that will ameliorate the effects of aging on the organ systems of both humans and animals. This textbook will simplify approaches when the skin may be an efficient approach to aging based on Dr. Blackburn’s team research. The skin approachability and the opportunities to work on humans will provide us in the near future with rapid therapeutic and preventive applications. Contributors are internationally recognized experts from multiple disciplines germane to this topic. We gratefully acknowledge all contributors for sharing their time and expertise. We expect this handbook to be valuable to researchers and students with an interest in aging skin. Because research progress in this area is so rapid, we hope to update this compendium periodically as advances in the field dictate. The editors welcome suggestions for the second edition. Miranda A. Farage, Kenneth W. Miller, and Howard I. Maibach October 2009
Table of Contents
Editors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxiii List of Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxv
Part 1
Basic Sciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1
Skin Aging in Animal Models: Histological Perspective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Tapan K. Bhattacharyya
2
Histology of Microvascular Aging of Human Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Peter Helmbold
3
Basophilic (Actinic) Degeneration of the Dermis: An Easy Histological Scoring Approach in Dermal Photoaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Peter Helmbold
Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 4
Degenerative Changes in Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Miranda A. Farage . Kenneth W. Miller . Howard I. Maibach
5
Skin Aging: A Brief Summary of Characteristic Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Christina Raschke . Peter Elsner
6
Physiological Variations During Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 Ge´rald E. Pie´rard . Philippe Paquet . Emmanuelle Xhauflaire-Uhoda . Pascale Quatresooz
7
The Stratum Corneum and Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 Anthony V. Rawlings
8
The Importance of Extracellular Matrix Protein 1 as Basement Membrane Protein in Maintaining Skin Function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 Sandy Sercu . Noritaka Oyama . Joseph Merregaert
9
Pathomechanisms of Endogenously Aged Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93 Evgenia Makrantonaki . Christos C. Zouboulis
10
Pathomechanisms of Photoaged Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101 Jean Krutmann
xiv
Table of Contents
11
Proteoglycans in Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109 Franc¸ois-Xavier Maquart . Ste´phane Bre´zillon . Yanusz Wegrowski
12
Possible Involvement of Basement Membrane Damage by Matrix Metalloproteinases and Serine Proteinases in Skin Aging Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121 Satoshi Amano
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations . . . . . . . . . . . . . . . . . . . . . . . . . . . 129 Hanan Assaf . Mohamed A. Adly . Mahmoud R. Hussein
14
Buffering Capacity Considerations in the Elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139 Jacquelyn Levin . Howard I. Maibach
15
Neurotrophins and Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 Mohamed A. Adly . Hanan Assaf . Mahmoud R. Hussein
16
Considerations for Thermal Injury: The Elderly as a Sensitive Population . . . . . . . . . . . . . . . . . 159 Donald L. Bjerke
17
Skin Reactivity of the Human Face: Functional Map and Age Related Differences . . . . . . . . . . . 173 Slaheddine Marrakchi . Howard I. Maibach
18
Cluster of Differentiation 1d (CD1d) and Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 Mohamed A. Adly . Hanan Assaf . Mahmoud R. Hussein
19
Aging of Epidermal Stem Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 Alexandra Charruyer . Ruby Ghadially
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging . . . . . . . . . . . . . . . . . . . 201 Byung-Soon Park . Won-Serk Kim
21
Peroxisome Proliferator-activated Receptors: Role in Skin Health and Appearance of Photoaged Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213 Stacy S. Hawkins . William Shingleton . Jean Adamus . Helen Meldrum
22
Hyaluronan and the Process of Aging in Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225 Robert Stern
23
Changes in Nail in the Aged . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 239 Nelly Rubeiz . Ossama Abbas . Abdul Ghani Kibbi
Specialized Skin: Genital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245 24
Vaginal Secretions with Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247 Paul R. Summers
25
Unique Skin Immunology of the Lower Female Genital Tract with Age . . . . . . . . . . . . . . . . . . . 253 Paul R. Summers
Table of Contents
26
Aging Genital Skin and Hormone Replacement Therapy Benefits . . . . . . . . . . . . . . . . . . . . . . . . 257 William J. Ledger
Rheology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263 27
Facial Skin Rheology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265 Ge´rald E. Pie´rard . Fre´de´rique Henry . Pascale Quatresooz
Pathology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275 28
Pathology of Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277 Qunshan Jia . J. Frank Nash
Metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293 29
Alterations of Energy Metabolism in Cutaneous Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295 Thomas Blatt . Horst Wenck . Klaus-Peter Wittern
30
Cellular Energy Metabolism and Oxidative Stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313 Regina Hourigan
Molecular Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 321 31
DNA Damage and Repair in Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 323 Daniel B. Yarosh
32
Fibulin-5 Deposition in Human Skin: Decrease with Aging and UVB Exposure and Increase in Solar Elastosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 333 Satoshi Amano
Endocrinology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341 33
Sebum Production . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343 Claudine Pie´rard-Franchimont . Pascale Quatresooz . Ge´rald E. Pie´rard
34
Climacteric Aging and Oral Hormone Replacement Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . 353 Pascale Quatresooz . Claudine Pie´rard-Franchimont . Ge´rald E. Pie´rard
35
Biological Effects of Estrogen on Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 361 Zack Thompson . Howard I. Maibach
Stratum Corneum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 369 36
Corneocyte Size and Cell Renewal: Effects of Aging and Sex Hormones . . . . . . . . . . . . . . . . . . . 371 Enzo Berardesca . Joachim Fluhr
37
Stratum Corneum Cell Layers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 377 Hachiro Tagami
xv
xvi
Table of Contents
38
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 385 Mutsumi Okazaki
39
Cyanoacrylate Skin Surface Strippings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 393 Claudine Pie´rard-Franchimont . Jorge Arrese-Estrada . Pascale Quatresooz . Ge´rald E. Pie´rard
40
Biology of Stratum Corneum: Tape Stripping and Protein Quantification . . . . . . . . . . . . . . . . . . 401 Ali Alikhan . Howard I. Maibach
Endogenous and Exogenous Factors in Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . 409 41
Effect of Ozone on Cutaneous Tissues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411 Giuseppe Valacchi
42
Infrared A-induced Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421 Peter Schroeder . Jean Krutmann
43
Global Warming and its Dermatologic Impact on Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . 427 Young Hui . Haw-Yueh Thong . Howard I. Maibach
44
Skin Photodamage Prevention: State of the Art and New Prospects . . . . . . . . . . . . . . . . . . . . . 429 Denize Ainbinder . Elka Touitou
45
Environmental and Genetic Factors in Facial Aging in Twins . . . . . . . . . . . . . . . . . . . . . . . . . . . 441 David J. Rowe . Bahman Guyuron
46
Tobacco Smoke and Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 447 Akimichi Morita
Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 451 47
DNA Biomarkers in Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 453 Kimberly G. Norman . Alex Eshaghian . James E. Sligh
In vitro Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 459 48
The Use of Reconstructed Skin to Create New In Vitro Models of Skin Aging with Special Emphasis on the Flexibility of Reconstructed Skin . . . . . . . . . . . . . . . . . . . . . . . . . 461 Daniel Asselineau . Sylvie Ricois . Herve´ Pageon . He´le`ne Zucchi . Sole`ne Mine . Sarah Girardeau . Flore Nallet . Se´verine Teluob . Gae¨lle Claviez-Homberg
49
In vitro Method to Visualize UV-induced Reactive Oxygen Species in a Skin Equivalent Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 477 Akira Date . Tomohiro Hakozaki
50
Aging of Skin Cells in Culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 487 Suresh I. S. Rattan
Table of Contents
Pigmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 493 51
Hyperpigmentation in Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 495 Tomohiro Hakozaki . Cheri L. Swanson . Donald L. Bissett
52
Pigmentation in Ethnic Groups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503 Rupa Pugashetti . Howard I. Maibach
53
The New Face of Pigmentation and Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509 John Nip . S. Brian Potterf . Sheila Rocha . Shilpa Vora . Carol Bosko
Part 2
Disease State/Conditions with Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 523
Diseases Associated with Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 525 54
Non-neoplastic Disorders of the Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 527 Miranda A. Farage . Kenneth W. Miller . Enzo Berardesca . Howard I. Maibach
Malignant Skin Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 543 55
Neoplastic Skin Lesions in the Elderly Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 545 Miranda A. Farage . Kenneth W. Miller . Enzo Berardesca . Howard I. Maibach . Isaac M. Neuhaus
56
Carcinogenesis: UV Radiation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 567 Douglas E. Brash . Timothy P. Heffernan . Paul Nghiem
57
Melanoma and Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 579 Salina M. Torres . Marianne Berwick
58
Aging-associated Non-melanoma Skin Cancer: A Role for the Dermis . . . . . . . . . . . . . . . . . . . . 587 Davina A. Lewis . Jeffrey B. Travers . Dan F. Spandau
59
Non-surgical Modalities of Treatment for Primary Cutaneous Cancers . . . . . . . . . . . . . . . . . . . . 601 Ossama Abbas . Salah Salman
60
Sunlight Exposure and Skin Thickness Measurements as a Function of Age: Risk Factors for Melanoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 609 Panthea Heydari . Andia Heydari . Howard I. Maibach
Non-Malignant Skin Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 617 61
Influence of Race, Gender, Age, and Diabetes on the Skin Circulation . . . . . . . . . . . . . . . . . . . . 619 Jerrold Scott Petrofsky . Gurinder Singh Bains
62
Atopic Dermatitis in the Aged . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 639 Alexandra Katsarou . Melina C. Armenaka
xvii
xviii
Table of Contents
63
Dry Skin in Diabetes Mellitus and in Experimental Models of Diabetes . . . . . . . . . . . . . . . . . . . 653 Shingo Sakai . Hachiro Tagami
64
Cutaneous Effects and Sensitive Skin with Incontinence in the Aged . . . . . . . . . . . . . . . . . . . . . 663 Miranda A. Farage . Kenneth W. Miller . Enzo Berardesca . Howard I. Maibach
Part 3
Techniques and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 673
Bioengineering Methods and Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 675 65
Bioengineering Methods and Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 677 Francesca Giusti . Stefania Seidenari
66
Hydration of the Skin Surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 687 Hachiro Tagami
67
Transepidermal Water Loss and Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 695 Ali Alikhan . Klaus-Peter Wilhelm . Fatima S. Alikhan . Howard I. Maibach
68
Corneocyte Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 705 Tetsuji Hirao
69
The Structural and Functional Development of Skin During the First Year of Life: Investigations Using Non-invasive Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715 Georgios Stamatas
70
Structure of Stratum Corneum Lipid Studied by Electron Paramagnetic Resonance . . . . . . . . . . 725 Kouichi Nakagawa
71
Molecular Concentration Profiling in Skin Using Confocal Raman Spectroscopy . . . . . . . . . . . . 735 Jonathan M. Crowther . Paul J. Matts
72
The Measurement and Perception of Uneven Coloration in Aging Skin . . . . . . . . . . . . . . . . . . . 749 Paul J. Matts
Quality of Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 755 73
Assessing Quality of Life in Older Adult Patients with Skin Disorders . . . . . . . . . . . . . . . . . . . . 757 Miranda A. Farage . Kenneth W. Miller . Susan N. Sherman . Joel Tsevat
Percutaneous Penetration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 769 74
Percutaneous Penetration of Chemicals and Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 771 Michael F. Hughes
75
Animal Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 781 Sara Flores . Farzam Gorouhi . Howard I. Maibach
Table of Contents
Modeling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 787 76
Skin Aging: A Generalization of the Micro-inflammatory Hypothesis . . . . . . . . . . . . . . . . . . . . . 789 Paolo U. Giacomoni . Glen Rein
Probiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 797 77
The Potential of Probiotics and Prebiotics for Skin Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 799 Arthur C. Ouwehand . Kirsti Tiihonen . Sampo Lahtinen
78
Probiotics in Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 811 Benedetta Cinque . Paola Palumbo . Cristina La Torre . Esterina Melchiorre . Daniele Corridoni . Gianfranca Miconi . Luisa Di Marzio . Maria Grazia Cifone . Maurizio Giuliani
Part 4
Toxicological/Safety and General Considerations . . . . . . . . . . . . . . . . . . . . 821
Safety Evaluation for the Elderly Population . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 823 79
Irritant Contact Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 825 Florian Seyfarth . Peter Elsner
80
Susceptibility to Irritation in the Elderly: New Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 833 Miranda A. Farage . Kenneth W. Miller . G. Frank Gerberick . Cindy A. Ryan . Howard I. Maibach
81
Safety Evaluation in the Elderly via Dermatological Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . 845 Mario Bramante
82
Dermal Safety Evaluation: Use of Disposable Diaper Products in the Elderly . . . . . . . . . . . . . . . 857 Prashant Rai . Daniel S. Marsman . Susan P. Felter
Microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 869 83
Aging Skin Microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 871 Duane L. Charbonneau . Yen L. Song . Cheng Xu Liu
84
The Vaginal Microbiota in Menopause . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 883 Miranda A. Farage . Kenneth W. Miller . Jack D. Sobel
Wound Healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 895 85
Impaired Wound Repair and Delayed Angiogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 897 Matthew J. Ranzer . Luisa A. DiPietro
Wrinkles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 909 86
Facial Wrinkling: The Marquee Clinical Sign of Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 911 Greg G. Hillebrand
xix
xx
Table of Contents
Scales and Typing System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 919 87
Assessing Quality of Ordinal Scales Depicting Skin Aging Severity . . . . . . . . . . . . . . . . . . . . . . 921 Fabien Valet . Khaled Ezzedine . Denis Malvy . Jean-Yves Mary . Christiane Guinot
88
The Baumann Skin Typing System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 929 Leslie S. Baumann
Part 5
Global Skin Aging and its Management: Perception, Needs, Differences and Responses to Skin Aging . . . . . . . . . . . . . . . . . . . . . . . . . . 945
Psychosocial Implications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 947 89
Psychological and Social Implications of Aging Skin: Normal Aging and the Effects of Cutaneous Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 949 Miranda A. Farage . Kenneth W. Miller . Enzo Berardesca . Howard I. Maibach
90
Aging Skin: Some Psychosomatic Aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 959 Madhulika A. Gupta
Aging Perception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 971 91
Facial Skin Attributes and Age Perception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 973 Alex Nkengne . Georgios Stamatas . Christiane Bertin
Gender, Ethnicity and Lifestyle Differences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 981 92
Determinants in the Rate of Skin Aging: Ethnicity, Gender, and Lifestyle Influences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 983 Miranda A. Farage . Kenneth W. Miller . Howard I. Maibach
93
Gender Differences in Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 999 Sarah Fitzmaurice . Howard I. Maibach
94
Aging in Asian Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1019 Low Chai Ling
Sensitive Skin and Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1025 95
Perceptions of Sensitive Skin with Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1027 Miranda A. Farage
96
Aging and Skin Sensitivity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1047 Michael K. Robinson
Ingredients and Products for Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1053 97
Aging and Anti-aging Strategies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1055 Giuseppina Candore . Giovanni Scapagnini . Calogero Caruso
Table of Contents
98
Cosmetics and Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1063 Robert L. Bronaugh . Linda M. Katz
99
Cosmetic Anti-aging Ingredients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1069 Donald L. Bissett . Mary B. Johnson
100
Topical Growth Factors for Skin Rejuvenation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1079 Vijayeta Rangarajan . Frank Dreher
101
Topical Peptides and Proteins for Aging Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1089 Farzam Gorouhi . Howard I. Maibach
Fem Care Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1119 102
Solutions and Products for Managing Female Urinary Incontinence . . . . . . . . . . . . . . . . . . . . . 1121 David J. Caracci
103
Changes in Vulvar Physiology and Skin Disorders with Age and Benefits of Feminine Wipes in Postmenopausal Women . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1127 Miranda A. Farage . Kenneth W. Miller . William J. Ledger
Cosmetic Surgeries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1137 104
A New Paradigm for the Aging Face . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1139 Samuel M. Lam
105
Cosmetic Surgery in the Elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1147 Dwight Scarborough . Kimberly M. Eickhorst . Emil Bisaccia
106
Facial Rejuvenation: A Chronology of Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1175 Alexander S. Donath
Part 6 107
Global Market Place for the Aged . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1185
Marketing and Product Design of Anti-aging Skin Care Products . . . . . . . . . . . . . . . . . . . . . . . 1187 Nancy C. Dawes
108
Key Trends Driving Anti-aging Skin Care in 2009 and Beyond . . . . . . . . . . . . . . . . . . . . . . . . . 1197 Mary Carmen Gasco-Buisson
Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1207
xxi
Editors
Miranda A. Farage, Ph.D. Principal Scientist The Procter & Gamble Company 6110 Center Hill Avenue Cincinnati, OH 45224 USA
[email protected] Kenneth W. Miller, Ph.D. Associate Director The Procter & Gamble Company 6110 Center Hill Avenue Cincinnati, OH 45224 USA
[email protected]
Howard I. Maibach, M.D. Professor Department of Dermatology University of California, School of Medicine San Francisco, CA 94122 USA
[email protected]
Contributors
Ossama Abbas Department of Dermatology American University of Beirut Medical Center Beirut Lebanon Jean Adamus Unilever R&D Trumbull, CT USA Mohamed A. Adly Department of Zoology Faculty of Science Sohag University Sohag Egypt Denize Ainbinder School of Pharmacy Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel Ali Alikhan Department of Dermatology School of Medicine University of California, Davis Sacramento, CA USA Fatima S. Alikhan University of California, Berkeley Berkeley, CA USA Satoshi Amano Shiseido Research Center Tsuzuki-ku, Yokohama Japan
Melina C. Armenaka Department of Dermatology University of Athens Kesariani, Athens Greece Jorge Arrese-Estrada Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium Hanan Assaf Department of Dermatology and Venereology Faculty of Science Sohag University Sohag Egypt Daniel Asselineau L’Ore´al Life Sciences Research Clichy France Gurinder Singh Bains Department of Physical Therapy School of Allied Health Professions Loma Linda University Loma Linda, CA USA Leslie S. Baumann Department of Dermatology and Baumann Cosmetic Medicine and Research Institute University of Miami Miami, FL USA Thomas Blatt Skin Research Centre Beiersdorf AG Hamburg Germany
xxvi
Contributors
Enzo Berardesca San Gallicano Dermatological Institute IRRCS Roma Rome Italy Christiane Bertin Johnson & Johnson Consumer France Issy-les-Moulineaux France Marianne Berwick Division of Epidemiology and Biostatistics Department of Internal Medicine University of New Mexico Albuquerque, NM USA Tapan K. Bhattacharyya Department of Otolaryngology-Head & Neck Surgery University of Illinois, Chicago Chicago, IL USA Emil Bisaccia College of Physicians and Surgeons Columbia University New York, NY USA Donald L. Bissett The Procter & Gamble Company Cincinnati, OH USA Donald L. Bjerke The Procter & Gamble Company Cincinnati, OH USA Carol Bosko Unilever R&D Trumbull, CT USA Mario Bramante Procter & Gamble Service GmbH Schwalbach am Taunus, Hesse Germany
Douglas E. Brash Departments of Therapeutic Radiology, Genetics and Dermatology School of Medicine Yale University New Haven, CT USA Robert L. Bronaugh CFSAN Food and Drug Administration College Park, MD USA Ste´phane Bre´zillon Laboratory of Biochemistry and Molecular Biology Faculty of Medicine University of Reims Champagne-Ardenne Reims France Giuseppina Candore Department of Pathobiology and Biomedical Methodologies University of Palermo Palermo Italy David J. Caracci The Procter & Gamble Company Cincinnati, OH USA Calogero Caruso Department of Pathobiology and Biomedical Methodologies University of Palermo Palermo Italy Duane L. Charbonneau The Procter and Gamble Company Cincinnati, OH USA Alexandra Charruyer Department of Dermatology and Institute for Regeneration Medicine University of California, San Francisco San Francisco, CA USA
Contributors
Maria Grazia Cifone Department of General Pathology Faculty of Medicine and Surgery University of L’Aquila Coppito Italy Benedetta Cinque Department of Health Sciences University of L’Aquila Coppito Italy Gae¨lle Claviez-Homberg L’Ore´al Life Sciences Research Clichy France Daniele Corridoni Department of Health Sciences University of L’Aquila Coppito Italy Jonathan M. Crowther Procter & Gamble Technical Centres Ltd Egham, Surrey UK Akira Date Procter & Gamble Japan K.K Kobe, Hyogo Japan Nancy C. Dawes The Procter and Gamble Company Cincinnati, OH USA Luisa A. DiPietro Center for Wound Healing and Tissue Regeneration College of Dentistry University of Illinois, Chicago Chicago, IL USA Alexander S. Donath Cincinnati Facial Plastic Surgery Cincinnati, OH USA
Frank Dreher NEOCUTIS Inc. San Francisco, CA USA Kimberly M. Eickhorst Procedural Dermatology Fellow Morristown, NJ USA Peter Elsner Department of Dermatology and Allergology University of Jena Jena Germany Alex Eshaghian Department of Internal Medicine University of New Mexico Albuquerque, NM USA Khaled Ezzedine Department of Dermatology CHU Saint-Andre´ Bordeaux France Miranda A. Farage The Procter & Gamble Company Cincinnati, OH USA Susan P. Felter The Procter & Gamble Company Cincinnati, OH USA Sarah Fitzmaurice School of Medicine University of California, Davis Sacramento, CA USA Sara Flores Department of Dermatology School of Medicine University of California, San Francisco San Francisco, CA USA
xxvii
xxviii
Contributors
Joachim Fluhr Bioskin, GmBH Hamburg Germany G. Frank Gerberick The Procter & Gamble Company Cincinnati, OH USA Mary Carmen Gasco-Buisson The Procter and Gamble Company Cincinnati, OH USA Paolo U. Giacomoni Clinique Laboratories Melville, NY USA Ruby Ghadially Department of Dermatology University of California, San Francisco and Veteran’s Affairs Medical Center San Francisco, CA USA Sarah Girardeau L’Ore´al Life Sciences Research Clichy France Maurizio Giuliani Department of Health Sciences University of L’Aquila Coppito Italy Francesca Giusti Department of Dermatology University of Modena and Reggio Emilia Modena Italy Farzam Gorouhi Department of Dermatology University of California, San Francisco San Francisco, CA USA
Christiane Guinot Biometrics and Epidemiology Unit CE.R.I.E.S. Neuilly-sur-Seine France Madhulika A. Gupta Department of Psychiatry Schulich School of Medicine and Dentistry University of Western Ontario London, ON Canada Bahman Guyuron Department of Plastic Surgery University Hospitals of Cleveland and Case Western Reserve University Cleveland, OH USA Tomohiro Hakozaki The Procter & Gamble Company Cincinnati, OH USA Stacy S. Hawkins Unilever R&D Trumbull, CT USA Timothy P. Heffernan Departments of Therapeutic Radiology, Genetics and Dermatology School of Medicine Yale University New Haven, CT USA Peter Helmbold Department of Dermatology University of Heidelberg Heidelberg Germany Fre´de´rique Henry Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium
Contributors
Andia Heydari University of California, Los Angeles Los Angeles, CA USA Panthea Heydari University of California, Los Angeles Los Angeles, CA USA Greg G. Hillebrand The Procter & Gamble Company Cincinnati, OH USA Tetsuji Hirao Shiseido Research Center Tsuzuki-ku, Yokohama Japan Regina Hourigan Colgate-Palmolive Company Piscataway, NJ USA Michael F. Hughes Office of Research and Development US Environmental Protection Agency National Health and Environmental Effects Research Laboratory Research Triangle Park, NC USA Young Hui University of California, San Francisco San Francisco, CA USA
Mary B. Johnson The Procter & Gamble Company Cincinnati, OH USA Alexandra Katsarou Department of Dermatology University of Athens Kesariani, Athens Greece Linda M. Katz Office of Cosmetics and Colors CFSAN Food and Drug Administration College Park, MD USA Abdul Ghani Kibbi Department of Dermatology American University of Beirut Medical Center Beirut Lebanon Won-Serk Kim Department of Dermatology Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea Jean Krutmann Environmental Health Research Institute (IUF) Heinrich-Heine-University Duesseldorf Germany
Mahmoud R. Hussein Department of Pathology Faculty of Medicine Assuit University Abha Saudi Arabia
Cristina La Torre Department of Health Sciences University of L’Aquila Coppito Italy
Qunshan Jia The Procter & Gamble Company Cincinnati, OH USA
Sampo Lahtinen Danisco Health and Nutrition Kantvik Finland
xxix
xxx
Contributors
Samuel M. Lam Willow Bend Wellness Center and Lam Facial Plastic Surgery Center & Hair Restoration Institute Plano, TX USA
Denis Malvy Department of Internal Medicine and Infectious Diseases CHU St.Andre´ Bordeaux France
William J. Ledger Department of Obstetrics and Gynecology Cornell University-Weill Medical College New York, NY USA
Franc¸ois-Xavier Maquart Laboratoire Central de Biochimie Hoˆpital Robert Debre´ Reims France
Jacquelyn Levin Arizona College of Osteopathic Medicine Midwestern University Glendale, AZ USA
Slaheddine Marrakchi Department of Dermatology Hedi Chaker Hospital Sfax Tunisia
Davina A. Lewis Department of Dermatology School of Medicine Indiana University Indianapolis, IN USA
Daniel S. Marsman The Procter & Gamble Company Cincinnati, OH USA
Low Chai Ling The Sloane Clinic Singapore Singapore Cheng Xu Liu The Procter and Gamble Company Cincinnati, OH USA Howard I. Maibach Department of Dermatology School of Medicine University of California, San Francisco San Francisco, CA USA Evgenia Makrantonaki Departments of Dermatology, Venereology Allergology and Immunology Dessau Medical Center Dessau Germany
Jean-Yves Mary INSERM Department of Biostatistics and Clinical Epidemiology Saint-Louis Hospital Paris France Luisa Di Marzio Department of Health Sciences University of L’Aquila Coppito Italy Paul J. Matts Procter & Gamble Technical Centres Ltd Egham, Surrey UK Esterina Melchiorre Department of Health Sciences University of L’Aquila Coppito Italy
Contributors
Helen Meldrum Unilever R&D Trumbull, CT USA Joseph Merregaert Laboratory of Molecular Biotechnology Department of Biomedical Sciences University of Antwerp Antwerp Belgium Gianfranca Miconi Department of Health Sciences University of L’Aquila Coppito Italy Kenneth W. Miller The Procter & Gamble Company Cincinnati, OH USA Sole`ne Mine L’Ore´al Life Sciences Research Clichy France Akimichi Morita Department of Geriatric and Environmental Dermatology Nagoya City University Nagoya Japan Kouichi Nakagawa RI Research center Fukushima Medical University Fukushima Japan Flore Nallet L’Ore´al Life Sciences Research Clichy France J. Frank Nash The Procter & Gamble Company Cincinnati, OH USA
Isaac M. Neuhaus Department of Dermatology University of California, San Francisco San Francisco, CA USA Paul Nghiem Departments of Therapeutic Radiology, Genetics and Dermatology School of Medicine Yale University New Haven, CT USA
John Nip Unilever R&D Trumbull, CT USA Alex Nkengne Johnson & Johnson Consumer France Issy-les-Moulineaux France Kimberly G. Norman Vanderbilt University Medical Center Nashville, TN USA Mutsumi Okazaki Department of Plastic and Reconstructive Surgery Tokyo Medical and Dental University Bunkyo-ku, Tokyo Japan
Arthur C. Ouwehand Danisco Health and Nutrition Kantvik Finland
Noritaka Oyama Department of Dermatology School of Medicine Fukushima Medical University Fukushima Japan
xxxi
xxxii
Contributors
Herve´ Pageon L’Ore´al Life Sciences Research Clichy France Paola Palumbo Department of Health Sciences University of L’Aquila Coppito Italy Philippe Paquet Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium Byung-Soon Park Department of Dermatology College of Medicine Seoul National University Seoul Korea Jerrold Scott Petrofsky School of Allied Health Loma Linda University Loma Linda, CA USA Ge´rald E. Pie´rard Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium Claudine Pie´rard-Franchimont Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium S. Brian Potterf Unilever R&D Trumbull, CT USA
Rupa Pugashetti UCSF Psoriasis Treatment Center School of Medicine University of California, Irvine Irvine, CA USA Pascale Quatresooz Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium Prashant Rai Procter and Gamble Japan KK Higashinada-ku Japan Vijayeta Rangarajan NEOCUTIS Inc. San Francisco, CA USA Matthew J. Ranzer Center for Wound Healing and Tissue Regeneration College of Dentistry University of Illinois, Chicago Chicago, IL USA Christina Raschke Department of Dermatology and Allergology University of Jena Jena Germany Suresh I. S. Rattan Laboratory of Cellular Ageing Department of Molecular Biology Aarhus University Aarhus Denmark Anthony V. Rawlings AVR Consulting Ltd Northwich, Cheshire England UK
Contributors
Glen Rein Estee Lauder Companies Melville, NY USA Sylvie Ricois L’Ore´al Life Sciences Research Clichy France Michael K. Robinson The Procter & Gamble Company Cincinnati, OH USA Sheila Rocha Unilever R&D Trumbull, CT USA David J. Rowe University Hospitals Case Western Reserve University Cleveland, OH USA Nelly Rubeiz Department of Dermatology American University of Beirut Medical Center Beirut Lebanon Cindy A. Ryan The Procter & Gamble Company Cincinnati, OH USA Shingo Sakai Basic Research Laboratory Kanebo Cosmetics Inc. Kanagawa Japan Salah Salman Department of Dermatology American University of Beirut Medical Center Beirut Lebanon
Giovanni Scapagnini Department of Health Sciences University of Molise Campobasso Italy Dwight Scarborough Division of Dermatology Ohio State University Hospital Columbus, OH USA Peter Schroeder Environmental Health Research Institute (IUF) Heinrich-Heine-University Duesseldorf Germany Stefania Seidenari Department of Dermatology University of Modena and Reggio Emilia Modena Italy Sandy Sercu Laboratory of Molecular Biotechnology Department of Biomedical Sciences University of Antwerp Antwerp Belgium Florian Seyfarth Department of Dermatology and Allergology University of Jena Jena Germany Susan N. Sherman SNS Research Cincinnati, OH USA William Shingleton Unilever R&D Colworth UK James E. Sligh Skin Diseases Research Center Vanderbilt University Medical Center Nashville, TN USA
xxxiii
xxxiv
Contributors
Jack D. Sobel Division of Infectious Diseases Department of Internal Medicine Wayne State University Detroit, MI USA Yen L. Song The Procter and Gamble Company Cincinnati, OH USA Dan F. Spandau Department of Dermatology School of Medicine Indiana University Indianapolis, IN USA Georgios Stamatas Johnson & Johnson Consumer France Issy-les-Moulineaux France Robert Stern Department of Pathology Touro College of Osteopathic Medicine New York, NY USA Paul R. Summers University Health Care University of Utah Salt Lake City, UT USA Cheri L. Swanson The Procter & Gamble Company Cincinnati, OH USA Hachiro Tagami Department of Dermatology Tohoku University School of Medicine Sendai Japan Se´verine Teluob L’Ore´al Life Sciences Research Clichy ce´dex France
Zack Thompson University of California, San Francisco San Francisco, CA USA Haw-Yueh Thong Department of Dermatology University of California, San Francisco San Francisco, CA USA Kirsti Tiihonen Danisco Health and Nutrition Kantvik Finland Salina M. Torres Division of Epidemiology and Biostatistics Department of Internal Medicine University of New Mexico Albuquerque, NM USA Elka Touitou School of Pharmacy Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel Jeffrey B. Travers Department of Dermatology School of Medicine Indiana University Indianapolis, IN USA Joel Tsevat Department of Internal Medicine College of Medicine University of Cincinnati Cincinnati, OH USA Giuseppe Valacchi Department of Biomedical Sciences University of Siena Siena Italy
Contributors
Fabien Valet INSERM, Biostatistics and Clinical Epidemiology DBIM, Saint-Louis Hospital University Paris 7 France
Klaus-Peter Wittern Skin Research Centre Beiersdorf AG Hamburg Germany
Shilpa Vora Unilever R&D Bangalore India
Emmanuelle Xhauflaire-Uhoda Laboratory of Skin Bioengineering and Imaging Department of Dermatopathology University Hospital of Lie`ge Lie`ge Belgium
Yanusz Wegrowski Laboratory of Biochemistry and Molecular Biology Faculty of Medicie University of Reims Champagne-Ardenne Reims France Horst Wenck Skin Research Centre Beiersdorf AG Hamburg Germany Klaus-Peter Wilhelm proDERM Institut fuer Angewandte Dermatologische Forschung GmbH Hamburg Germany
Daniel B. Yarosh Estee Lauder Companies Melville, NY USA Christos C. Zouboulis Institute of Clinical Pharmacology & Department of Toxicology Charite´ Universitaetsmedizin Berlin Campus Benjamin Franklin Berlin Germany He´le`ne Zucchi L’Ore´al Life Sciences Research Clichy France
xxxv
20 Adipose-derived Stem Cells and their Secretory Factors for Skin Aging Byung-Soon Park . Won-Serk Kim
Introduction The term ‘‘stem cell’’ has attracted increasing attention of the scientific community as well as of the general public. In many aspects, however, it is still confusing and difficult to understand and interpret information about stem cells. They are vital to humans for numerous reasons. Groups of stem cells in some adult tissues give rise to replacement cells for the tissues that are destroyed through injury, disease, or aging [1]. Knowledge relating to how healthy cells replace diseased or otherwise damaged cells, would allow development of medical therapies focusing on creation of compatible cell lines to replace aged or diseased cells in the body. The concept of regenerative medicine using the body’s own stem cells and growth factors to repair tissue may be realizable as science and clinical experience converge to develop alternative therapeutic strategies to treat the damaged or diseased tissue. Stem cell-based therapies are also being tried in tissue engineering: The aim of tissue engineering is to repair and regenerate damaged organs or tissues using a combination of cells, biomaterials, and cytokines [1–4]. This chapter addresses the human subcutaneous adipose tissue as a promising source of adult stem cells. Adipose-derived stem cells (ADSCs) may offer a solution for the problem of limited availability of human cells that are capable of self-renewal and differentiation. ADSCs can be easily obtained from liposuction of human adipose tissue, cultured in a large scale, and display multi-lineage developmental plasticity. In addition, ADSCs secrete various cytokines and growth factors, which control and manage the damaged neighboring cells, and this has been identified as essential functions of ADSCs [5–7]. As reviewed elsewhere in this book, aging and photoaging are complex processes involving the wound-healing cascade and/or repetitive oxidative stress. Conventional anti-aging skin treatments such as light-based or radiofrequency devices and/or peelings have been less than satisfactory because their primary mechanism is mainly inducing new collagen synthesis via activation of dermal fibroblasts. On the basis of previous studies that
demonstrated wound healing, antioxidant, antiwrinkle, and antimelanogenic effects of ADSCs and their secretory factors, they may be good candidates for the treatment of aging [5–9]. Therefore, this chapter describes the authors’ recent research and clinical developments on the anti-aging effects of ADSCs and their secretory factors.
Stem Cells and ADSCs Stem cells are a population of immature tissue precursor cells capable of self-renewal and provision of multi-lineage differentiable cells for tissues. Although embryonic stem cell has multi-potency, there are many limitations such as difficulties in control of differentiation and issues relating to ethics. As a result, use of adult stem cells with fewer implicating issues is becoming an area of increased interest in stem cell medicine. Given the vast potential of treatments utilizing stem cells, validation and evaluation regarding safety and efficacy will result in greater benefits.
ADSCs and Regeneration Due to the lack of a specific and universal molecular marker for adult stem cells, functional assays for multiple differentiations must be used to identify stem cells in a tissue. Mesenchymal stem cells (MSCs) were first characterized in bone marrow, but many studies have reported the existence of MSCs in the connective tissue of several organs [10, 11]. The role of these cells is not entirely clear, but they are generally believed to constitute a reserve for tissue maintenance and repair. It was recently demonstrated that the most abundant and accessible source of adult stem cells is adipose tissue. The yield of MSCs from adipose tissue is approximately 40-fold greater than that from bone marrow [12–14]. The following are the highly consistent, although not identical, expression profiles of cell-surface proteins on ADSCs [2, 15]: adhesion molecules, receptor molecules, surface enzymes, extracellular matrix (ECM) proteins,
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_20, # Springer-Verlag Berlin Heidelberg 2010
202
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
and glycoproteins. However, hematopoietic cell markers such as CD14, CD31, and CD45 are not expressed. Interestingly, the immunophenotype of ADSCs resembles that reported for other adult stem cells prepared from human bone marrow (bone marrow stromal cell [BMSC]) and skeletal muscle [2]. Differentiation of ADSCs is not restricted to the adipocyte lineage, but they can be differentiated into chondrocyte, osteocyte, cardiomyocyte, neuron, etc. [16, 17]. In addition, activity comparison with BMSC revealed a similar regenerative capacity. Therefore, this abundant and accessible cell population has potential clinical utility for regenerating damaged or aged tissue and tissue engineering. As with many rapidly developing fields, diverse names have been proposed to describe the plastic-adherent cell population isolated from collagenase digests of adipose tissue: adipose-derived stem/stromal cells, adiposederived adult stem cells, adipose-derived adult stromal cells, adipose stromal cells (ASCs), adipose mesenchymal stem cells (AdMSCs), lipoblast, pericyte, preadipocyte, and processed lipoaspirate (PLA) cells. To address the confusion due to diverse nomenclature, the International Fat Applied Technology Society reached a consensus to adopt the term ‘‘adipose-derived stem cells’’ to identify the isolated, plastic-adherent, multipotent cell population. Questioning the validity of the term ‘‘stem cell’’, led to the use of the acronym to mean ‘‘adipose-derived stromal cells’’ [18]. Although studies are limited, the quality and quantity of the ADSCs varies according to interperson differences, the harvest site, harvesting method, and culture conditions. Age and sex are the most obvious of the interperson differences. Stem cell recovery varies between subcutaneous white adipose tissue depots [19, 20]. Yield and growth characteristics of ADSC (> Fig. 20.1) are also affected by the type of surgical procedure used for adipose tissue harvesting. Resection and tumescent liposuction seem to be preferable above ultrasound-assisted liposuction [21].
Mechanism of Action for Regeneration Stem cell therapy is a safe, practical, and effective source for repair of damaged tissue [22, 23]. Despite rapid translation to the bedside, the mechanism of action for regeneration is not well characterized. It was initially hypothesized that immature stem cells migrate to the injured area, differentiate into the phenotype of injured
. Figure 20.1 ADSCs display adherent and fibroblastic morphology. They show abundant endoplasmic reticulum and large nucleus relative to the cytoplasmic volume (Reprinted with permission from Elsevier, Kim WS et al. [6])
tissue, repopulate the diseased organ with healthy cells, and subsequently repair the tissue (building-block function). However, this theory has some drawbacks because the levels of engraftment and survival of engrafted cells are too low to be therapeutically relevant [24]. In addition, acute stem cell-mediated improvement within days or even hours makes it difficult to fully explain the mechanisms by which regeneration occurs [25, 26]. Instead, much of the functional improvement and attenuation of injury afforded by stem cells can be repeated by treatment with cell-free conditioned media derived from ADSCs (ADSCCM) [27]. Thus, it can be deduced that ADSCs may exert their beneficial effects via complex paracrine actions (manager function) in addition to building-block function.
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
Proteomic Analysis of ADSCs and Their Secretomes Proteomics, large-scale studies of proteins, can be used to analyze the intracellular and secretory proteins of ADSCs. For example, Roche et al., conducted a 2-DE gel analysis of BMSCs and ADSCs, and confirmed the similarity [28]. Zvonic et al., also analyzed the ADSC-CM by 2-DE gel electrophoresis, detected approximately 300 features from ADSC-CM, and found that secretomes are up-/downregulated by induction of adipogenesis [29]. Although the intracellular and secretory proteins of ADSCs have been analyzed through 2-DE-coupled mass spectrometry or non-gel-based mass spectrometry, the active proteins of ADSCs responsible for the tissue regeneration are not fully identified. This may be due to the fact that studies using proteomics has limitations as this approach is capable of analyzing highly abundant proteins only. Therefore, new mass spectrometry-based proteomic analysis techniques for stem cell proteins in correlation with other state-of-the-art analytical tools and functional study by neutralizing the candidate proteins are needed to clearly characterize the active proteins of regeneration.
Diverse Pharmacologic Actions of ADSCs and Their Secretory Factors Wound-Healing Effect of ADSCs Several studies of the pathophysiology of photoaging have detected similarities with certain aspects of acute and/or chronic wounds. Histologically, photoaged skin shows marked alterations in ECM composition. Skin wound repair by adult stem cells was originally demonstrated using BMSC. Wu et al. showed that BMSC injection around the wound significantly enhanced wound healing in normal and diabetic mice compared with that of allogeneic neonatal dermal fibroblasts [30]. Sasaki et al. demonstrated that BMSCs can differentiate into multiple skin cell types including keratinocytes, pericytes, and endothelial cells, which contribute to wound repair [31]. Notably, analyses of proteins in conditioned medium of BMSC (BMSC-CM) indicated that BMSCs secret distinctively different cytokines and chemokines compared to dermal fibroblasts [32]. ADSCs have surface markers and gene profiling similar to BMSCs and their soluble factors are not significantly different [6, 10]. Given their convenient isolation compared with BMSCs and extensive proliferative capacities ex vivo, ADSCs hold great promise
20
for use in wound repair and regeneration. However, there is little evidence demonstrating the wound-healing effects of ADSCs. It was also demonstrated that ADSCs accelerate wound healing, especially with regard to fibroblast activation [6]. They promote proliferation of dermal fibroblasts, not only by direct cell-to-cell contact, but also by paracrine activation through secretory factors. This fibroblast-stimulating effect of ADSCs was superior to that of the fibroblasts. Furthermore, ADSC-CM enhanced secretion of type I collagen from dermal fibroblasts and stimulated fibroblast migration in in vitro wound-healing models. ADSCs secreted a variety of growth factors such as basic fibroblast growth factor (bFGF), KGF, TGF-b, hepatocyte growth factor (HGF), and VEGF into the conditioned medium, which might mediate the woundhealing effect of ADSCs. In addition to the in vitro evidence, the wound-healing effect of ADSCs was also verified in an animal study, which showed that topical administration of ADSCs significantly reduced the wound size (34% reduction) and accelerated the re-epithelialization at the wound edge (> Fig. 20.2). Similar to ADSC treatment, ADSC-CM treatment also accelerated wound healing in laser-induced burn mouse models (authors’ unpublished data). In this experiment, burn wounds were made by laser surgery in the epidermis and they were significantly reduced by single and multiple administration of ADSC-CM. As ADSCs are physiologically located beneath dermal fibroblasts, they may interact with dermal fibroblasts. However, ADSCs and secretomes of ADSCs may reach the epidermis in wounded area and may affect the recovery of this layer. As such, ADSC-CM was treated in cultured primary human keratinocytes and shown to increase the proliferation and migration of keratinocytes (authors’ unpublished data). This result suggests that secretomes of ADSC also accelerate the healing of epidermal layer.
Antioxidant and Antimelanogenic Effects of ADSC Reactive oxygen species (ROS) produced in the catalytic reactions by many environmental stimuli may be involved in the pathogenesis of a number of skin disorders including photoaging, photosensitivity diseases, and some types of cutaneous malignancy. Antioxidants, as a popular term in drug and cosmetics, take the form of enzymes, hormones, vitamins, and minerals. In biological systems, the normal processes of oxidation produce highly reactive free radicals, which may continue to damage even the
203
204
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
. Figure 20.2 Wound healing effect of ADSCs in nude mice. Artificial wounds were made using a 6-mm punch biopsy and ADSCs were topically applied. The wound size was reduced significantly in the ADSC-treated side (right side of the back) 7 days after surgery (Reprinted with permission from Elsevier, Kim WS et al. [6])
body’s own cells. Antioxidants scavenge free radicals before they get a chance to harm the body. As of now, there are few reports on the antioxidant action of stem cells. However, some evidences support the protective role of secretomes of ADSCs against the skin damage induced by reactive oxygen species. For example, IGF reportedly protects fibroblasts and intestinal epithelial cells from free radicals [33, 34]. HGF protects the retinal pigment epithelium against oxidative stress induced by glutathione depletion [35]. Pigment epithelium-derived factor (PEDF) is an anti-angiogenic/neurotropic factor and has been shown to have antioxidant effects [36]. Interleukin-6 (IL-6) reduces the epithelial cell death induced by hydrogen peroxide [37]. In addition, subtypes of superoxide dismutase (SOD) are expressed and secreted from ADSC [38]. Therefore, antioxidant function of ADSC was investigated in dermal fibroblasts after inducing chemical oxidative stress by the tert-butyl hydroperoxide (tbOOH). Morphological change and cell survival assay revealed that incubation with ADSC-CM aided dermal fibroblasts to resist free radicals induced by tbOOH. In addition, activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) were enhanced in the dermal fibroblasts treated with ADSC-CM. In a cell cycle analysis, ADSC-CM treatment reversed the apoptotic cell death induced by ROS, which was demonstrated by a significant decrease of subG1 phase of dermal fibroblasts [8]. Photoaging is believed to be responsible for up to almost 80% of the skin changes commonly attributed to the aging process. The study further investigated the antioxidant and protective effects of ADSCs in the photodamage of the primarily cultured dermal fibroblasts (> Fig. 20.3). In this experiment, ADSC-CM pretreatment significantly
. Figure 20.3 Antioxidant effect of ADSCs in UVB-irradiated fibroblasts as shown by cell cycle analysis of DNA contents. Untreated fibroblasts showed little or no sub-G1 phases (a). However, UVB irradiation significantly increased sub-G1 (apoptotic) cells (b), which were reversed by ADSC-CM pretreatment (c) (Reprinted with permission from Elsevier, Kim WS et al. [5])
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
reduced the apoptosis of dermal fibroblasts from UVBinduced damage, which was demonstrated by a significant decrease of sub-G1 phase of dermal fibroblasts after ADSC-CM pretreatment. In addition, ADSC-CM treatment increased the production of collagen and reduced the expression of matrix metalloproteinase-1 in the dermal fibroblasts. These results indicated that ADSCs can play a key role in protecting dermal fibroblast from UVBinduced oxidative stress [5]. As antioxidants inhibit the chemical reactions leading to melanin formation, change the type of melanin formed,
20
and interfere with the distribution of pigment and melanosome transfer, they are good candidates for skin whitening resources. As ADSC-CM is a free radical scavenger and has potent antioxidant activity, antimelanogenic effect of ADSC was investigated. ADSC-CM treatment inhibited the synthesis of melanin and the activity of tyrosinase in melanoma B16 cells. In addition, expressions of tyrosinase and tyrosinase-relating protein 1 were down-regulated by ADSC-CM treatment, which indicated the mechanism of action for antimelanogenic effect of ADSCs and their soluble factors (> Fig. 20.4) [9].
. Figure 20.4 (a) Antimelanogenic effect of ADSC-CM. Expression of MITF and TRP2 remained unchanged, but expressions of tyrosinase and TRP1 were down-regulated by ADSC-CM treatment in B16 melanoma cells. (b) The inhibitory effect of ADSC on melanin synthesis is schematically represented (Reproduced with permission from Pharmacological Society of Japan, Kim WS et al. [9])
205
206
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
Animal Studies for Skin Aging To study the effects on in vivo skin, ADSCs (1 106 cells) and ADSCs-CM were intradermally injected on the back of a micropig, twice in a 14-day interval (n = 3). One month after the second injection, skin samples were obtained at the treatment and the control sites of adjacent normal skin. Although the increase in the dermal thickness was not significant, increased collagen expression was noted by western blot in the ADSCs- and ADSCs-CMtreated skin samples (> Fig. 20.5) [7]. In another experiment, photodamage was induced by an 8-week UVB irradiation in hairless mice. The irradiation dose was one MED (minimal erythema dose; 60 mJ/cm2) in the first 2 weeks, two MED in the third week, three MED in the forth week, and four MED in the fifth through eighth weeks. After wrinkle induction, varying numbers of ADSCs (A group: control; B group: 1 103 cells; C group: 1 104 cells; and D group: 1 105 cells) were subcutaneously injected into the mice (n = 8 for each group). In a replica analysis, parameters involving skin roughness were improved with mid-level and higher dose groups of ADSCs (C and D group) (> Fig. 20.6). Dermal thickness was increased in the ADSC-injected groups (16% and 28% in C and D groups, respectively) and ECM contents in the dermis were also increased by Massson’s trichrome staining results of collagen (blue) in the ADSCtreated groups (> Fig. 20.7). As cell transplantation between species mediates immune rejection, the survival of
ADSC from humans was investigated after injection of ADSCs labeled with PKH26 (red color, > Fig. 20.8 inset). As shown in > Fig. 20.8, survival of the ADSCs was clearly demonstrated [5].
Clinical Application of ADSCs and the ADSC Protein Extract ADSCs and the ADSC Protein Extract for Skin Aging As a pilot study, intradermal injections of purified autologous PLA cells (1 106 cells), which contain approximately 20–30% ADSCs, were tried with photoaged skin of one patient [7] after informed conset. The female patient had two successive injections at 2-week intervals. Two months after the second injection, the patient showed improvements in general skin texture and wrinkling as evidenced by medical photographs of periorbital wrinkles. Measurements of dermal thickness by a 20 MHz high-frequency ultrasonographs (Dermascan-C, Cortex, Hadsund, Denmark) also indicated increased thickness (2.054 vs. 2.317 mm) (> Fig. 20.9). In a large-scale pilot study, the effects of the ADSC protein extract applied transdermally in the treatment of the various signs of skin aging were evaluated: (1) wrinkles, (2) acquired pigmentary lesions, and (3) dilated pores [39]. Korean patients visiting for the treatment of
. Figure 20.5 Micropig experiment shows the change of dermal thickness without (a) and with (b) intradermal injections of ADSCs. Increased collagen expression was noted by western blot in the ADSCs- and ADSCs-CM-treated skin (c) (Reproduced with permission from Wiley-Blackwell, Park BS et al. [7])
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
20
. Figure 20.6 Antiwrinkle effects of ADSCs. Photodamage was induced by 8-week UVB irradiation in hairless mice, and ADSCs were intradermally and subcutaneously injected three times. Wrinkles were evaluated by replica analysis. (a) Control; (b) 1 ¥ 103 cells; (c) 1 ¥ 104 cells; (d) 1 ¥ 105 cells (Reprined with permission from Elsevier, Kim WS et al. [5])
. Figure 20.7 Massson’s trichrome staining shows that collagen contents (blue) are significantly increased in the mid-level and higher dose groups of ADSCs (c and d groups in photodamaged hairless mice experiment) (Reprined with permission from Elsevier, Kim WS et al. [5])
207
208
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
. Figure 20.8 Survival of ADSCs labeled with PKH26 (insert) injected in the skin of hairless mice. Two weeks after injection, mouse skin block was cryosectioned and counterstained with green-fluorescent nucleic acid stain. ADSCs are stained red (Reprined with permission from Elsevier, Kim WS et al. [5])
skin aging were recruited during September 2006–August 2007. The population (n = 235) aged 28–71 years (mean 41 years) had skin phototypes III and IV with mild to moderate photodamage. The advanced ADSC Protein Extract(AAPE; Prostemics Inc., Seoul, Korea) was applied three to twelve times at two-week intervals. The changes were evaluated objectively by photographic documentation and Robo Skin Aanlyzer CS100/VA100 (Inforward Inc., Tokyo, Japan), and subjectively by patient questionnaire. The evaluation score was based upon the following scales: 0 = poor/worsend; 1 = no change/no change; 2 = fair/mild improvement; 3 = good/moderate improvement; and 4 = excellent/marked improvement. As compared to 47.4% showing good to excellent improvement in wrinkle, 63% of the patients were judged to have good to excellent improvement in acquired pigmentary lesions and dilated pores (> Fig. 20.10). Melasma is a multifactorial disorder caused by sun exposure, hormonal imbalance, and genetic predisposition. In many countries including Asia, melasma ranks among the top ten most common skin conditions. Ethnic differences between Asian and other skin types may influence the efficacy and tolerability of melasma treatments.
. Figure 20.9 Clinical study using intradermal injections of purified autologous PLA cells. Medical photographs of periorbital wrinkles were taken before (a) and after (b) treatment, and dermal thickness was measured by ultrasonographs before (c) and after (d) treatment. Improved general skin texture and increase thickness (2.054 vs. 2.317 mm) were evident 2 months after two injections (b and d) (Reprined with permission from Wiley-Blackwell, Park BS et al. [7])
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
. Figure 20.10 Objective and subjective evaluation of the protein extracts from ADSC-CM in a large-scale (n = 235) pilot study in terms of: (a) wrinkles, (b) acquired pigmentary lesions, and (c) dilated pores. The evaluation score is based upon the following scales: 0 = poor/worsend; 1 = no change/no change; 2 = fair/mild improvement; 3 = good/moderate improvement; and 4 = excellent/marked improvement. As compared to 47.4% showing good to excellent improvement in wrinkle (a), 63% of the patients were judged to have good to excellent improvement in acquired pigmentary lesions (b) and dilated pores (c)
20
Recent clinicopathologic studies on melasma show that lesional skin showed more prominent solar elastosis when compared to the normal skin [40]. Moreover, it has been suggested that interactions between the cutaneous vasculature and melanocytes might have an influence on the development of pigmentation [41]. The coexistence of telangiectasia and/or solar elastosis with melasma points out that photodamage is closely linked to the pathogenesis of melasma. The actions of ADSCs in wound healing, antioxidation, antimelanogenic effects and the reversal of photodamage in vitro, and in animal models prompted the clinicians to bring these biologic actions to bedside. The representative cases with marked response in photoaging and melasma were shown in > Fig. 20.11a–d. These clinical results for the past 4 years suggest that the ADSCs and the protein extract are promising rational strategies for melasma and photodamage.
Combination with Other Procedures and Active Transdermal Delivery Various light source and radiofrequency devices have been used for the treatment of skin aging by selectively heating up the collagen in the dermis to stimulate collagen remodeling. In general, both ablative and nonablative techniques lead to new collagen formation. As ADSCs and their secretory factors promote the wound healing by activating dermal fibroblasts, it can be speculated that when combined, ADSCs and the protein extracts might augment the clinical effects beyond the intrinsic fibroblast-stimulatory effect of the various devices. Based upon the previous documentation of woundhealing and antimelanogenic effects of ADSCs, the efficacy of the protein extract of ADSCs in reducing healing time and PIH or erythema was investigated after fractional CO2 laser treatment (MiXto SX1, Lasering, Italy) in a pilot study as prospective, randomized, placebocontrolled, double-blinded, and split-face setting [42]. CO2 fractional treatments have emerged as one of the new technologies in skin rejuvenation. However, comparatively increased incidence of PIH is problematic especially in dark-skinned patients. In this study, Korean patients of Fitzpatrick skin types III and IV (mean age 45.7 years) with facial wrinkles were treated with full-face fractional CO2 laser (Parameter: 8 W, index level 8). All subjects were randomly allocated to split-face application of either the protein extracts of ADSCs or emollient only. Serial photographs were taken at each visit during the treatment and three-month follow-up period. Marked difference in
209
210
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
. Figure 20.11 The representative cases with marked response before (a, c) and after (b, d) treatment with the protein extracts of ADSCs
the duration of erythema and healing was observed (> Fig. 20.12). The quality of wound healing was noted to be improved. This therapy was well-tolerated by majority of patients with minimal adverse effects. It was concluded that the protein extracts of ADSCs can be safely and effectively used to prevent PIH and to accelerate wound healing after fractional CO2 laser treatment in dark skin. As the secretory factors of ADSC generally contain ingredients of large molecular weights, various new ‘‘active’’ enhancement technologies designed to transiently circumvent the barrier function of the stratum corneum would be required for transdermal delivery: e.g., iontophoresis, sonophoresis, electroporation, or microneedle arrays or skinstamp.
Conclusion The current topics of increasing interest in the dermatological field are anatomical–functional damage to the skin
and every possible means to counteract the injurious effects. In the beginning, ADSCs were shown to increase the survival rate in fat transplantation [43]. This chapter explains that ADSCs and their secretory factors have diverse pharmacologic effects for skin aging. However, clinical application of cultured ADSCs for human skin is in the early stage and might be related to issues/concerns: the threat of passing on viruses, passing on diseases from other animal source nutrients to cultured stem cells in the laboratory, uncontrolled growth, and misdirected growth, especially of embryonic stem cells. In addition, ADSCs have to overcome the obstacles in that they are difficult both to handle and to commercialize in an industrial point of view: how to store the ADSCs, the containers to store them, how to transport them to the point, and the shelf life in various environments. Therefore, new methods and materials to overcome these limitations are needed. Secretomes of ADSC have some advantages over cell-based therapies and might have greater potential in skin regeneration, because they can
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
20
. Figure 20.12 A split-face comparison shows that the application of the protein extract of ADSCs results in less intense erythema and microcrusting 2 days after fractional CO2 laser resurfacing
be manufactured in a large scale with long-term stability and they are relatively devoid of safety issues. As such, the study demonstrated that photodamage can be reversed by utilizing the ADSCs/their secretory factors alone [5, 7, 39], or in combination with other devices minimizing unwanted effects [42]. Identification of active proteins will be the next goal, and drug development using these proteins will suggest better strategies for skin aging in the future.
References 1. Barry FP, et al. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36: 568–584. 2. Gimble J, et al. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5:362–369. 3. Kinnaird T, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678–685. 4. Zuk PA, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–4295. 5. Kim WS, et al. Antiwrinkle effect of adiposederived stell cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci. 2009;53:96–102. 6. Kim WS, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48:15–24. 7. Park BS, et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008;34: 1323–1326.
8. Kim WS, et al. Evidence supporting antioxidant action of adiposederived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci. 2008;49:133–142. 9. Kim WS, et al. Whitening effect of adipose-derived stem cells: a critical role of TGF-beta 1. Biol Pharm Bull. 2008;31:606–610. 10. Izadpanah R, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99:1285–1297. 11. Porada CD, et al. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1:365–369. 12. Boquest AC, et al. Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev. 2006;2:319–329. 13. Huang T, et al. Neuron-like differentiation of adipose derived stem cells from infant piglets in vitro. J Spinal Cord Med. 2007;30:35–40. 14. Kern S, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294–1301. 15. Katz AJ, et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells. 2005;23:412–423. 16. Anghileri E, et al. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev. 2008;17:909–916. 17. Bunnell BA, et al. Differentiation of adipose stem cells. Methods Mol Biol. 2008;456:155–171. 18. Gimble JM, et al. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–1260. 19. Schipper BM, et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg. 2008;60: 538–544. 20. Jurgens WJ, et al. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: Implications for cell-based therapies. Cell Tissue Res. 2008;332:415–426.
211
212
20
Adipose-derived Stem Cells and their Secretory Factors for Skin Aging
21. Oedayrajsingh-Varma MJ, et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8:166–177. 22. Schachinger V, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355: 1210–1221. 23. Schachinger V, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775–2783. 24. Uemura R, et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98:1414–1421. 25. Wang M, et al. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock. 2006;25:454–459. 26. Crisostomo PR, et al. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery. 2007;142:215–221. 27. Patel KM, et al. Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res. 2007;143:281–285. 28. Roche S, et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics. 2009;9:223–232. 29. Zvonic S, et al. Secretome of primary cultures of human adiposederived stem cells. Mol Cell Proteomics. 2007;6:18–28. 30. Wu Y, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem cells. 2007;25:2648–2659. 31. Sasaki M, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581–2587.
32. Chen L, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE. 2008;3:e1886. 33. Baregamian N, et al. IGF-1 protects intestinal epithelial cells from oxidative stressinduced apoptosis. Surg Res. 2006;136:31–37. 34. Rahman ZA, et al. Antioxidant effects of glutathione and IGF in a hyperglycaemic cell culture model of fibroblasts: some actions of advanced glycaemic end products (AGE) and nicotine. Endocr Metab Immune Disord Drug Targets. 2006;6:279–286. 35. Shibuki H, et al. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest Ophthalmol Visual Sci. 2002;43:528–536. 36. Tsao YP, et al. Pigment epithelium derived factor inhibits oxidative stress-induced cell death by activation of extracellular signalregulated kinases in cultured retinal pigment epithelial cells. Life Sci. 2006;79:545–550. 37. Kida H, et al. Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. Am J Physiol. 2005;288:342–349. 38. Liochev SI, et al. How does superoxide dismutase protect against tumor necrosis factor: a hypothesis informed by effect of superoxide on ‘‘free’’ iron. Free Radic Biol Med. 1997;23:668–671. 39. Kang SH, et al. Improvement of melasma and scars with the secretory factors from ADSCs. Korean J Dermatol. 2007;45(Suppl. 2):136. 40. Kang WH, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237. 41. Kim EH, et al. The vascular charateristics of melasma. J Dermatol Sci. 2007;46:111–116. 42. Park BS, et al. Rejuvenation of aging skin using fractional CO2 laser resurfacing followed by topical application of ADSC protein extract. Kor J Dermatol. 2008;46(Suppl 1):266–267. 43. Matsumoto D, et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006;12:3375–3382.
13 Aging and Intrinsic Aging: Pathogenesis and Manifestations Hanan Assaf . Mohamed A. Adly . Mahmoud R. Hussein
Introduction Cutaneous aging is a complex biological phenomenon consisting of two components: intrinsic aging and extrinsic aging. Intrinsic aging is also termed true aging which is an inevitable change attributable to the passage of time alone and is manifested primarily by physiologic alterations with subtle but undoubtedly important consequences for both healthy and diseased skin and is largely genetically determined [1]. Extrinsic aging is caused by environmental exposure, primarily to UV light, and more commonly termed photoaging. In sun-exposed areas, photoaging involves changes in cellular biosynthetic activity that lead to gross disorganisation of the dermal matrix [2]. The intrinsic rate of skin aging in any individual can be dramatically influenced by personal and environmental factors, particularly the amount of exposure to ultraviolet light. Photodamage, which considerably accelerates the visible aging of skin, also greatly increases the risk of cutaneous neoplasms. So, the processes of intrinsic and extrinsic aging are superimposed. As the population ages, dermatological focus must shift from ameliorating the cosmetic consequences of skin aging to decreasing the genuine morbidity associated with problems of the aging skin. Therefore, a better understanding of both the intrinsic and extrinsic influences on the aging of the skin, as well as distinguishing the retractable aspects of cutaneous aging (primarily hormonal and lifestyle influences) from the irretractable cutaneous aging (primarily intrinsic aging), is very important to solve the problem of aging [2].
Pathogenesis of Intrinsic Aging Logic dictates that one or more molecular events must underlie the aging process. These changes are now beginning to be unraveled and are discussed. As these mechanisms are identified, further insights into the underlying processes of skin aging should emerge and better strategies to prevent the undesirable effects of age on skin appearance should follow. The process of intrinsic
skin aging resembles that seen in most internal organs and an explanation is thought to involve decreased proliferative capacity leading to cellular senescence, and altered biosynthetic activity of skin derived cells [2]. The molecular mechanisms partly underlying skin aging comprise a multifaceted process influenced by various factors affecting different body sites at variable degrees. A stochastic process that implies random cell damage as a result of mutations during metabolic processes due to the production of free radicals is also implicated [2–4]. As the molecular mechanisms leading to human senescence are complex processes, different research approaches are used to study aging including studies of monogenic segmental progeroid syndromes. Two progeria syndromes, Werner’s syndrome (WS) and Hutchinson-Gilford progeria syndrome (HGPS), which are characterized by clinical features mimicking physiological aging at an early age, provide insights into the mechanisms of natural aging. They suggest a model of human aging. Based on recent findings on WS and HGPS, human aging can be triggered by two main mechanisms: telomere shortening and DNA damage. In telomere-dependent aging, telomere shortening and dysfunction may lead to DNA damage responses which induce cellular senescence. In DNA damage-initiated aging, DNA damage accumulates, along with DNA repair deficiencies, resulting in genomic instability and accelerated cellular senescence. In addition, aging due to both mechanisms (DNA damage and telomere shortening) is strongly dependent on p53 status. These two mechanisms can also act cooperatively to increase the overall level of genomic instability, triggering the onset of human aging phenotypes [3, 5]. Data from another trial revealing the molecular changes of intrinsic skin aging were analyzed by applying ‘‘Serial Analysis of Gene Expression’’ (SAGE(TM)) to skin biopsies of young and aged donors. The analysis resulted in several hundred differentially expressed genes with varying statistical significance. Of these, several genes were identified that either have never been described in skin aging before (e.g., APP) or have no identified function (e.g., EST sequences). This is the first time that
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_13, # Springer-Verlag Berlin Heidelberg 2010
130
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations
intrinsic skin aging has been analyzed in such a comprehensive manner, offering a new and partially unexpected set of target genes that have to be analyzed in more detail in terms of their contribution to the skin aging process [4, 6]. Moreover, normal human fibroblasts undergoing serial passaging have been extensively used to identify genes linked with aging. Most of the isolated genes relate to growth retardation signals and the failure of homeostasis that accompanies aging and senescence. In contrast, there is still limited knowledge regarding the nature of the genes that influence positively the rate of aging and longevity. Healthy centenarians represent the best example of successful aging and longevity. Studies using samples from these individuals have proved very valuable for identifying a variety of factors that contribute to successful aging [5, 7].
Manifestation of Skin Aging Various expressions of intrinsic aging include smooth, thinning skin with exaggerated expression lines. Extrinsically aged skin is characterized by photodamage as wrinkles, pigmented lesions, patchy hypopigmentations, and actinic keratoses [2].
The Wrinkle and Its Measurement There is a new method for the measurement of the size and function of the wrinkle, called ‘‘Profilometric’’ method. Facial wrinkles are not a single groove, but comprise an anatomical and functional unit (the ‘‘Wrinkle Unit’’) along with the surrounding skin. This Wrinkle Unit participates in the functions of a central neuromuscular system of the face responsible for protection, expression, and communication. Thus, the Wrinkle Unit, the superficial musculoaponeurotic system (superficial fascia of the face), the underlying muscles controlled by the CNS and Psyche, are considered to be a ‘‘Functional Psycho-Neuro-Muscular System of the Face for Protection, Expression and Communication’’. The three major functions of this system exerted in the central part of the face and around the eyes are: (1) to open and close the orifices (eyes, nose, and mouth), contributing to their functions; (2) to protect the eyes from sun, foreign bodies, etc.; and (3) to contribute to facial expression, reflecting emotions (real, pretended, or theatrical) during social communication. These functions are exercised immediately and easily, without any opposition (‘‘Wrinkling Ability’’) because of the presence of the Wrinkle Unit that gives (a) the site of refolding (the wrinkle is a waiting fold, ready to respond quickly at any moment for any skin
mobility need) and (b) the appropriate skin tissue for extension or compression (this reservoir of tissue is measured by the parameter of WTRV). The ‘‘Wrinkling Ability’’ of a skin area is linked to the wrinkle’s functions and can be measured by the parameter of ‘‘Skin Tissue Volume Compressed around the Wrinkle’’ in cubic millimetre per 30 mm wrinkle during maximum wrinkling. The presence of wrinkles is a sign that the skin’s ‘‘Recovery Ability’’ has declined progressively with age. The skin’s ‘‘Recovery Ability’’ is linked to undesirable cosmetic effects of aging and wrinkling. This new Profilometric method can be applied in studies where the effectiveness of anti-wrinkle preparations or the cosmetic results of surgery modalities are tested, as well as in studies focused on the functional physiology of the Wrinkle Unit [6]. Nevertheless, the gradual physiologic decline of aging skin is well documented [7, 8].
Aging of the Epidermis The most striking and consistent histologic change is flattening of the dermoepidermal junction, a considerably smaller surface between the two compartments and presumably less communication and nutrient transfer [9]. Dermal–epidermal separation has been demonstrated to occur more readily in old skin under experimental conditions. Inter-rete epidermal thickness probably remains constant with advancing age, but variability in epidermal thickness and in individual keratinocyte size increases [9]. Average thickness and degree of compaction of the stratum corneum appears constant with increasing age, although individual corneocytes become larger. The skin surface pattern examination reveals slight age-associated loss of regularity. There is also an age-related decrease in the barrier function of intact stratum corneum as measured by percutaneous absorption of at least some substances. Subsequent work suggests that age effects on percutaneous absorption depend, in part, on drug structure, with hydrophilic substances being less well absorbed through the skin of old subjects, but hydrophobic substances being equally well absorbed [1]. More recent work indicates that there is an age-associated decrease in percutaneous absorption for hydrophilic substances like hydrocortisone and benzoic acid, but no change for hydrophobic substances like testosterone and estradiol [10]. An age-associated decrease in epidermal turnover rate of approximately 30–50% between the third and eighth decades has been determined by a study of desquamation rates for corneocytes at selected body sites. The thymidine-labeling index of the epidermis in vivo has been reported to decline nearly 50% with age [1].
Aging and Intrinsic Aging: Pathogenesis and Manifestations
There is also a corresponding 100% prolongation in stratum corneum replacement rate and a decrease in the linear growth rates for hair and nails. A study of epidermal wound healing showed that the repair rate in the skin linkwise declines with age, as restoration of normal skin surface markings in deroofed subcorneal blister sites required a median of approximately 3 weeks in subjects aged 18–25 years, but 5 weeks in subjects 65–75 years. Healing was essentially complete in all young subjects who were healed by 7 weeks, and the last by 8 weeks [11]. Clinical observations suggest that the development of chronic wounds frequently associate with persistent low tissue oxygen supply (hypoxia). The prolonged tissue hypoxia exposes wounds to bacterial infection, a prolonged inflammatory response, and eventually tissue necrosis. The elderly population accounts for a large portion of this morbidity [12]. Consistent with clinical observations, compelling evidence from laboratory studies has shown that age affects wound healing in several aspects: sprouting of aged microvessels was significantly less than the sprouting of young microvessels [13], increased gelatinase and collaginase levels in skin of aged donors and in wound fluid from chronic leg ulcers, and decreased TIMP (tissue inhibitor of matrix metalloproteinase) levels in the skin of aged donors as well as reduced deposition of matrix components and re-epithelialization [14–16]. A novel study about wound healing with increasing age done by Yu-Ping Xia et al. (2001) [17] revealed that keratinocytes isolated from elderly donors, in contrast to those from young individuals, had depressed migratory activity when they were exposed to hypoxia [17]. Analysis of underlying biochemical changes demonstrated a differential activation of matrix metalloproteinases by hypoxia in keratinocytes isolated from young and old ages. Matrix metalloproteinases-1 and Matrix metalloproteinases-9 and tissue inhibitor of matrix metaloproteinases-1 were strongly upregulated by hypoxia in young cells, whereas no induction was observed in aged cells. Furthermore, transforming growth factor-b1 signaling appears to be involved in keratinocyte differential response to hypoxia, as transforming growth factor-b type 1 receptor was upregulated by hypoxia in young cells, while there was no induction in aged cells. Transforming growth factor-b neutralizing reagents blocked hypoxia-induced matrix metalloproteinase-1, matrix metalloproteinase-9 expression, and hypoxia-induced cell migration as well. These results introduced by Yu-Ping Xia et al. (2001) [17] suggest that an age-related decrease in response to hypoxia plays a crucial part in the pathogenesis of related re-epithelialization in wounds [17]. A decrease in the number of the enzymatically active melanocytes per unit surface area of the skin,
13
approximately 10 20% of the remaining cell population each decade, has been repeatedly documented [8]. It is not known whether the cells truly disappear or simply become undetectable by ceasing to produce pigment, but in either case the protective barrier of the body against ultraviolet radiation presumably is reduced. The number of melanocytic nevi (moles) also progressively decreases with age from a peak of 15 40 in the third and fourth decade to an average of four per person after age 50; moles are rarely observed in persons above age 80 [18]. The contribution of extracellular matrix components to intrinsic skin aging has been investigated thoroughly; however, there is little information as to the role of the cytoskeletal proteins in this process. Therefore, the new studies highlight the importance of the cellular compartment in this process and demonstrate that special attention has to be given to RNA as well as protein normalization in aging studies. OeNder et al. (2008) demonstrated that the mRNA levels of the genes for K1, K3, K4, K9, K13, K15, K18, K19 and K20 are downregulated in aged skin, K5 and K14 are unchanged, and K2, K16 and K17 are upregulated in aged skin. The mRNA data were confirmed on the protein level. This diverse picture is in contrast to other cytoskeletal proteins including components of the desmosome (JUP), microtubuli (TUBA) and microfilaments (ACTB) – often regarded as house-keeping genes – that were all reduced in aged skin [19]. The incidence of cancers, infectious diseases, and autoimmune disorders increases with advancing age [20]. In addition, aging is accompanied by a number of changes in immune function such as decreased lymphocyte proliferative responses to both mitogens and antigens, reduced delayed type hypersensitivity reactions, and decreased antibody responses to vaccination and infection [19]. Murine models of aging have demonstrated that there is an age-associated dysregulation in cytokine production, as evidenced by consistently decreased production of interleukin-2 (IL-2) and generally increased production of interleukin-4 [21]. These data, coupled with the increased incidence of cancer and the recurrence of latent viral infection in aged humans, have led to the hypothesis that the process of aging per se induces a switch from a predominantly type 1 cytokine (IL-2, INF-g, IL-12) profile supporting a dominant cellmediated immune response, to a predominantly type 2 cytokine (IL-4, IL-5, IL-6, IL-10) profile, promoting a dominant humoral response. A 20 50% reduction in the number of morphologically identifiable epidermal Langerhans cells occurs between early and late adulthood and may account in part for the age-associated decrease in immune responsiveness observed in the skin [7, 8].
131
132
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations
In principle, inhibition of aging should delay cancer. But the question which arises is whether it is possible to slow aging. As recently proposed, the nutrient-sensing TOR (target of rapamycin) pathway is involved in cellular and organismal aging. In rodents, certain conditions that interfere with the TOR pathway slow aging and prevent cancer. Retrospective analysis of clinical data reveals that in animals, from worms to mammals, caloric restrictions, life-extending agents, and numerous mutations that increase longevity all converge on the TOR pathway. And, in humans, cell hypertrophy, hyper-function and hyperplasia, typically associated with activation of TOR, contribute to diseases of aging. Theoretical and clinical considerations suggest that rapamycin may be effective against atherosclerosis, hypertension and hyper-coagulation (thus, preventing myocardial infarction and stroke), osteoporosis, cancer, autoimmune diseases and arthritis, obesity, diabetes, macula-degeneration, Alzheimer’s and Parkinson’s diseases. Finally, the extended life span will reveal new causes for aging (e.g., ROS, ‘‘wear and tear’’, Hayflick limit, stem cell exhaustion) that play a limited role now, in relation to TOR. So, there is a potential clinical use of TOR inhibitors in order to slow aging and delay cancer [22]. Richardson et al. (2004) also emphasized that regulation of growth and proliferation in higher eukaryotic cells results from an integration of nutritional, energy, and mitogenic signals [23]. Biochemical processes underlying cell growth and proliferation are governed by the phosphatidylinositol 3-kinase (PI3K) and TOR signaling pathways. The importance of the interplay between these two pathways is underscored by the discovery that the TOR inhibitor rapamycin is effective against tumors caused by misregulation of the PI3K pathway. Moreover, one of the recent breakthrough studies in TOR signaling resulted in the identification of the tuberous sclerosis complex gene products, TSC1 and TSC2, as negative regulators for TOR signaling. Furthermore, the discovery that the small GTPase Rheb is a direct downstream target of TSC1-TSC2 and a positive regulator of the TOR function has significantly advanced the understanding of the molecular mechanism of TOR activation. So, the regulation of TOR signaling is very important to control cell growth during normal development and tumorigenesis [24]. Vitamin D production, which is an important endocrine function of human epidermis, is suspected to decline with age. With advancing age, bone mass decreases markedly, especially in postmenopausal women, predisposing to trabicular bone fractures. Osteoporosis, or lack of cortical and trabicular bone, is a prominent factor, but some elderly individuals also have osteomalacia, since the decreased mineralization of bone is classically associated
with vitamin D deficiency. Although avoidance of dairy products, the principal dietary source of vitamin D, insufficient sun exposure, and sun screen use, undoubtedly contribute to vitamin D deficiency in the elderly [25]. The level of epidermal 7-dehydrocholesterol per unit skin surface area also appears to decrease linearly by approximately 75% between early and late adulthood suggesting that lack of its immediate biosynthetic precursor may also limit vitamin D production. In one study, old adult volunteers exposed to total body UV irradiation produced far less vitamin D3, over the ensuing week, than did complexion-matched young adult volunteers exposed to the same UV dose [2]. Neoplasia is associated with aging in virtually all organ systems, but is especially characteristic for aged skin. Acrochorrdon, cherry angioma, seborrheic keratosis, lentigo, sebaceous hyperplasia, one or more of these benign epidermal tumors is present in nearly every adult beyond age 65 years, and most individuals have dozens of lesions [20]. Actinically induced basal cell carcinoma and squamous cell carcinoma are by far the most common human malignancies. These benign and malignant neoplasms almost certainly reflect in part the loss of proliferative homeostasis with age.
Epidermal Proteins and Skin Aging Recent studies revealed by gel electrophoresis of healthy human skin (sun protected skin) from donors of different ages that there are age-associated changes in five proteins, which were identified as Keratin 10, Involucrin, Prealbumin, Hsp 27, and Rho B. More recently, it was found by the tool of immunohistochemistry that these epidermal proteins are expressed in the human skin epidermis and that their expression patterns undergo age-associated changes [26]. Examination of cryosections from healthy sun-protected skin derived from individuals ranging from the first decade of life until the ninth decade revealed that Keratin 10, Involucrin, Prealbumin, Hsp 27, and Rho B proteins are present in high density nearly in all layers of young epidermis (> Fig. 13.1). In contrast, the expression of the investigated epidermal proteins is reduced as a function of age. In some skin specimens from very old individuals, the proteins were not detectable [26]. All five proteins are known to be closely related to differentiation and proliferation of keratinocytes. Moreover, prealbumin, Hsp27 and Rho B have been demonstrated to play a crucial role in tumor cell biology. Thus, decreased expression of these proteins could be
Aging and Intrinsic Aging: Pathogenesis and Manifestations
13
. Figure 13.1 Expression of Hsp27 protein in normal human skin. A moderate to strong expression is found in most epidermal layers, including the stratum corneum. a: Tyramid signal amplification (TSA) technique (200x), b: Avidin-Biotin complex (ABC) technique (200x). (Reprinted with permission from Adly et al. [47].) ß 2006, Elsevier
one reason for the increased prevalence of skin cancer in old individuals. Additionally, these proteins are possible marker proteins for intrinsic aging of the epidermis [26]. Additionally, Hsp27 and other epidermal proteins were found to be expressed in the human skin hair follicles and involved in hair follicle cycle control [26]. (> Fig. 13.2).
Aging of the Dermis Loss of dermal thickness approaches 20% in elderly individuals, although in sun-protected sites significant thinning occurs only after the eighth decade [27]; the remaining tissue is relatively acellular and avascular [1, 9]. Precise histologic concomitants of wrinkling, if any, are unknown, although the age-related loss of normal elastin fibers may be contributory [9]. Deep expression lines seem to result from contractions of connective tissue septae within the subcutaneous fat. In one study, an approximately 50% reduction in mast cells and a 30% reduction in venular cross-sections was noted in the papillary dermis of buttock skin from elderly adults compared to that from young adult controls, associated with a corresponding reduction in histamine released and other manifestations of the inflammatory response following UV radiation exposure [7]. The striking age-associated loss of vascular bed, especially of the vertical capillary loops that occupy the dermal papillae in young
skin, is felt to underlie many of the physiologic alterations in old skin. Reduction in the vascular network surrounding hair bulbs and eccrine, apocrine, and sebaceous glands may contribute to their gradual atrophy and fibrosis with age [1]. An age-associated decrease in dermal clearance of trans-epidermally absorbed materials has been reported and is probably due to alterations in both the vascular and extracellular matrix. A previous study showed that wheal resorption after intradermal saline injection required almost twice as long on average in elderly versus young adult subjects [1]. Controversely, the time required for development of a tense blister after topical application of 50% ammonium hydroxide is nearly twice as long in older subjects, suggesting a decreased transduction rate with age in injured skin. Impaired transfer of cells as well as solutes between the extravascular and intravascular dermal compartments is suggested by several studies to occur by age, but it is difficult to isolate these components in a complex inflammatory reaction. Decreased vascular responsiveness in the skin of older individuals has been documented clinically assessing vasodilation and transudation after application of standardized irritants, histamine, and the mast cell degranulating agent 48/80 [11]. Intensity of erythema following a standardized UV exposure is also decreased with age in normal skin, although factors other than decreased vascular responsiveness may also contribute [7]. A previous study that assessed cutaneous vascular response to the vasodilator
133
134
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations
. Figure 13.2 Expression of Hsp27 protein in normal human scalp skin anagen VI hair follicle, immunostained with (ABC) and (TSA) techniques. a and d show the distal region (200x), b and e show the central region (200x), c and f show the proximal bulb region (200x). D: shows schematic representation of anagen VI hair follicle. (Reprinted with permission from Adly et al. [47].) ß 2006, Elsevier
methyl nicotinate concluded that there was no difference between young adult and old adult subjects after correction for rate of drug absorption [28]. Compromised thermoregulation, which predisposes the elderly to sometimes fatal heat stroke, or hypothermia may be due in part to reduced vascularity of dermal arterioles, and in the latter instance, to loss of subcutaneous fat as well. The skin of healthy older subjects is less sensitive to dinitrochlorobenzene (DNCB) and to standard recall antigens, compared to the skin of young adult controls [29]. This decrease undoubtedly reflects the well documented decrease in total number of circulating thymus derived lymphocytes and in their responsiveness to standard mitogens. The elastic fibers in the skin are less well studied, but have been reported to show progressive cross linkage and
calcification with age in adult skin. On average, older skin has thicker elastic fibers than young skin, and elastic fiber alterations extend deeper into the dermis with advancing age [30, 31]. Small cysts and lacuna are common in aging elastic fibers, sometimes progressing to complete fragmentation. Similar changes can be produced experimentally by incubation of dermal slices with elastase or chymotrypsin (but not collagenase) in vitro, suggesting that enzymatic degradation of elastin may be a mechanism of normal dermal aging [30, 31]. The dermal microvasculature in middle-aged or elderly subjects may show mild vascular wall thickening; vascular wall thinning to less than half of the normal young adult measurement, associated with absent or reduced perivascular veil cells that has been reported in skin of very old subjects and probably contributes to vascular fragility [30, 31].
Aging and Intrinsic Aging: Pathogenesis and Manifestations
Significant decrease in thrombomodulin-positive cells and vascularity were evidenced in the aged group. Specific subsets of the dermal dendrocyte populations and the blood microvasculature appear affected by aging. Capsaicin may limit these aging effects. [32]. Biochemical changes in collagen, elastin and dermal ground substance that have been described during foetal and early postnatal development are far greater than those that have been described with advancing age during adulthood. With advancing adult age, rat tail collagen does manifest a slight increase in the force of contraction (isometric tension), when heated above its shrinkage temperature, consistent with increasing cross-linkage of the collagen molecule [33]. Both rat tail tendon and human skin display a progressive decrease in the ratio of soluble to insoluble collagen [34]. The predominant cross-links in skin have been reported to decrease and virtually disappear with age in mature animals, however, using techniques that measure borohydride reducible cross-links, despite evidence of increasing mechanical stability. This suggests that some collagen cross-links in vivo may be progressively reduced or oxidized and are, therefore, no longer measurable. Certain non enzymatic cross-links in connective tissue, such as histidinoalanine and the Millard reaction product, do show a strong positive correlation with adult age, and have been suggested to contribute to age-associated changes in the dermis [1]. The proportion of recently synthesized dermal collagen, as determined by neutral salt extraction, is small and does not vary with age in adult [35, 36]. However, there is a significant decrease with age in the percent of total collagen that is released by pepsin digestion, and hence incompletely cross-linked, from approximately 25% at age 30 years to approximately 10% at age 75 years with a proportionate increase in the percent of insoluble collagen from approximately 70 88%. The amount of ketoaminelinked glycosylation of insoluble dermal collagen also increases with age, possibly related to slower collagen turnover or higher average glucose levels in the tissue [35, 36]. Prolyl- and lysyl-hydroxylase, enzymes necessary for intercellular stabilization of the collagen triple helix and for its intermolecular cross-linking, show an ageassociated decline in activity in human skin, although these coenzyme activities in cultured dermal fibroblasts from donors ranging in age from a few months to 94 years do not. This apparent contradiction could be explained by an age-associated decrease in either dermal fibroblast number in vivo or fibroblast responsiveness to a serumderived enzyme stimulating factor in vitro. There is some data concerning the possible postmaturational age-associated changes in mucopolysaccharides
13
(glycosaminoglycans and proteoglycans) or other molecules of the ground substance in which collagen and elastic fibers are embedded. There appears to be a slight decrease with age in mucopolysaccharide content relative to dry weight or collagen content of the skin, especially for hyaluronic acid. Although mucopolysaccharides constitute only 0.1 0.3% of dry weight for whole skin, their decrease may adversely influence skin turgor, as proteoglycans bind a high volume of water in the dermis [37, 38]. Mechanical properties of the skin also change with age. Uniaxial and biaxial tension tests performed on excised abdominal skin stripes demonstrate progressive loss of elastic recovery, consistent with gradual destruction of the dermal elastin network, and the time required for excised skin to return to its original thickness after 50% compression is markedly prolonged [39]. This early work, which has been confirmed and extended by in vivo studies of ventral forearm skin of 133 volunteers in each decade of life, showed linear declines of approximately 25% in both men and women for elasticity and extensibility. Loss of elasticity began in childhood and continued through the ninth decade, while extensibility was constant through the sixth decade and then declines more rapidly thereafter. Overall, a picture emerges of aging dermis as an increasingly rigid, inelastic and unresponsive tissue, less capable of undergoing modification in response to stress. IGF-I is a key regulator of human skin aging and declining IGF-I levels with age may play a significant role in the reduction of skin surface lipids and thickness [40].
Nerves and Appendages By the end of the fifth decade, approximately half the population has at least 50% grey (white) body hair with an even higher proportion of depigmented scalp hair, and virtually everyone has some degree of greying due to progressive and eventually total loss of melanocytes from the hair bulb. Loss of melanocytes is believed to occur more rapidly in hair than in skin because the cells proliferate and manufacture melanin at maximal rates during the anagen phase of the hair cycle, while epidermal melanocytes are comparatively inactive throughout their lifespan. Scalp hair may gray more rapidly than other body hair because its anagen to telogen ratio is considerably greater than that of other body hair. Advancing age is also accompanied by a modest decrease in number of hair follicles. Remaining hairs may be smaller in diameter and grow more slowly. The process called balding results primarily from the androgen-dependent conversion of the relatively dark thick scalp hairs to lightly pigmented short
135
136
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations
fine hairs similar to those on the ventral forearm. Bitemporal hair line recession begins during late adolescence in most women and virtually all men. Assessment of baldness is hampered by lack of a precise definition, but by certain criteria advanced bitemporal and occipital hair loss in men increases in prevalence, respectively from 20% and 3% at the end of the third decade to more than 60% by the seventh decade. Eccrine glands decrease approximately 15% in average number during childhood in most body sites. Spontaneous sweating in response to dry heat is further reduced by more than 70% in healthy old subjects as compared to young controls, attributable primarily to a decreased output per gland. Maximal sweat production has not been quantified in the elderly, but is almost certainly reduced and probably predisposes to heat stroke in this age group [41]. Similar studies have not been performed for apocrine glands, although the apparently decreased requirement for under-arm deodorants in the elderly suggests decreased function. Lipofuscin gradually accumulates with age in the secretory cells of both eccrine and apocrine glands. Sebaceous gland size and number appear not to change with age [9]. The exponential decrease in sebum production of approximately 23% per decade beginning in the second decade in both men and women, approximately 60% over the adult lifespan, is attributed to the concomitant decrease in production of gonadal or adrenal androgen to which sebaceous glands are exquisitely sensitive. The clinical effects of decreased sebum production, if any, are unknown. There is no direct relationship to xerosis or seborrheic dermatitis [42]. Pacinian and Meissner’s corpuscles, the cutaneous end organs responsible for pressure perception, light and touch, progressively decrease to approximately one third of their initial average density between the second and ninth decades of life and display greater size variation. There are very few histologically demonstrable aging related changes in Merkel corpuscles or in free nerve endings. Decreased sensory perception was documented in old skin more than 3 decades ago by several techniques. Cutaneous pain threshold has been reported to increase up to 20% with advancing age [43]. The available data do not permit differentiation among an age-associated increase in the prevalence of peripheral neuropathy, a true aging change in healthy subjects, increased rate of heat dispersion in old skin due to age-associated dermal alterations, an increased peripheral nerve threshold to painful stimuli, and an increased central threshold to pain perception [43]. The many psychological and social factors influencing an individual reaction to pain may also be presumed to vary with age. In any case, either decreased awareness of, or reaction to, noxious stimuli
would facilitate wounding and irritation of old skin. Sympathetic nervous system activity is altered in aging.
Aging and Skin Diseases Disorders of the skin are known to be common and bothersome in the elderly, but existing incidence and morbidity figures are suspect [44]. Few dermatologic disorders occur predominantly in the elderly, and none is restricted to this age group. Perhaps the prototypic disease of old skin is bullous pemphigoid, characterized by subepidermal blister formation with fixation of complement and immunoglobulins along the basement membrane. Its predilection for the elderly may partially explained by the age-associated increase in circulating autoantibodies and ease of dermal epidermal separation, although other autoimmune and blistering dermatoses are not more common in old age. Possibly age-associated changes in the basement membrane itself render it specifically vulnerable to the disease process. More than two thirds of herpes zoster cases occur after the fifth decade, with an age adjusted annual incidence rate of approximately 0.25% at 20 50 years vs. more than 1% at age 80 years [45]. Post-herpetic neuralgia, uncommon in patients less than 40 years old, occurs frequently in older patients; more than half of those beyond age 60 years. In one large series this altered response to varicella virus has been established, however no mechanism explaining this altered response to varicella virus has been found. Recurrent herpes simplex infection also involves reactivation of latent virus in regional ganglia and T cell-mediated host defenses, but is more common in young adults and indeed rare among immunocompetent elders. The general phenomenon of impaired wound healing in the elderly may account for slower resolution of the acute eruption, but its relevance, if any, to post-herpetic neuralgia is unclear [45]. Age-associated muting of the inflammatory response might indeed be expected to reduce the risk of neuralgia, since prophylactic use of anti-inflammatory corticosteriods is often successful. Xerosis, the dry rough quality of old skin, may be attributable to a subtle disorder of epidermal maturation, although histologic studies reveal little alteration of either the viable epidermis or the stratum corneum with age. Available data fails to support water loss [1], decreased stratum corneum lipids [42] or altered amino acid composition as etiologic factors [42]. The surface irregularity may also be attributed simply to slower transit of corneocytes through the stratum corneum, allowing accumulation of damage in situ. Similarly, there is no explanation
Aging and Intrinsic Aging: Pathogenesis and Manifestations
for the pruritus that often accompanies xerosis. Unsupported hypotheses include frequent penetration of irritants through an abnormal stratum corneum and an altered sensory threshold due to subtle neuropathy. Many dermatoses more commonly observed in the elderly reflect the higher prevalence of systemic diseases such as diabetes, vascular insufficiency, and various neurologic syndromes in this population. In the case of chronic leg ulcers, for example, healing of previously recalcitrant lesions can sometimes be achieved by use of neonatal epidermal allograft, postulated to elaborate needed growth factors and/or matrix materials that the surrounding senescent host epithelium is incapable of producing. The allegedly increased incidence of other disorders such as tinea pedis or seborrheic dermatitis may reflect reduced local skin care with subsequent exacerbation of previously unapparent problems, rather than an age-associated change in the skin itself. Alternatively, subtle changes in the immune status may be responsible, in analogy to the increased prevalence and severity of those disorders in patients with acquired immunodeficiency syndrome [1]. Reduced tolerance to systematically administrated drugs is well documented in the elderly due to the decrements in lean body mass and metabolism and renal excretion of the active ingredients [46]. Comparable data for topically applied medication do not exist, but it is tempting to postulate that retarded dermal clearance of absorbed material reduced dermal mass and cellularity, and possibly altered metabolic capacity may render old skin more susceptible to both beneficial and adverse effects of topical medications, or at least alter the optimal dosage frequency [1]. In the case of corticosteriod preparations, relative vascular unresponsiveness may render blanching of erythema as an unreliable indicator of other effects in old skin.
Conclusion A better understanding of both the intrinsic and extrinsic influences on the aging of the skin, as well as distinguishing the retractable aspects of cutaneous aging (primarily hormonal and lifestyle influences) from the irretractable cutaneous aging (primarily intrinsic aging), is very important to solve the problem of aging.
Cross-references > Degenerative
Changes in Aging Skin
13
References 1. Balin AK, Pratt LA. Physiological consequences of human skin aging. Cutis. 1989;43(5):431–436. 2. Puizina-Ivic N. Skin aging. Acta Dermatovenerol Alp Panonica Adriat. 2008;17(2):47–54. 3. Ding SL, Shen CY. Model of human aging: recent findings on Werner’s and Hutchinson-Gilford progeria syndromes. Clin Interv Aging. 2008;3(3):431–444. 4. Holtkotter O, Schlotmann K, Hofheinz H, Olbrisch RR, Petersohn D. Unveiling the molecular basis of intrinsic skin aging(1). Int J Cosmet Sci. 2005;27(5):263–269. 5. Chondrogianni N, de CMSD, Franceschi C, Gonos ES. Cloning of differentially expressed genes in skin fibroblasts from centenarians. Biogerontology. 2004;5(6):401–409. 6. Hatzis J. The wrinkle and its measurement – a skin surface Profilometric method. Micron. 2004;35(3):201–219. 7. Gilchrest BA, Stoff JS, Soter NA. Chronologic aging alters the response to ultraviolet-induced inflammation in human skin. J Invest Dermatol. 1982;79(1):11–15. 8. Gilchrest BA. Age-associated changes in the skin. J Am Geriatr Soc. 1982;30(2):139–143. 9. Montagna W, Carlisle K. Structural changes in aging human skin. J Invest Dermatol. 1979;73(1):47–53. 10. Roskos KV, Maibach HI, Guy RH. The effect of aging on percutaneous absorption in man. J Pharmacokinet Biopharm. 1989;17(6): 617–630. 11. Grove GL. Age-related differences in healing of superficial skin wounds in humans. Arch Dermatol Res. 1982;272(3–4):381–385. 12. Van de Kerkhof PC, Van Bergen B, Spruijt K, Kuiper JP. Agerelated changes in wound healing. Clin Exp Dermatol. 1994;19(5): 369–374. 13. Arthur WT, Vernon RB, Sage EH, Reed MJ. Growth factors reverse the impaired sprouting of microvessels from aged mice. Microvasc Res. 1998;55(3):260–270. 14. Ashcroft GS, Horan MA, Ferguson MW. Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J Invest Dermatol. 1997;108(4):430–437. 15. Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol. 1997;183(2):169–176. 16. Ashcroft GS, Kielty CM, Horan MA, Ferguson MW. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous wounds of healthy humans. J Pathol. 1997;183(1):80–89. 17. Xia YP, Zhao Y, Tyrone JW, Chen A, Mustoe TA. Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: implication for chronic wounds in the elderly. J Invest Dermatol. 2001;116(1):50–56. 18. Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol. 1979;4(1):49–58. 19. Oender K, Trost A, Lanschuetzer C, Laimer M, Emberger M, Breitenbach M, Richter K, Hintner H, Bauer JW. Cytokeratin-related loss of cellular integrity is not a major driving force of human intrinsic skin aging. Mech Ageing Dev. 2008;129(10):563–571. 20. Blagosklonny MV. Prevention of cancer by inhibiting aging. Cancer Biol Ther. 2008;7(10):1520–1524.
137
138
13
Aging and Intrinsic Aging: Pathogenesis and Manifestations
21. Albright JW, Mease RC, Lambert C, Albright JF. Trypanosoma musculi: tracking parasites and circulating lymphoid cells in host mice. Exp Parasitol. 1999;91(2):185–195. 22. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008;7(21): 3344–3354. 23. Richardson CJ, Schalm SS, Blenis J. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol. 2004;15(2):147–159. 24. Inoki K, Ouyang H, Li Y, Guan KL. Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev. 2005; 69(1):79–100. 25. Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol. 1988;124(12): 1802–1804. 26. Hussein MR. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles. Exp Mol Pathol. 2009. 27. de Rigal J, Escoffier C, Querleux B, Faivre B, Agache P, Leveque JL. Assessment of aging of the human skin by in vivo ultrasonic imaging. J Invest Dermatol. 1989;93(5):621–625. 28. Roskos KV, Bircher AJ, Maibach HI, Guy RH. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: the effect of aging on microcirculation. Br J Dermatol. 1990;122(2): 165–171. 29. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol. 1990;45(2):M45–48. 30. Braverman IM, Fonferko E. Studies in cutaneous aging: II. The microvasculature. J Invest Dermatol. 1982;78(5):444–448. 31. Braverman IM, Fonferko E. Studies in cutaneous aging: I. The elastic fiber network. J Invest Dermatol. 1982;78(5):434–443. 32. Quatresooz P, Pierard GE. Immunohistochemical clues at aging of the skin microvascular unit. J Cutan Pathol. 2009;36(1):39–43. 33. Escoffier C, de Rigal J, Rochefort A, Vasselet R, Leveque JL, Agache PG. Age-related mechanical properties of human skin: an in vivo study. J Invest Dermatol. 1989;93(3):353–357.
34. Miyahara T, Murai A, Tanaka T, Shiozawa S, Kameyama M. Agerelated differences in human skin collagen: solubility in solvent, susceptibility to pepsin digestion, and the spectrum of the solubilized polymeric collagen molecules. J Gerontol. 1982;37(6):651–655. 35. Schnider SL, Kohn RR. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest. 1981;67(6):1630–1635. 36. Schnider SL, Kohn RR. Effects of age and diabetes mellitus on the solubility of collagen from human skin, tracheal cartilage and dura mater. Exp Gerontol. 1982;17(3):185–194. 37. Lipson MJ, Silbert JE. Acid mucopolysaccharides of tadpole tail fin and back skin. Biochim Biophys Acta. 1965;101(3):279–284. 38. Kondo K, Seno N, Anno K. Mucopolysaccharides from chicken skin of three age groups. Biochim Biophys Acta. 1971;244(3):513–522. 39. Daly CH, Odland GF. Age-related changes in the mechanical properties of human skin. J Invest Dermatol. 1979;73(1):84–87. 40. Makrantonaki E, Vogel K, Fimmel S, Oeff M, Seltmann H, Zouboulis CC. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol. 2008;43 (10):939–946. 41. Silver AF, Chase HB. An in vivo method for studying the hair cycle. Nature. 1966;210(5040):1051. 42. Downing DT, Stewart ME, Strauss JS. Changes in sebum secretion and the sebaceous gland. Dermatol Clin. 1986;4(3):419–423. 43. Procacci P, Zoppi M, Maresca M. Experimental pain in man. Pain. 1979;6(2):123–140. 44. Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. 1987;123(12):1638–1643. 45. Hope-Simpson RE. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc R Soc Med. 1965;58:9–20. 46. Vestal RE. Aging and pharmacology. Cancer. 1997;80(7):1302–1310. 47. Adly MA, Assaf HA, Hussein MR. Expression of the heat shock protein-27 in the adult human scalp skin and hair follicle: hair cycle-dependent changes. J Am Acad Dermatol. 2006;54(5):811–817.
38 Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast Mutsumi Okazaki
Introduction
Fibroblast
In the skin pigmentation, the actinic damage plays a major role [1], but the effect of chronologic cellular aging is also an important factor. The chief cellular components of the skin other than melanocytes are keratinocytes and fibroblasts, whose paracrine effects on melanocytes (rather than melanocyte itself) play an important role in the epidermal pigmentation [2–11]. Human keratinocytes express several melanogenic cytokines, such as endothelin-1 (ET-1) [2–4], granulocyte macrophage colony stimulating factor (GM-CSF) [5], stem cell factor (SCF), and basic fibroblast growth factor (bFGF) [7–9]. Human fibroblasts, on the other hand, secrete several melanogenic cytokines such as bFGF, HGF, and SCF [6, 10, 11]. Further, interleukin-1a (IL-1a), a pro-inflammatory cytokine, stimulates the production of ET-1 by keratinocytes and of HGF by fibroblasts [3, 12–14]. It has been reported that the overexpression of these melanogenic cytokines is responsible for the age-related pigment ary cutaneous disorders [15–17]. The age-associated change was studied in cytokine secretion by keratinocytes and fibroblasts based upon this paracrine cytokine network within the skin for epidermal pigmentation mechanisms.
Normal skin specimens were taken from Japanese patients (disused skin during plastic surgery, i.e., after the dog-ear correction). Informed consent was obtained from all patients. Fibroblasts were cultured from 19 specimens (age = 26.7 15.6, from 7 to 65 year old, 8 males, 11 females). The methods of isolation and culture of fibroblasts were reported previously [18]. Fibroblasts were grown in the fibroblast growth medium (FGM), which consists of Dulbecco’s modified Eagle’s medium (DMEM), 0.6 mg/mL glutamine, and 10% fetal calf serum (FCS). Third cultures of fibroblasts were used for the experiments. Fibroblasts were seeded in a 60 mm culture dish at a density of 5 105 cells/5 mL and cultured in FGM. After human fibroblasts had been cultured for 96 h at 37 C under a 5% CO2 atmosphere, the medium was collected to quantify HGF, SCF, and bFGF, respectively, by ELISA.
Correlation Between Age and Secretion of Melanogenic Cytokine Studies were planned to elucidate whether the aging of keratinocytes and fibroblasts was related to the potential to secrete several melanogenic cytokines. In the first experiment, the keratinocytes and fibroblasts derived from the skin of different chronological ages were cultured, and the secretions of melanogenic cytokines were evaluated by ELISA (enzyme-linked immuno-sorbent assay). The series of study were carried out with the informed consent of the person whose skin samples were used.
Keratinocyte Normal skin specimens were obtained from Japanese patients, and keratinocytes were cultured from 16 specimens (age = 28.0 17.1, from 7 to 64 years, 6 males, 10 females). The methods of isolation and culture of keratinocytes were reported previously [18]. Keratinocytes were grown in the serum-free keratinocyte growth medium (KGM; Kyokuto Seiyaku, Tokyo) which consists of MCDB153 with high concentrations of amino acids, transferrin (final concentration 10 g/mL), insulin (5 g/mL), hydrocortisone (0.5 g/mL), phosphorylethanolamine (14.1 g/mL), and bovine pituitary extract (40 g/mL). The final concentration of Ca2+ in the medium was 0.03 mM. Second cultures of keratinocytes were used for the experiment. Keratinocytes were seeded in a 60 mm culture dish at a density of 1.5 105 cells/5 mL, and cultured in KGM supplemented with 0.5% FCS. After human
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_38, # Springer-Verlag Berlin Heidelberg 2010
386
38
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast
keratinocytes had been cultured at 37 C under a 5% CO2 atmosphere for 72 h, the keratinocyte-conditioned medium was collected to quantify IL-1a, ET-1, and GM-CSF, respectively, by ELISA. The comparison of the cytokine concentration between male and female was carried out using unpaired t-test. And the scatter diagrams showing the relationship between age and cytokine concentration were drawn, and simple linear regression equations were calculated, and simple linear regression test was used to determine whether there was any correlation between age and
concentration of cytokine. A value of P <0.05 was considered statistically significant. 1. Cytokine secretion by fibroblasts No gender differences in the donor age and cytokine concentration were found between male and female. There was no correlation between age and cytokine concentration (R: coefficient of determination; HGF: R = 0.0054, P = 0.98; SCF: R = 0.19, P = 0.44; bFGF: R = 0.0064, P = 0.98) (> Fig. 38.1a–c).
. Figure 38.1 Scatter diagram showing the relationship between donor age and value of cytokine concentration in fibroblasts. The lines represent the linear regression equation (n = 19; R, coefficient of determination). (a) HGF y = 159 0.034x, R = 0.0054, P = 0.98; (b) SCF y = 191 0.84x, R = 0.19, P = 0.44; (c) bFGF y = 2.62 0.00079x, R = 0.0064, P = 0.98
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast
2. Cytokine secretion of keratinocytes No gender differences in the donor age and cytokine concentration were found between male and female. There was a significant correlation between age and IL-1a concentration (R = 0.71, P = 0.002). There was a relatively weak correlation between age and ET-1 concentration, but the correlation was not significant (R = 0.41, P = 0.051). No correlation existed between age and GM-CSF concentration (R = 0.32, P = 0.23) (> Fig. 38.2a–c).
38
In the second experiment, the secretions of IL-1a and ET-1 by keratinocytes were compared between the second and fifth cultures. In this study, the fifth cultures of keratinocytes derived from nine donors who were less than 30 years old were used. Cell cultures and ELISA assay were performed in the same way as the first experiments. A comparison of the cytokine concentrations between the second and fifth culture keratinocytes was carried out using paired t-test. A value of P <0.05 was considered statistically significant.
. Figure 38.2 Scatter diagram showing the relationship between donor age and value of cytokine concentration in keratinocytes. The lines represent the linear regression equation (n = 16; R, coefficient of determination). (a) IL-1a y = 4.0 + 0.36x, R = 0.71, P = 0.002*; (b) ET-1 y = 11.0 + 0.24x, R = 0.41, P = 0.051; (c) GM-CSF y = 15.3 + 0.17x, R = 0.32, P = 0.23
387
388
38
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast
. Figure 38.3 Comparison of IL-1a and ET-1 secretion by keratinocytes between second and fifth cultures. Each ELISA values (values are means SD derived from three wells of each specimens) of nine donors and average values (AV) are shown. *P <0.005 to second cultures. (a) IL-1a; (b) ET-1
The concentration of IL-1a was significantly increased in fifth cultures compared with second cultures (P <0.005), but the levels of ET-1 did not differ significantly (P = 0.52) (> Fig. 38.3a, b).
Conclusion The results suggest that increasing secretion (occurring as the cell ages) of IL-1a by keratinocytes may play a role in the age-associated skin change. Because IL-1a stimulated the ET-1 production by keratinocytes [3], and ET-1 induced an increase in tyrosinase activity and stimulated melanocyte proliferation [2–4], the increasing secretion of IL-1a by keratinocytes may be responsible for the accentuated cutaneous pigmentation associated with
aging. In the study, however, the correlation between age and ET-1 secretion by keratinocytes was not significant, although there was a weak correlation (R = 0.41, P = 0.051). One of the possible reasons for this is small sample size, and another is that the autocrine stimulation by IL-1a might not be as efficient on the aged keratinocytes under the specific culture condition. This is supported by the second experiment; the levels of ET-1 secretion did not differ significantly, although IL-1a secretion was significantly increased in old (the fifth) cultures compared with young (the second) cultures. In the culture methods used, keratinocytes derived from aged skin (approximately older than 30 years of age) can no longer proliferate vigorously after three to four serial subcultures. In a preliminary study, the keratinocytes derived from 1-year-old child could be cultivated
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast
serially for about seven to eight passages under these culture conditions when they are subcultured every 7 days. At seventh or eighth cultures, most of the cultures were composed of enlarged and flattened cells, and such cultures were considered senescent, and subculturing was not continued. These findings were consistent with those reported by Boyce and Ham [19], and the chronologic cellular age of the fifth culture can be estimated 30–40 years older than that of second culture. It was reported that after irradiation with ultraviolet B (UVB), ET-1 production by keratinocytes increased accompanied by significant secretion of IL-1a [3]. The study suggests that melanocytes in the aged skin are stimulated persistently by keratinocytes via IL-1a-ET-1 cascade, as if the skin were irradiated with UVB. Thus, epidermal pigmentation might be persistently accentuated in the aged skin. The study also suggests that there was no correlation between secretions of melanogenic cytokine by fibroblasts and cellular age. It was reported that human dermal fibroblasts from aged donors (over 80 years) produced more HGF than fibroblasts from young and middle-aged donors, and the production of HGF by human embryonic lung fibroblasts increased sharply after about 70% completion of their lifespan in culture, which is mainly due to autocrine stimulation by IL-1a [20]. IL-1a was reported to stimulate the expression of HGF in the fibroblasts
38
[12–14]. In this study, however, there was no correlation between age and HGF secretion, probably because the age of donor ranged from 7 to 65 years old. One hypothesis concerning age-associated cutaneous pigmentation can be proposed (> Fig. 38.4); the secretion of IL-1a by keratinocytes gradually increase with age, which stimulates ET-1 production by keratinocytes autocrinely and HGF production by dermal fibroblasts paracrinely, and these cytokines stimulate melanocyte proliferation and induce an increase of tyrosinase activity in melanocytes. On the other hand, the production of IL-1a by fibroblast would increase abruptly from the age of about 70 to 80 years, which stimulates HGF production by dermal fibroblasts autocrinely and ET-1 production by keratinocytes paracrinely. One of the limitations of the study is that skin specimens were obtained from various sites of the body; sitespecific differences of cytokine secretion could not be assessed because of small number of specimen involved. It is an essential variable whether the specimen was obtained from sun-exposed or sun-protected sites. To exclude the influence of acute sunlight exposure to the skin on the cytokine secretion, the isolated skin cells were used in culture (not use freshly isolated cells). Conversely, it was inevitable that biological age of the cultured cells used in the study is larger than age of donors (as was
. Figure 38.4 Schematic showing the hypothesis of the accentuated pigmentation in the aged skin. The secretion of IL-1a by keratinocytes gradually increase with age, which stimulates ET-1 production by keratinocytes autocrinely and HGF production by dermal fibroblasts paracrinely, and these cytokines stimu late melanocyte proliferation and induce an increase of tyrosinase activity in mel anocytes. On the other hand, the production of IL-1a by fibroblast would increase abruptly from the age about 70–80, which stimulates HGF production by dermal fibroblasts autocrinely and ET-1 production by keratinocytes paracrinely
389
390
38
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast
mentioned above, it is estimated that 7 days’ culture of keratinocyte corresponds to about 10–12 years of age). Another limitation of the study is that only Japanese specimens were used. There are some reports describing the differences of pigmentation, or response to ultraviolet radiation in the skin of different ethnic groups [21, 22]. It is probable that the general tendency for age-related change in the melanogenic cytokine secretion is common in all ethic groups, but there may be some ethnic difference. Because cytokine expression was evaluated with ELISA (protein level) in the study, the expression of membrane-bound SCF (m-SCF) of keratinocyte was not assessed; in epidermal keratinocyte, SCF is expressed as a membrane-bound form, not in a secretory or soluble cytokine form such as ET-1 [23]. Even in stimulated conditions such as following UVB exposure, only the expression of m-SCF is accentuated in epidermal keratinocytes [23]. Evaluation of the expression of m-SCF, mRNA might reveal a different mechanism of accentuated cutaneous pigmentation. It was reported that accentuated epidermal pigmentation in lentigo senilis and seborrheic keratosis are attributed to a larger amount of secretion of ET-1 by keratinocytes [15, 17]. The study suggests the probability that formations of such lesions in the older person are associated with an increasing production of IL-1a by epidermal keratinocyte. Furthermore, because IL-1a is a primary mediator that responds to inflammation and injury [24], the transcription of genes involved in skin inflammation may be persistently induced in the aged skin. Thus, it is probable that the aged skin are always exposed to the conditions like inflammation, and the increased potential to secrete IL-1a in aged keratinocytes is associated with various skin aging in addition to the epidermal pigmentation.
Acknowledgment I wish to thank Kotaro Yoshimura, Gentaro Uchida, and Kiyonori Harii for their contribution as co-researcher, and Hiroshi Ohtsu and Junji Kishimoto for their statistical suggestions.
References 1. Leyden JJ. Clinical features of aging skin. Br J Dermatol. 1990; 122(35):1–3.
2. Yada Y, Higuchi K, Imokawa G. Effect of endothelins on signal transduction and proliferation in human melanocytes. J Biol Chem. 1991;266:18352–18357. 3. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem. 1992;267:24675–24680. 4. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol. 1995; 105:32–37. 5. Imokawa G, Yada Y, Kimura N, et al. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem J. 1996;313:625–631. 6. Grabbe J, Welker P, Dippel E, et al. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res. 1994;161:78–84. 7. Halaban R, Langdon R, Birchall N, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol. 1988;107:1611–1619. 8. Puri N, van der Weel MB, de Wit FS, et al. Basic fibroblast growth factor promotes melanin synthesis by melanocytes. Arch Dermatol Res. 1996;288:633–635. 9. Scott G, Stoler M, Sarkar S, et al. Localization of basic fibroblast growth factor mRNA in melanocytic lesion by in situ hybridization. J Invest Dermatol. 1991;96:318–322. 10. Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun. 1991;176:45–51. 11. Imokawa G, Yada Y, Morisaki N, et al. Characterization of keratinocyte- and fibroblast-derived mitogens for human melanocytes – their roles in stimulated cutaneous pigmentation. Melanogenesis and malignant melanoma. In: Hori Y, Hearing VJ, Nakayama J (eds) Biochemistry, Cell Biology, Molecular Biology, Pathophisiology, Diagnosis and Treatment. Amsterdam: Elsevier Science B.V., 1996, pp. 35–48. 12. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of Hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun. 1992;188:235–243. 13. Maas-Szabowski N, Fusenig N. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol. 1996;107:849–855. 14. Mildner M, Mlitz V, Gruber F, et al. Hepatocyte growth factor establishes autocrine and paracrine feedback loops for the protection of skin cells after UV irradiation. J Invest Dermatol. 2007;127: 2637–2644. 15. Kadono S, Manaka I, Kawashima M, et al. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. J Invest Dermatol. 2001;116:571–577. 16. Hattori H, Kawashima M, Ichikawa Y, et al. The epidermal stem cell factor is over-expressed in lentigo senilis: Implication for the mechanism of hyperpigmentation. J Invest Dermatol. 2004;122: 1256–1265. 17. Teraki E, Tajima S, Manaka I, et al. Role of endothelin-1 in hyperpigmentation in seborrheic keratosis. Br J Dermatol. 1996;135: 918–923. 18. Okazaki M, Yoshimura K, Uchida G, et al. Correlation between age and the secretions of melanocyte-stimulating cytokines in cultured keratinocytes and fibroblasts. Br J Dermatol. 2005; 153(s3):23–29.
Aging and Melanocytes Stimulating Cytokine Expressed by Keratinocyte and Fibroblast 19. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol. 1983;81:33s–40s. 20. Miyazaki M, Gohda E, Kaji K, et al. Increased Hepatocyte growth factor production by aging human fibroblasts mainly due to autocrine stimulation by interleukin-1. Biochem Biophys Res Commun. 1998;246:255–260. 21. Tadokoro T, Yamaguchi Y, Batzer J, et al. Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol. 2005;124:1326–1332.
38
22. Wagner JK, Parra EJ, L Norton H, et al. Skin responses to ultraviolet radiation: effects of constitutive pigmentation, sex, and ancestry. Pigment Cell Res. 2002;15:385–390. 23. Hachiya A, Kobayashi A, Ohuchi A, et al. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet B-induced pigmentation. J Invest Dermatol. 2001; 116:578–586. 24. Murphy JE, Robert C, Kupper TS. Interleukin-1 and Cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol. 2000;114:602–608.
391
26 Aging Genital Skin and Hormone Replacement Therapy Benefits William J. Ledger
Introduction
Vaginal Changes
The most precise word that can be used to describe menopause is change. The most dramatic alteration in body function for older women is the cessation of menses, the usual monthly flow of bloody vaginal fluid. This obviously easily perceived and recognized phenomenon announces a new era for aging women; a new life passage with a loss of fertility and a growing awareness with new symptoms of the inexorable process of aging. This chapter will focus upon the impact of this part of the woman’s life cycle upon the vagina and the vulva.
This diminishment in estrogen levels dramatically changes the vagina. There is a major decrease in the amount of vaginal secretion and a loss in both the elasticity and capacity of the vagina. These changes become very apparent to women. The annual or biannual visit to the gynecologist becomes an unwelcome chore, for it is increasingly uncomfortable. Socially, intercourse can change from a pleasurable sensation to a painful event with a subsequent drop in libido. Parallel to these unpleasant alterations, the vaginal pH changes from the normal acid range of 4.5 or less to an alkaline reading greater than 4.5. Upon microscopic examination of the vaginal secretion in a saline preparation, menopausal women have smaller, more rounded immature vaginal squamous cells and a markedly diminished number of acid-producing bacteria, such as the lactobacilli. (> Fig. 26.1) These microscopic changes in the bacterial flora can be confirmed by culture. One report shows a marked diminishment in the number of probiotic lactobacilli, with lactobacilli the dominant vaginal species in only 13% of the menopausal subjects [2]. Anaerobes become the dominant species. The numbers of these organisms were previously held in check by the dominance of acid-producing bacteria like the lactobacilli. There are clinical consequences of these changes in the vaginal bacterial flora that can result in lifestyle alterations for these women. Perimenopausal and particularly post-menopausal women are colonized by Escherichiae coli at an increased incidence, and this is inversely related to the presence of lactobacilli [3]. These vaginal bacterial changes make the woman much more susceptible to lower urinary tract infection due to E. coli [4]. The protective effect of the lactobacilli, keeping the numbers of these gram-negative aerobes in check, has been lost, and the relatively short female urethra becomes an easier transit site for these pathogens. The perimenopausal woman is also much more prone to suffer from a grossly purulent and persistent vaginitis, named Desquamative Inflammatory Vaginitis (DIV) [5]. The hallmarks of this troublesome syndrome,
Estrogen The lack of the female hormone estrogen brings down hormonal activity that helps maintain the health of lower genital tract tissue. This loss results in the many changes that confront post-menopausal women. This absence is not an abrupt shift, the curtain does not suddenly fall one evening as the human drama of reproductive life ends, with the new playbill, postmenopausal existence beginning the next day. Instead, perimenopause, the transition period’s new name, describes the very gradual changes in the years or decades before the cessation of menses. This is a slow and inexorable process in which minute bodily alterations occur over months and years that are gradually perceived by the woman involved. Although early on, menstruation continues unabated, there is a drastic falloff in reproductive success. Assisted reproductive physicians note a stunning drop after the age of 42 in the ability of women to become pregnant, and those few who succeed have a high number of spontaneous first-trimester pregnancy losses [1]. Subsequently, these perimenopausal women notice changes in their menstrual cycle, which can vary from too frequent and heavier periods, to less frequent and lighter periods. Along with these menstrual changes, these women become aware of ‘‘hot flashes,’’ i.e., vasomotor instability, sleeping trouble, a dry and less lubricated vagina that makes intercourse much less pleasurable.
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_26, # Springer-Verlag Berlin Heidelberg 2010
258
26
Aging Genital Skin and Hormone Replacement Therapy Benefits
. Figure 26.1 Microscopic examination of vaginal secretions of an asymptomatic post-menopausal woman
. Figure 26.2 Superficial tissue changes of post-menopausal woman not on hormone replacement therapy
seen most commonly in women over the age of 40, are an alkaline pH, a negative whiff test when a drop of vaginal secretion is placed in a 10% potassium hydroxide mixture, the absence of lactobacilli, an increase in other bacterial forms, many immature vaginal squamous cells, and most significantly, an outpouring of inflammatory white cells. These vaginal changes have made older women more susceptible to urinary tract and vaginal infections.
Some women of this age group who are susceptible will develop a chronic inflammatory skin disease, lichen sclerosis, which predominantly affects the skin and mucous membranes of the vulvar and rectal area. This thinned vulvar skin also loses much of its natural surface defense mechanisms and is more likely to become and stay inflamed. This is an expected response. Post-menopausal women, not taking estrogen, have higher induced levels of the pro-inflammatory cytokine interleukin-1, interleukin-6, and tumor necrosis factor a when compared to women in their reproductive years [7]. The body’s response to this new inflammation is a repair process with new tissue formation. This new tissue regeneration in an inflammatory site is almost always accompanied by vulvar and perineal itching. This initiates a vicious cycle. The itching leads to scratching, often when the patient is asleep and unaware of her response. The scratching increases the tissue inflammation, and the cycle begins anew. This becomes a constant source of symptomatology leading to patient frustration. The thinning of the keratin layer of the labia majora and labia minora also diminishes the protection normally afforded against bacterial and fungal adhesion to this tissue site. The epithelial cells of reproductive-age women also produce many substances, such as peptides [8], that can kill potential bacterial or fungal pathogens. Lessened production of these substances in menopausal women increases the chances of infection. The resulting skin infections add to the inflammation. Vulvar fungal infections occur commonly in this aging population (> Fig. 26.3), and if not eradicated by treatment contribute to the cycle of inflammation,
Vulvar Changes There are visually apparent alterations in the vulva of postmenopausal women. The tremendous reduction in the levels of estrogen results in a loss of tissue elasticity and an obvious thinning of the vulvar tissue (> Fig. 26.2). This thinning, apparent to the naked eye, is accompanied by other significant subcutaneous changes. These become more noticeable when the V-600 Syris imaging system is used, which allows the observer to view the tissue two cell layers beneath the surface [6]. The thinning of the skin is highlighted. In addition, using a system of cross-polarized light visualization, there is decreased vascularity, more dryness, and more subdermal inflammation. On the surface, the vulvar skin becomes retracted with the tissue demarcations between the labia majora and labia minora becoming blunted. These changes are particularly apparent using the magnification of the colposcope. This thinner tissue area is much more fragile and more prone to splitting and cracking, at times leaving the distressed patient with a new symptom: a painful, slow-healing vulvar cut.
Aging Genital Skin and Hormone Replacement Therapy Benefits
. Figure 26.3 Candida Albicans infection of vulva of post-menopausal woman
26
this response by using commercially available, over-thecounter lubricants can have unintended results. These products contain propylene glycol, a chemical preservative to which some women with inflamed mucous membranes can develop sensitivities. This contact dermatitis increases even more the local inflammation and pain. To avoid this possibility, these couples should be advised to use mineral oil or olive oil as a pre-coital lubricant. They are unquestionably messy, but do not dry out over time with firm residual kernels of commercial products that can be an additional source of irritation, and they contain no chemicals that could cause a local tissue reaction.
Outside Influences: Hormone Replacement Therapy (HRT)
itching, scratching, and more inflammation. Bacterial infection of the vulva can be a life-threatening problem in post-menopausal women, particularly in diabetics in whom synergistic bacterial vulvar infections can occur, with tissue death requiring operative intervention for survival [9].
Outside Influences: Male The television advertisements of the American pharmaceutical industry are dominated by concerns about both male urinary function and sexual prowess. The theme of male erectile dysfunction vies with difficulty in urinary voiding as a lead-in to capture the attention of the male drug consumer. The models in the ads blend the knowing smiles of the older, but still physically rugged and vigorous male with the ‘‘come hither’’ looks of their very attractive female partners. For the viewer, the obvious result will be the nirvana of continued sexual satisfaction. For the post-menopausal sexual partner of these newly invigorated older males, there can be a tremendous downside for vaginal and vulvar skin health. The resulting increase in heterosexual activity can cause vaginal and/or vulvar lacerations because of the dryness and decreased elasticity of the lower genital tract skin and mucous membranes. This genital tract pain sets in place a cascade of continuing problems. Pain will reduce vaginal secretion and the memory of prior discomfort can result in heightened pelvic floor muscle contraction when insertion is attempted, making a prior unpleasant sexual experience even more uncomfortable. Reflex attempts to modify
Since most of the changes in the health of the vagina and vulva in perimenopausal and menopausal women are related to a lessened production of estrogen, it would be logical to assume that estrogen supplementation would be an aid for these women. This is true, within limits. Estrogen therapy is most helpful as a preventive measure. It is usually beneficial if given before the aging vaginal and vulvar tissue changes of thinning, loss of turgor and elasticity have become grossly apparent. It either prevents or markedly slows these genital skin and mucous membrane alterations. In the vagina of women receiving estrogen supplementation, the pH is as acidic as it was in the reproductive years, and the dominant bacterial flora remains the acid-producing lactobacilli. If the progressive tissue changes of thinning, inflammation, or lacerations occur, the effects of estrogen are much less dramatic. They may accelerate the healing of these cuts and decrease inflammation, but they do not return the tissue to a premenopausal state. These are not formulae for the ‘‘fountain of youth,’’ but they do halt further deterioration. Other pharmaceutical agents, such as topical adrenocortical steroids, are much better in combating local tissue inflammation and are frequently prescribed as an alternative therapy in women with inflammatory vulvar changes. Despite these shortcomings, the lifestyle of women taking supplemental estrogen is usually much improved. They experience less discomfort with intercourse and have fewer lower urinary tract infections. All of these are positive observations. The reader should reflexively wonder why there has not been a deluge of television advertisements for the improvement in female well-being and pleasure with estrogen replacement therapy to parallel the onslaught of ads trumpeting male well-being. This would give equal time to the current focus upon male
259
260
26
Aging Genital Skin and Hormone Replacement Therapy Benefits
sexual satisfaction. Instead, there is an absence of these ads and market evidence of a decrease in the current use of hormone replacement therapy (HRT) in American women. Why? This phenomenon of the current less frequent use of HRT in the United States has been largely driven by the publicity surrounding the results of Women’s Health Initiative (WHI) studies. These studies, sponsored by the National Institutes of Health (NIH), have highlighted the potential dangers for women taking systemic HRT. There is a small but increased risk of developing breast cancer in women taking HRT for 5 years or more [10]. This had been previously reported in earlier studies [11]. Other unexpected adverse outcomes were noted in asymptomatic menopausal women taking HRT. They had a greater chance of having either a heart attack or a stroke as compared to the population of women taking a placebo [10]. This was a surprise, for prior studies of HRT had shown beneficial effects, with a lowering of blood lipids [12]. This had been the basis for the medical dogma of the 1980s that HRT had cardiovascular and cerebrovascular benefits for all post-menopausal women. These WHI studies raised doubts about that hypothesis and led to a precipitous drop in the numbers American women using HRT. There were some major problems in the WHI postmenopausal women study design that have been too often overlooked. The focus of the WHI study was upon asympotomatic menopausal women. This in itself was appropriate, for if symptomatic women had been studied, there would have been an inordinate loss of women recruited for the study who were given the placebo. Their symptoms would have continued, and they would have been more likely to drop out of the study. Using asymptomatic women avoided this, but to recruit this population, one third of the women had been menopausal for over 5 years and another third had been menopausal for over 10 years. This fact should raise some concerns about the interpretation of the study. This is not the usual target group for HRT. The focus should be upon women who become symptomatic with perimenopause, with symptoms becoming more pronounced as they become menopausal. For the skin, the greatest benefits from estrogen treatment result from the prevention or slowing of the skinaging process and not from the treatment of established aging skin changes. This goal of HRT therapy – prevention, not treatment – was not reached in two thirds of the WHI study population. An interesting aside is that the minority one-third of these WHI study patients who received HRT within the first 5 years of menopause did not have the
increased cardiovascular and cerebrovascular risks noted in the other two-thirds. There are dangers of the use of systemic HRT for women, particularly an increased risk of breast cancer [13], but these have been over-emphasized to include local estrogren products while downplaying the benefits. Many women with vaginal or vulvar symptoms due to skin aging will benefit from a wide variety of local estrogen products, including creams, vaginal tablets, or a vaginal ring, none of which to date have been associated with any of the systemic risks that have been attributed to systemic HRT. The concerns about HRTs have been too widely publicized. All too often, many women will avoid these potentially beneficial local medications for they have been led to believe that the risks associated with systemic HRT apply to all estrogen products. This is unfortunate, because for many women, these agents improve their sense of worth for they help to modify at least some of the pitfalls of aging. Most of the older women using estrogen look and feel better. They are a selected population, for they were symptomatic prior to the use of these hormones. For them, the hormones improve their daily lives and the quality of their social interactions. These benefits for women should be cited as they have been for men. Males, taking drugs for erectile dysfunction, have an increased risk of heart attacks and blindness, both serious medical problems. These have not been the primary focus in discussion as have been the concerns about the risks for HRT for women.
Conclusion There is a gender gap here. For women, downplay benefits and stress the risks; for men, emphasize pleasure and gloss over the risks. This is a curious commentary upon the current American scene.
Cross-references > Biological
Effects of Estrogen on Skin Aging and Oral Hormone Replacement
> Climacteric
Therapy
References 1. American Society for Reproductive Medicine. Age and Fertility: A Guide for Patients (Patient Information Series). Birmingham: American Society for Reproductive Medicine, 2003.
Aging Genital Skin and Hormone Replacement Therapy Benefits 2. Hillier SL, Lau RJ. Vaginal microflora in post-menopausal women who have not received estrogen replacement therapy. Clin Infect Dis. 1997;25(Suppl 2):S123–126. 3. Pabich WL, Fihn SD, Stamm WE, et al. Prevalence and determinants of vaginal flora alternations in post-menopausal women. J Infect Dis. 2003;188:1054–1058. 4. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N Engl J Med. 1993;329:753–756. 5. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol. 1994;171:1215–1220. 6. Farage M, Singh M, Ledger WJ. Investigation of the sensitivity of a cross-polarized light visualization system to detect subclinical erythema and dryness in women with vulvovagintis. Am J Obstet Gynecol. 2009;201:1e1–1e6. 7. Pfeilschifter J, Kodtiz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23:90–119.
26
8. Hancock REW. Lationic peptides: effectors in innate immunity and novel antimocrobials. Lancet Infect Dis. 2001;1:156–164. 9. Addison WA, Livengood CH III, Hill GB, et al. Necrotizing fasciitis of vulvar origin in diabetes patients. Obstet Gynecol. 1984;63: 473–479. 10. Rossouw TE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomize controlled trial. JAMA. 2002;288:321–333. 11. Hulley S, Grady B, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA. 1998;280:605–613. 12. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–1477. 13. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in post-menopausal women. N Engl J Med. 2009;360:573–582.
261
19 Aging of Epidermal Stem Cells Alexandra Charruyer . Ruby Ghadially
Introduction Advances in aging biology indicate that stem cells have a crucial role in organ maturation and aging. Studies have demonstrated molecular and biochemical changes in tissue-resident progenitor cells and their microenvironments during chronological aging of tissues such as the heart [1], brain [2], and hematopoietic system [3]. In this chapter knowledge in the field of aging and stem cells derived from tissues other than the epidermis is reviewed, and the challenges of studying aging stem cells discussed. Subsequently, epidermal stem cells are reviewed and changes in progenitor populations of the epidermis that occur with age discussed. Finally, the body of knowledge specifically related to the aging of epidermal stem cells and the implications of stem cell aging for carcinogenesis are examined.
Aging and Stem Cells Changes in Stem Cell Frequency with Aging Information about the impact of aging on stem cells has been obtained from the hematopoietic system and it remains an ideal system for this type of study as stem and progenitor cells are most well defined in the hematopoietic system. The loss of immune function and the increased incidence of myeloid leukemia associated with aging were thought to be due to a decrease in hematopoietic stem cell frequency. Research has now contradicted this assumption. Several studies indicate that murine hematopoietic stem cell numbers increase substantially with age [4, 5]. Limiting dilution assays have shown that hematopoietic stem cells from aged mice were more efficient at myeloid reconstitution than hematopoietic stem cells from young mice. Aged hematopoietic stem cells were found to be five times as numerous, but one quarter as efficient at engrafting, as young hematopoietic stem cells, suggesting a small increase in reconstitution ability [5]. In another study, the relative number of the most primitive stem cell was found to be three- to fourfold higher in aged over young mice but there was a decrease in the proliferative activity
of aged hematopoietic stem cells [4]. These studies show that there is an increase in primitive precursors and a decrease in proliferative ability with aging. In skeletal muscle, estimates of stem cell (satellite cell) number have produced varying results. One study looking at DNA content and nuclei count by electron microscopy demonstrated an increase in the satellite cell number in aging rats [6]. Using flow cytometry and CD34 expression there was no difference in satellite cell frequency in aged and young murine muscles [7]. Finally, a microscopic study of skeletal muscle reported a decrease in satellite cells during aging [8]. Thus, a consensus has yet to be reached regarding the effect of aging on skeletal stem cell frequency.
Intrinsic Cellular Modifications in Stem Cells with Aging While changes in stem cell frequency play a role in aging, there is also evidence for intrinsic cellular modifications in stem cells with aging. It is challenging to distinguish intrinsic cellular aging from the effects of the cellular milieu when stem cells are studied in their natural environment, and the isolation of a pure stem cell population is needed (for review see [9]). Epidermal stem cells isolated from young and old mice based on their Hoechst dye exclusion were analyzed for gene expression profile by cDNA arrays. There was similar gene expression of 422 genes assayed in young and old epidermal stem cells [10]. Expression profiles of highly purified long-term repopulating hematopoietic stem cells showed that aging was associated with a down-regulation of genes mediating lymphoid function and up-regulation of genes involved in myeloid fate, indicating that the loss of immune function and the increase in leukemia in the elderly is due to intrinsic alterations in hematopoietic stem cells [11]. These latter studies provide evidence that the intrinsic properties of stem cells change with age.
Changes in the Stem Cell Niche with Aging Stem cell homeostasis is maintained not only by intrinsic factors, but also by extrinsic factors, such as the local
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_19, # Springer-Verlag Berlin Heidelberg 2010
192
19
Aging of Epidermal Stem Cells
environment of the stem cell niche, the surrounding tissue, the systemic milieu of the organism and the external environment (for review see [9, 12]). Age-related modifications of extrinsic factors may include alterations in the composition of the extracellular matrix, in membrane proteins and lipids, and in factors that constitute the systemic milieu. Modifications in the stem cell niche during the aging process have been addressed in Drosophila. The Drosophila germline stem cells together with the somatic cells present in the niche is one of the most well-defined stem cell niches [13]. In somatic niche cells from older Drosophila testes there is a decrease in expression of a cell adhesion molecule (DE-cadherin) and a self-renewal ligand (unpaired). This was correlated with an overall decrease in stem cell numbers inside the niche [14]. Furthermore, restoring self-renewal (unpaired) resulted in an increase of the number of germline stem cells in older males compared with age-matched controls. Thus modifications of the somatic cells that constitute the niche in aged testes, can affect the frequency of stem cells inside the niche. Furthermore, murine spermatogonial stem cells could be serially transplanted in young mice recipients without showing any decline in stem cell number or colony forming ability for more than 3 years, indicating that a young environment can influence stem cell self renewal capacity, and that the failure of niche integrity plays a key role in the reproductive deficit in aged mice [15]. The effect of environment on skeletal muscle satellite cells has been studied [16]. No significant differences were found in mass or maximum force between old muscles grafted into young hosts and young muscle grafted into those same young hosts. Conversely, young muscles grafted into old recipients did not regenerate better than old muscles grafted into the same old hosts, indicating an important role for the environment in muscle regeneration after transplantation. Conditioned medium from differentiated myotubes of young mice exhibited a strong mitogenic action on aged satellite cells in vitro, whereas no mitogenic action was observed from conditioned media of myotubes from aged mice, either on young or on aged satellite cells [17] (for review see [18]). More recently, systemic influences on aged satellite cells were investigated using parabiotic pairings in which regenerating tissues in aged animals were exposed either to their own serum or that of young mice (isochronic or heterochronic parabioses respectively) [19]. In this study, exposing injured muscles from old mice to heterochronic parabioses greatly improved muscle regeneration and myotubule formation was similar to that observed in young mice. The authors concluded that a young systemic environment
could improve the impaired regenerative ability of aged skeletal stem cells. These studies demonstrate the important influence of both the local and systemic environment within which stem cells reside.
Symmetric and Asymmetric Stem Cell Division and Aging Stem cells in the niche undergo two types of division, symmetric self-renewal divisions leading to two identical daughter cells and asymmetric divisions leading to one daughter cell identical to the original stem cell and another non-stem daughter cell that leaves the niche and undergoes differentiation [13, 20]. It is predicted that aged stem cells would have preserved or increased self-renewal potential (symmetrical divisions) and decreased asymmetrical divisions, and in order to maintain a constant rate of cellular production the aged will have more proliferation in the transit amplifying cells [21, 22]. Studies agree with this prediction; in different stem cell compartments including the hematopoietic system and the intestinal crypt there is an increase in transit amplifying cells with age [23] (for review see [21]).
Challenges of Studying Aging and Stem Cells Issues surrounding the study of aging include the study of aging versus development, the study of animals of an appropriate age, the heterogeneity of aged animals, and the lack of a pure population of stem cells from most tissues. Many studies are confounded by the use of neonatal versus adult or neonatal versus aged tissue. Such studies may not reflect changes of aging, but rather changes occurring during development from birth to adulthood. It is important to keep these studies distinct, and the focus here is on aging of epidermal stem cells from the adult to aged individual. In aging studies, the age of the aged animals to be studied is of great importance, and guidelines for such studies are limited. The definition of aging varies depending on the physiological system under question. For example, many age-related changes in the immune system are evident by the 70% survival point and even earlier, while kidney changes start later. The most common age used to model old age is somewhere around the 50% survival point, although it may vary from the 70% survival point to the 30% survival point. It has been stated that ‘‘without epidemic disease or exaggerated or lopsided
Aging of Epidermal Stem Cells
tumor incidence, the 50% survival point can be considered as an indicator of the onset of the senescent period’’ [24]. It is important to note that results from extremely aged animals are not reliable because they may be the consequence of advanced disease rather than aging. The best approach, although often difficult in practice, is to study multiple time points during the senescent period [25]. Aging is also difficult to study because of the heterogeneity that is associated with the aging process. Indeed, the variance in vital characteristics in the elderly is substantially higher compared with other groups of the population [26]. One universal characteristic of aging is the accumulation of molecular damage, which induces alterations in gene expression, genomic instability, mutations, tissue disorganization and organ dysfunction. Because of the low probability that two molecules will be damaged in the same way and with the same intensity substantial molecular heterogeneity results, and this leads to clinical heterogeneity in the elderly population [27]. While hematopoietic stem cells can be isolated at a single cell level [28], epidermal stem cell markers that allow isolation of epidermal stem cells at a single cell level are yet to be found. Studying populations of stem cells that are of unknown purity poses a challenge. Furthermore, the lack of a good understanding of the stem cell hierarchy in epidermis complicates studies further. In summary, studies of aging and in particular aged epidermal stem cells are profoundly affected by the choice of age for the young cohort, the choice of age for the aged cohort, the heterogeneity of the aged cohort, and the lack of a pure epidermal stem cell population for study.
Characterization of Epidermal Stem Cells The integrity of the epidermis is maintained by division of cells in the proliferative basal layer that replace differentiated cells in the outermost stratum corneum layer. Not all proliferative cells in the basal layer are stem cells. Transit-amplifying cells amplify the basal cell population but are limited to a finite number of divisions before they differentiate and are lost from the epidermis [29]. Stem cells of the basal layer are responsible for maintaining and generating the adult epidermis and its appendages, including hair follicles and sebaceous glands. Different stem cell niches have been described: (1) the follicular stem cell that resides in the hair follicle bulge [30, 31] (for review see [32]), (2) the interfollicular stem cell [33] (for review see [34]), and (3) the melanocyte stem cell localized in the hair follicle [35].
19
Phenotypic analysis of hematopoietic stem cells has provided the ability to separate the long-term proliferating cell from the less primitive cells detected in colonyforming assays [36]. These types of studies have allowed a hierarchy of hematopoietic stem cell differentiation to be determined. Different methods to isolate epidermal stem cells have been proposed, although very little has been achieved in defining a hierarchy of progenitors in the epidermis. Several of the most prevalent methods for isolating putative epidermal stem cells that have been used to study aging of epidermal stem cells are discussed here (> Table 19.1), including (1) side population (SP) cells that efflux Hoechst 33342 fluorescent dye [37, 38], (2) integrin a6 bright/CD71 dim human keratinocytes [39, 40], (3) collagen adhesion, and (4) a quantitative epidermal regeneration assay [33, 41]. Other methods/ markers such as label retaining cells [42], p63 [43], keratin 19 [44], keratin 15 [45] and elevated levels of b catenin [46] have also been reported as putative stem cell markers. Hoechst dye exclusion is an example of a method borrowed from other tissues that may be useful for isolating epidermal stem cells. Hematopoietic and muscle stem cells are identified by the ability of stem cells to exclude Hoechst 33342 dye [47, 48]. A multidrug resistance P-glycoprotein pump present in stem cells mediates this exclusion. This multidrug resistance pump is also associated with resistance to anti-cancer drugs and is over expressed in some cancer cell lines [49]. Basal epidermal cells also express this P-glycoprotein [50]. Cells showing Hoechst exclusion were defined as stem cells by their clonal ability, high proliferative potential, and the ability to recapitulate an epidermis in vitro [51]. Transit amplifying cells were identified as cells showing a medium forward and orthogonal scatter without regard to Hoechst exclusion. These cells could not maintain an epidermis in vitro [51]. A recent study of mouse epidermis, characterizing side population and non-side population cells showed that a6 integrin, b1 integrin, Sca-1, keratin 14, and keratin 19 were all highly expressed by side population cells, while CD34, CD71, and E-cadherin were more weakly expressed by side population cells than by non-side population cells. This demonstrates that side population cells express previously established stem cell associated proteins [52]. In contrast, it was found that side population keratinocytes are distinct from the label-retaining cell population, since side population cells and label retaining cells showed distinctly different and non-overlapping expression profiles of b1 and a6 integrins [37]. Thus although the frequency of epidermal stem cells in the Hoechst dye excluding population is unknown, this population
193
194
19
Aging of Epidermal Stem Cells
. Table 19.1 Prevalent methods for isolating putative epidermal stem cells Method Side population
Description
References
Cells that efflux Hoechst 33342 dye are highly clonogenic and recapitulate an epidermis in vitro.
Terunuma et al. [37], Triel et al. [38]
Integrin Quiescent cells. Li A, Simmons PJ, a6brightCD71dim High long-term Kaur P. [39], proliferative Terunuma et al. [40] capacity. Produce human skin equivalents with a stratified epidermis. Collagen adhesion
Cells that adhere rapidly to type IV collagen are highly proliferative in vitro. Can form a robust stratified epidermis in vitro.
Watt FM. [55], Jones PH, Harper S, Watt FM. [56], Kaur et al. [57]
In vivo epidermal repopulating unit
In vivo Schneider et al. [33], transplantation Strachan et al. [41], model (in chambers, Charruyer et al. [78] or by subcutaneous injection). Individual keratinocytes regenerate a cornified, stratified epithelium (epidermal repopulating unit/ ERU) for the long term.
Others
Label retaining cells, p63, keratin 19, keratin 15, b catenin.
Bickenbach JR. [42], Yang et al. [43], Stasiak et al. [44], Lyle et al. [45], Zhu AJ, Watt FM. [46]
contains cells with phenotypic attributes of stem cells and high proliferative potential in vitro. High a6 integrin and low transferrin receptor (CD71) expression are perhaps the most accepted epidermal stem cell markers to date [39, 53]. The a6 integrin bright, CD71 dull cells are relatively quiescent and populations of these cells have very high long-term proliferative capacity [39]. Tani et al observed that a6briCD71dim murine dorsal keratinocytes were a quiescent population of small cells, with
a high nuclear to cytoplasmic ratio, consistent with primitive cells. In addition, 1.4% of total isolated keratinocytes were both a6briCD71dim and label retaining cells [53]. In human skin, the a6briCD71dim population contained smaller cells with a high nuclear to cytoplasmic ratio, was capable of producing a high number of large colonies after 10 days of culture, and produced skin equivalents with a stratified and thick epidermis [54]. In summary, although the stem cell purity is unknown, in both human and mouse epidermis the a6briCD71dim population contains undifferentiated cells with colony forming ability in vitro. Determining how in vitro assays relate to stem cell behavior in vivo is complex and much of the evidence is inconsistent with the concept that a colony forming cell is a stem cell [33, 41]. Nonetheless the analysis of colony formation in vitro is an attractive and prevalent procedure used to define stem cell behavior. b1 integrin is expressed in all basal keratinocytes. As keratinocytes leave the basal layer they down-regulate the expression of b1 integrin [55]. Cells that adhere rapidly to a b1 integrin ligand, type IV collagen, were found to have a high proliferative potential in vitro, whereas cells that adhere slowly divide only a few times before all of their progeny undergo terminal differentiation [56]. Rapidly adherent cells also form a robust stratified epidermis in vitro [54]. 20–40% of basal cells have high b1 integrin expression, which is in great excess of the proportion of basal cells that are estimated to be stem cells in vivo and thus it is likely that high b1 integrin expression does not uniquely select for epidermal stem cells [56]. It is believed that stem cells cannot be defined based solely on their proliferative behavior in culture [57]. Stem cell populations lack the appropriate stimuli for growth in vitro and surrogate in vitro analyses to assess putative stem cell behavior may not accurately distinguish between epidermal stem cells and progenitors cells [41]. A quantitative epidermal regeneration assay was developed that involved the use of dissociated keratinocytes allowed to regenerate a cornified, stratified epithelium on top of dermal fibroblasts seeded onto the subcutaneous fascia of immunodeficient mice. By seeding progressively lower numbers of GFP-positive keratinocytes in this repopulation assay, limiting dilution analysis quantifies the frequency of cells with long-term repopulating ability in a given population. Chambers are kept for 9 weeks [33]. The value of an in vivo assay for epidermal stem cells is well recognized [41, 58]. Using the quantitative in vivo regeneration assay described above it is possible to quantify epidermal stem cells from different keratinocyte populations. The study of epidermal stem cells from different sources such as aged versus young or diseased versus
Aging of Epidermal Stem Cells
healthy would be greatly enhanced by the availability of pure populations of epidermal stem cells. To date techniques have been developed for enriching populations of keratinocytes for early progenitors, but not at the single cell level. Given the difficulty in finding specific stem cell markers, investigation is needed to determine combinations of markers that can enrich for epidermal stem cells at a single cell level. Markers found in stem cells from other tissues, embryonic stem cell markers, or even cancer stem cell markers found in tumorigenic tissues may provide useful strategies for the isolation of normal epidermal stem cells at a single cell level.
Aging and the Keratinocyte Proliferative Compartment Abundant historical studies in both human and animal models demonstrate that aging of the epidermis is accompanied by decreased proliferation, both basally and in response to proliferative stimuli [59–66]. These studies have led to the concept that epidermal stem cells, which are responsible for the maintenance of the epidermis, are involved in the aging process. The effect of aging on the keratinocyte proliferative compartment (stem cells and transit amplifying cells) has been studied in vivo. After skin injury, the regeneration of tissue requires stem cell mobilization [30, 67], which has made wound healing a valuable model for the study of the impact of aging on epidermal stem cells. A battlefield surgeon performed an early study of wound healing and age during World War I [68]. Using a cicatrisation index, the biological age of an injured soldier could be determined by measuring the rate of closure of war wounds. Soldiers in their thirties healed more slowly than those in their twenties. Standardized superficial skin wounds were created in young adults (18–25 years) and aged adults (65–75 years) and healing was monitored. By day 28, the younger group had completely restored their original skin markings, while the older cohort took double the time (56 days) [62]. A nonradioactive method, using Dansyl chloride that binds only to nonviable corneocytes, was used to measure stratum corneum transit time. Transit time was increased in aged persons and there was no difference in the number of horny layers, indicating that the increase in stratum corneum transit time in the aged was a reflection of decreased epidermal proliferation [63]. These studies of stem cells and transit amplifying cells provide some information on how the proliferative compartment of epidermis changes with aging in vivo, but not specifically on how the stem cell changes.
19
The effect of aging on keratinocyte proliferation has also been studied using in vitro models of aging. Rheinwald and Green compared the proliferative behavior of seven human newborn-derived keratinocyte cultures with 3-, 12- and 34-year-derived cultures [69]. Newborn-derived cultures were able to undergo 25– 51 cell generations versus 20–27 for older person-derived cultures and could be maintained through three to six passages versus two to three passages. In addition, plating efficiency (colony forming ability) was up to 15.7% for the newborn versus 0.7% for the older person-derived cultures. Another study using newborn human keratinocytes compared with adult human keratinocytes reported that while attachment rate is independent of donor age, plating efficiency was strongly dependent on donor age. Plating efficiency was 2–10% in newborn cultures and below 0.01% in adult cultures [61, 70]. It should be noted that the above in vitro studies may reflect development, aging, or a combination of development and aging since they used newborn human keratinocytes.
Aging and Epidermal Stem Cells The above in vivo and in vitro observations of aging and proliferation were made on the entire keratinocyte population and not on different proliferative subpopulations. To address the differences in behavior of proliferative keratinocyte subpopulations (stem cells versus transit amplifying cells), the growth potential of individual proliferative clones from different donors (two neonatal, one 64-year-old, and one 78-year-old) was studied [71]. After plating individual cells, resultant clones were passaged into a second dish. The original clone was classified by the appearance of cells in the secondary dish into holoclones (cells that form large rapidly growing colonies), paraclones (that form uniformly small, terminal colonies) and meroclones (that form both types of colonies). With age, the number of holoclones decreased and the number of paraclones increased when compared with newborns. The authors concluded that the culture lifetime of a keratinocyte population declines with the age of the donor, as demonstrated by the change in the proportion of the three clone types. After studying the effects of aging on keratinocyte proliferation in vitro, and with the study of stem cell frequency in the hematopoietic system, and the discovery of epidermal stem cell markers, several studies have now addressed the influence of aging on epidermal stem cell number. Such studies have produced varying results. There were twice as many stem cells in neonatal mouse
195
196
19
Aging of Epidermal Stem Cells
epidermis (1–2 days) as in adult (8–14 weeks) (8.4% versus 3.8%, respectively), using small size and Hoechst fluorescence to define a stem cell [72]. In a study of four human foreskins (from 1, 4, 35 and 61 year old donors), there was a decrease in the number of putative epidermal stem cells in adult versus neonatal human epidermis, as defined by a6 integrinhi CD71lo expression [73]. Such comparisons of adult and neonatal samples may reveal changes of development and/or aging. However, while neonatal murine epidermis had three times as many Hoechst dye-excluding cells as adult epidermis, the number of cells that could exclude Hoechst dye was unchanged in aged adult versus young adult murine epidermis [10]. The epidermal stem cells from young adults and aged adults had similar characteristics in culture, similar gene expression, and did not show extensive loss of telomeres with age. In the same study, epidermal stem cells isolated from 22-month-old transgenic mice that expressed GFP were injected into mouse blastocysts. Six months later various tissues of the resultant mice contained GFP positive cells, demonstrating that the developmental potency of murine epidermal stem cells is not altered with aging. It was concluded from this study that epidermal stem cells are resistant to cellular aging [10]. Furthermore, human and mouse keratinocytes that exclude Hoechst dye showed little variability in protein expression profiles in aged versus neonatal epidermis, suggesting that as epidermal stem cells age they do not substantially change their cellular characteristics [74]. The differing findings presented above could result from the study of keratinocytes of varying ages, their human or murine derivation, the possibility that different putative epidermal stem cells markers are not isolating the same population of progenitor cells, or that different methods have different efficacy in isolating epidermal stem cells. While the previous in vitro studies are very informative, skin aging has been difficult to study in vivo due to the lack of relevant models. A recent study attempted to address this issue by studying the effect of aging on keratin 15 positive progenitors from young (2–6 months) and aged (22–26 months) mice [75]. Using whole-mount immunostaining, they observed a similar number of keratin 15 positive bulge stem cells in follicles of both young and aged mice, suggesting that epidermal stem cell frequency is not affected by aging. Surprisingly, there was only a modest, and not statistically significant, decrease in proliferation as measured by Ki67. This is different from previous in vitro studies, and suggests that in vivo assays may produce different results in the study of skin aging and epidermal stem cells.
In order to examine in vivo, whether the decreased proliferative ability of aged epidermis could be explained by either quantitative and/or qualitative alterations in the stem and/or transit amplifying cell proliferative compartments, a quantitative in vivo transplantation assay was used similar to the hematopoietic assays that have been informative about changes in hematopoietic progenitors with aging [5, 76, 77]. In vivo transplantation assays of aged and young adult keratinocytes showed that while no significant difference in epidermal stem cell frequency could be detected, transit amplifying cell frequency was greater in the aged. With aging there was both an increased growth fraction (proportion of actively cycling cells) and longer cell cycle duration, resulting in prolonged existence of the short term repopulating cells in vivo. Finally, there was decreased cellular output from both individual epidermal stem cells and transit amplifying cells with aging (> Fig. 19.1). This suggests that increased cell cycle
. Figure 19.1 Epidermal repopulating units from aged progenitors are smaller and contain less cells than those from young progenitors at 1 and 11 weeks (bar = 10 mm)
Aging of Epidermal Stem Cells
duration contributes to the decreased cellular output from epidermal progenitors, while the larger growth fraction may be a compensatory mechanism [78].
5. 6.
Aging, Carcinogenesis, and Stem Cells Given the ability of stem cells to self-renew, proliferate and maintain homeostasis and the increase in incidence of cancer with aging, it is assumed that stem cells are involved in carcinogenesis. Recently a mechanistic link has been made between aging and carcinogenesis. It has been shown that senescent cells are more resistant to apoptosis [79] and have impaired DNA repair mechanisms [80]. Furthermore, senescent cells can survive for long periods of time, leading to the accumulation of damaged cells [81]. The resulting genetic instability leads to an increase in carcinogenesis (for review see [82]). The cancer stem cell hypothesis is being verified in different tissues including skin (for review see [83]). Because of similarities in the behavior of aging stem cells, senescent cells and cancer stem cells, it is thought that aged stem cells have a major role in the increased carcinogenesis associated with aging (for review see [84]).
7. 8.
9. 10. 11. 12. 13. 14.
15. 16.
17.
Conclusion This review discusses the changes in progenitor populations that occur with aging, and more specifically changes of the epidermis that occur with aging. The consensus of opinion appears to be that changes responsible for aging of tissues occur not only in the stem cell pool itself, but also in the transit amplifying cell compartment and in the stem cell environment. In order to study aging of epidermal stem cells it is essential to isolate epidermal stem cells at the single cell level to better define them at a molecular level. It will also be important to study the intrinsic and extrinsic changes that occur in the environment/niche of the epidermal stem cell with aging.
References 1. Anversa P, et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation. 2006;113:1451–1463. 2. Galvan V, Jin K. Neurogenesis in the aging brain. Clin Interv Aging. 2007;2:605–610. 3. Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007;42:385–390. 4. de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during
18. 19. 20.
21.
22.
23.
24. 25. 26. 27. 28. 29.
19
aging: correlation between lifespan and cycling activity. Blood. 1997; 89:1543–1550. Morrison SJ, et al. The aging of hematopoietic stem cells. Nat Med. 1996;2:1011–1016. Gibson MC, Schultz E. Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve. 1983;6:574–580. Conboy IM, et al. Notch-mediated restoration of regenerative potential to aged muscle. Science. 2003;302:1575–1577. Brack AS, Bildsoe H, Hughes SM. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J Cell Sci. 2005;118:4813–4821. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006;441:1080–1086. Stern MM, Bickenbach JR. Epidermal stem cells are resistant to cellular aging. Aging Cell. 2007;6:439–452. Rossi DJ, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA. 2005;102:9194–9199. Wallenfang MR. Aging within the Stem Cell niche. Dev Cell. 2007;13: 603–604. Xie T, Spradling AC. A niche maintaining germ line stem cells in the Drosophila ovary. Science. 2000;290:328–330. Boyle M, et al. Decline in self-renewal factors contributes to aging of the stem cell niche in the Drosophila testis. Cell Stem Cell. 2007;1: 470–478. Ryu BY, et al. Effects of aging and niche microenvironment on spermatogonial stem cell self-renewal. Stem Cells. 2006;24:1505–1511. Carlson BM, Faulkner JA. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol. 1989;256:C1262–C1266. Mezzogiorno A, et al. Paracrine stimulation of senescent satellite cell proliferation by factors released by muscle or myotubes from young mice. Mech Ageing Dev. 1993;70:35–44. Gopinath SD, Rando TA. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell. 2008;7:590–598. Conboy IM, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–764. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990;110:1001–1020. Lynch MD. Selective pressure for a decreased rate of asymmetrical divisions within stem cell niches may contribute to agerelated alterations in stem cell function. Rejuvenation Res. 2004;7:111–125. Meineke FA, Potten CS, Loeffler M. Cell migration and organization in the intestinal crypt using a lattice-free model. Cell Prolif. 2001; 34:253–266. Holt PR, Yeh KY, Kotler DP. Altered controls of proliferation in proximal small intestine of the senescent rat. Proc Natl Acad Sci USA. 1988;85:2771–2775. Walford RL. Letter: when is a mouse ‘‘old’’? J Immunol. 1976;117:352. Miller RA, Nadon NL. Principles of animal use for gerontological research. J Gerontol A Biol Sci Med Sci. 2000;55:B117–B123. Hocking TD. The physiology of human aging. www.ocf.berkeley. edu/tdhock/science/HumanAging.pdf. 2005. Rattan SI. Increased molecular damage and heterogeneity as the basis of aging. Biol Chem. 2008;389:267–272. Uchida N, et al. Heterogeneity of hematopoietic stem cells. Curr Opin Immunol. 1993;5:177–184. Potten CS. Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int Rev Cytol. 1981;69:271–318.
197
198
19
Aging of Epidermal Stem Cells
30. Taylor G, et al. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451–461. 31. Oshima H, et al. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell. 2001;104:233–245. 32. Ghadially R. In search of the elusive epidermal stem cell. In: The Promises and Challenges of Regenerative Medicine. Heidelberg: Springer, 2005. p. 45–62. 33. Schneider TE, et al. Measuring stem cell frequency in epidermis: a quantitative in vivo functional assay for long-term repopulating cells. Proc Natl Acad Sci USA. 2003;100:11412–11417. 34. Kaur P. Interfollicular epidermal stem cells: identification, challenges, potential. J Invest Dermatol. 2006;126:1450–1458. 35. Nishimura EK, et al. Dominant role of the niche in melanocyte stemcell fate determination. Nature. 2002;416:854–860. 36. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;1:661–673. 37. Terunuma A, et al. Side population keratinocytes resembling bone marrow side population stem cells are distinct from labelretaining keratinocyte stem cells. J Invest Dermatol. 2003;121: 1095–1103. 38. Triel C, et al. Side population cells in human and mouse epidermis lack stem cell characteristics. Exp Cell Res. 2004;295:79–90. 39. Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA. 1998;95:3902–3907. 40. Terunuma A, et al. Stem cell activity of human side population and alpha6 integrin-bright keratinocytes defined by a quantitative in vivo assay. Stem Cells. 2007;25:664–669. 41. Strachan LR, et al. Rapid adhesion to collagen isolates murine keratinocytes with limited long-term repopulating ability in vivo despite high clonogenicity in vitro. Stem Cells. 2008;26:235–243. 42. Bickenbach JR. Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res. 1981;60 (Spec No C):1611–1620. 43. Yang A, et al. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714–718. 44. Stasiak PC, et al. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol. 1989;92:707–716. 45. Lyle S, et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 1998;111(Pt 21):3179–3188. 46. Zhu AJ, Watt FM. Beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development. 1999;126:2285–2298. 47. Lin KK, Goodell MA. Purification of hematopoietic stem cells using the side population. Methods Enzymol. 2006;420:255–264. 48. Uezumi A, et al. Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun. 2006;341:864–873. 49. Kohno K, et al. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun. 1989;165:1415–1421. 50. Sleeman MA, Watson JD, Murison JG. Neonatal murine epidermal cells express a functional multidrug-resistant pump. J Invest Dermatol. 2000;115:19–23. 51. Dunnwald M, et al. Isolating a pure population of epidermal stem cells for use in tissue engineering. Exp Dermatol. 2001;10:45–54. 52. Yano S, et al. Characterization and localization of side population cells in mouse skin. Stem Cells. 2005;23:834–841.
53. Tani H, Morris RJ, Kaur P. Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA. 2000; 97:10960–10965. 54. Kim DS, et al. Isolation of human epidermal stem cells by adherence and the reconstruction of skin equivalents. Cell Mol Life Sci. 2004; 61:2774–2781. 55. Watt FM. Studies with cultured human epidermal keratinocytes: potential relevance to corneal wound healing. Eye. 1994;8(Pt 2): 161–162. 56. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell. 1995;80:83–93. 57. Kaur P, et al. Keratinocyte stem cell assays: an evolving science. J Investig Dermatol Symp Proc. 2004;9:238–247. 58. Kolodka TM, Garlick JA, Taichman LB. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA. 1998;95:4356–4361. 59. Cerimele D, Celleno L, Serri F. Physiological changes in ageing skin. Br J Dermatol. 1990;122(Suppl 35):13–20. 60. Gerstein AD, et al. Wound healing and aging. Dermatol Clin. 1993;11:749–757. 61. Gilchrest BA. In vitro assessment of keratinocyte aging. J Invest Dermatol. 1983;81:184s–189s. 62. Grove GL. Age-related differences in healing of superficial skin wounds in humans. Arch Dermatol Res. 1982;272:381–385. 63. Grove GL, Kligman AM. Age-associated changes in human epidermal cell renewal. J Gerontol. 1983;38:137–142. 64. Haratake A, et al. Intrinsically aged epidermis displays diminished UVB-induced alterations in barrier function associated with decreased proliferation. J Invest Dermatol. 1997;108:319–323. 65. Leyden JJ, et al. Age-related differences in the rate of desquamation of skin surface cells [proceedings]. Adv Exp Med Biol. 1978;97: 297–298. 66. Roberts D, Marks R. The determination of regional and age variations in the rate of desquamation: a comparison of four techniques. J Invest Dermatol. 1980;74:13–16. 67. Ito M, et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11: 1351–1354. 69. Nouy PLD. Biological Time. New York: The Macmillan Company, 1937. 69. Rheinwald JG, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature. 1977;265:421–424. 70. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6:331–343. 71. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA. 1987;84:2302–2306. 72. Dunnwald M, et al. Mouse epidermal stem cells proceed through the cell cycle. J Cell Physiol. 2003;195:194–201. 73. Youn SW, et al. Cellular senescence induced loss of stem cell proportion in the skin in vitro. J Dermatol Sci. 2004;35:113–123. 74. Liang L, et al. As epidermal stem cells age they do not substantially change their characteristics. J Investig Dermatol Symp Proc. 2004;9:229–237. 75. Giangreco A, et al. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell. 2008;7:250–259.
Aging of Epidermal Stem Cells 76. Harrison DE, Astle CM, Stone M. Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. J Immunol. 1989;142:3833–3840. 77. Sudo K, et al. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med. 2000;192:1273–1280. 78. Charruyer A, et al. Transit-amplifying cell frequency and cell cycle kinetics are altered in aged epidermis. J Invest Dermatol. 2009; 129(11):2574–2583. 79. Gniadecki R, Hansen M, Wulf HC. Resistance of senescent keratinocytes to UV-induced apoptosis. Cell Mol Biol (Noisy-le-grand). 2000;46:121–127. 80. Matta JL, et al. DNA repair and nonmelanoma skin cancer in Puerto Rican populations. J Am Acad Dermatol. 2003;49:433–439.
19
81. Bregegere F, et al. Cellular senescence in human keratinocytes: unchanged proteolytic capacity and increased protein load. Exp Gerontol. 2003;38:619–629. 82. Wulf HC, et al. Skin aging and natural photoprotection. Micron. 2004;35:185–191. 83. Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell. 2006;124:1111–1115. 84. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008;132:681–696.
199
50 Aging of Skin Cells in Culture Suresh I. S. Rattan
Introduction The study of age-related changes in the physiology, biochemistry, and molecular biology of isolated skin cell populations in culture has greatly expanded the understanding of the fundamental aspects of skin aging. In modern biogerontology, the terms ‘‘cellular aging,’’ ‘‘cell senescence,’’ or ‘‘replicative senescence’’ most commonly imply the study of normal diploid cells in culture, which during serial subcultivation undergo a multitude of changes culminating in the permanent cessation of cell division. This process of cellular aging in vitro is generally known as the Hayflick phenomenon, and the limited division potential of normal cells is called the Hayflick limit, in recognition of the observations first reported by Leonard Hayflick in 1961 [1]. With respect to skin aging, three main cell types have been studied extensively with respect to cellular aging in vitro: dermal fibroblasts, epidermal keratinocytes, and melanocytes [2–7]. The aim of this chapter is to describe the experimental system of aging of skin cells in culture, to provide an overview of the age-related changes in the structural and functional aspects of cells including physiological, biochemical, and molecular changes, and to evaluate the use of such a system in testing and developing effective interventions for maintaining and/or re-achieving a healthy skin during aging.
Experimental Model System of Cellular Aging in Culture Once the primary culture of normal cells is established in culture from the normal tissue (e.g., a skin biopsy), by using any of the standard methods such as the explant growth and enzymic dissociation of cells, the primary culture can then be subcultivated repeatedly at each time it becomes confluent. This repeated subculturing of cells is also known as serial passaging [1]. In a description of the Hayflick phenomenon, Phase I is the period of the establishment of the primary culture from normal tissue; Phase II is a relatively long period of serial passaging,
growth, and cell proliferation at a constant rate; and Phase III, is the final period of slowing-down of growth, which results in the cessation of cell division and end of replicative lifespan of cells. The whole duration of serial passaging is considered as the process of cellular aging and the end-stage irreversible growth arrest in G1 is termed as replicative senescence. After reaching a state of replicative senescence, some cells can still stay alive and be metabolically active at a minimal level for sometime and generally resist undergoing apoptosis [1]. Although the exact culturing conditions, such as the type of the culture medium, the source of growth factors, the use of antibiotics, and the incubation temperature, humidity, and gaseous composition may vary for different cell types, serial subcultivation of normal diploid cells can be performed only a limited number of times. This is in contrast to the high proliferative capacity of transformed, cancerous, and immortalized cells, whose cultures can be subcultivated and maintained indefinitely. The total number of cell divisions, measured as the cumulative population doublings (CPD), which can be achieved by a specific cell type in vitro, depends upon several biological factors. These include the maximum lifespan of the species, developmental and adult age of the donor of the tissue biopsy, the site of the biopsy, and the health status of the donor [8]. For example, for human fibroblasts the range of CPD for the cell strains originating from embryonic tissues is between 50 and 70, whereas for those originating from adult biopsies it is generally less than 50 CPD. A similar range for CPD attained by human keratinocytes and melanocytes has been reported [2–7]. Additionally, gaseous composition, especially oxygen levels, and the quality of the nutritional serum and growth factors added to the culture medium, can significantly affect the proliferative lifespan of cells in vitro. For example, culturing of fibroblasts in vitro in the air with about 20% oxygen levels reduces their replicative lifespan, which could be otherwise achieved at low level (2%) concentration akin to in vivo conditions [9, 10]. Furthermore, the site of the skin biopsy, for example, sun-exposed versus sun-protected area has a significant effect on the CPD levels achieved by cells in culture [1, 11, 12].
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_50, # Springer-Verlag Berlin Heidelberg 2010
488
50
Aging of Skin Cells in Culture
The Phenotype of Aging Skin Cells Serial passaging of normal diploid skin cells is accompanied by a progressive and accumulative occurrence of a wide variety of changes before the final cessation of cell replication occurs. The emerging senescent phenotype of serially passaged normal diploid skin cells can be categorized into the structural, physiological, and biochemical and molecular phenotypes, which can be used as biomarkers of cellular aging in vitro, as summarized in > Tables 50.1–50.3. There are more than 200 such structural, physiological, biochemical, and molecular characteristics that have been studied during cellular aging, and a list of major characteristics that appear progressively in cell cultures, and distinguish between young and senescent cells, generally before the end of proliferative lifespan and their irreversible arrest in the G1 phase of the cell cycle, can be found in several publications [13–15]. A summary of such phenotypic changes is given below. . Table 50.1 Structural phenotype of skin cells undergoing aging in culture ● Increased cell size ● Change of shape from thin, long, and spindle-like to flattened and irregular ● Loss of fingerprint-like arrangement in parallel arrays on the cell culture substrate ● Rod-like polymerization of the cytoskeletal actin filaments and disorganized microtubules ● Increased membrane rigidity ● Increased multinucleation ● Increased number of vacuoles and dense lysosomal autophagous bodies
Structural phenotype > Table 50.1 lists the major structural changes observed in aging skin cells in culture. Most commonly, a progressive increase in cell size and the loss of homogenous morphological pattern are the most dramatic and easily identifiable differences in early passage young and late passage old or senescent cells. Other structural changes during aging of skin cells include cytoskeletal and membrane rigidity, accumulation of intracellular debris, and incomplete cytokinesis leading to multinucleation (> Fig. 50.1). In addition to the gross structural alterations listed in > Table 50.1, there are several ultrastructural changes reported by using electron microscopic methods. These include the presence of distorted mitochondria, increased level of chromosomal aberrations, overcondensation of chromatin, increased nucleolar fragmentation, and the accumulation of lipid–protein conjugate lipofuscin in lysosomes [16–18]. Functional phenotype Numerous studies have been performed elucidating changes in various functional and physiological parameters of skin cells undergoing aging. > Table 50.2 lists some of the main changes, which clearly indicate that almost all aspects of cellular function and physiology become impaired during aging. Collectively, these data show that aging skin cells progressively become less active, have reduced ability to maintain various physiological functions, and become more prone to the negative effects of harmful substances.
. Table 50.3 Biochemical and molecular phenotype of skin cells undergoing aging in culture ● Permanent growth arrest in late G1 phase of the cell cycle near the S phase boundary ● Increased mRNA and protein levels of cell cycle inhibitors
. Table 50.2 Physiological phenotype of skin cells undergoing aging in culture ● Altered calcium flux, pH, viscosity, and membrane potential
● Increased mRNA and protein levels of inhibitors of proteases ● Decreased expression, levels, and activities of numerous house-keeping enzymes ● Decreased expression, levels, and activities of macromolecular turnover pathways ● Reduced levels of methylated cytosines in the DNA
● Reduced activity of ionic pumps
● Reduced length of telomeres
● Reduced mobility ● Reduced respiration and energy production
● Increased levels of damage in nuclear and mitochondrial DNAs
● Reduced response to growth factors and other mitogens
● Increased levels of damaged and abnormal proteins
● Increased sensitivity to toxins, drugs, irradiation, and other stresses
● Increased levels of macromolecular cross-linking ● Increased levels of reactive oxygen species
Aging of Skin Cells in Culture
50
. Figure 50.1 This figure shows Giemsa-stained light microscopic phase-contrast pictures of serially passaged human skin fibroblasts at various points in their in vitro lifespan. Sparse and confluent cultures at three stages during replicative lifespan are compared: (1) early passage young adult skin fibroblasts with less than 30% lifespan completed; (2) middle-aged cells with 60–80% replicative lifespan completed; and (3) late passage senescent cells with more than 95% lifespan completed
Altered responsiveness of cells during aging is one of the most significant age-related changes, which can be a rate-limiting factor for the use of any potential modulators of aging. Several studies have been performed in order to understand the mechanisms for age-related alteration of responsiveness, and the pathways include unaltered receptor numbers and affinities, ineffective signal transduction, and interrupted networks [8]. Biochemical and molecular phenotype At the biochemical and molecular levels, a large body of data is available, which indicates that skin cells undergo a plethora of changes, which form the mechanistic bases of structural and physiological alterations. > Table 50.3 gives a list of main categories of biochemical and molecular changes that have been reported in aging skin cells in culture.
Depending on the available technologies and the prevailing trends, changes in the amounts and activities of thousands of proteins, and in the levels of thousands of mRNAs have been reported for aging skin cells. Recently, data are beginning to be collected for age-related changes in the so-called epigenome, metabolome, and proteome, including posttranslational modifications [19–21]. All such data will further strengthen the descriptive understanding of the phenomenon of aging of skin cells. Although every single piece of descriptive data for aging skin cells is yet to be collected, a generalized picture of the aging phenomenon has emerged. Therefore, based on the large amount of data collected so far, important inferences and generalizations can already be made, which
489
490
50
Aging of Skin Cells in Culture
have implications with respect to developing effective interventions for a healthy skin. These are as follows: 1. The rate and phenotype of aging is different in different cell types. There are both common features and specific features of aging of skin fibroblasts, keratinocytes, melanocytes, and other cell types. 2. A progressive accumulation of damage in all types of macromolecules is a universal feature of cellular aging in all cell types. 3. Replicative senescence of cells in culture is not due to the activation of any aging-specific genes, but is an indirect consequence of occurrence and accumulation of molecular damage and molecular heterogeneity. 4. A progressive failure of molecular maintenance and repair pathways is the ultimate cause of cellular aging.
From Cellular Aging In Vitro to Understanding Aging In Vivo The Hayflick system of aging of skin cells in culture has proved to be very useful in developing the cellular and molecular understanding of the overall process of aging. A loss of proliferative capacity of any of the cell types has a deteriorative impact on the functioning and survival of the entire organism. A loss or slowing-down of proliferation of osteoblasts, glial cells, myoblasts, epithelial cells, lymphocytes, and fibroblasts can lead to the onset of many age-related diseases and impairments including osteoporosis, arthritis, immune deficiency, altered drug clearance, delayed wound healing, and altered functioning of the brain. Furthermore, occurrence of fully senescent or near-senescent heterogenous cells in vivo can promote dysfunctioning of the other tissues by producing harmful signals, and can also promote and stimulate the growth of other precancerous and cancerous cells [22–25]. However, the existence of the Hayflick-type senescent cells in vivo is not very well established so far. A commonly used biomarker of senescent cells is the so-called senescenceassociated beta-galactosidase (SABG), which has been used to demonstrate the presence of senescent cells in human skin and some other tissues [23, 26, 27]. However, there are several limitations regarding the use of SABG as a marker of cellular aging in vitro, since SABG can also be detected in immortal cells under various conditions [28]. More and multiple independent markers of senescent cells are needed for this purpose. The correlation between cellular aging in vitro and in vivo is often based on the evidence gathered from studies on the effects of donor age, species lifespan, and
premature aging syndromes on cellular proliferative capacity in culture. These studies indicate that the genetic and intrinsic Hayflick limit of diploid cell strains in culture is a true reflection of what is going on during aging of an organism. However, there are some recent critiques of this based on the replicative potential of stem cells, which in the case of the skin appear to be maintained throughout lifespan [8, 29, 30]. In contrast to this, there is evidence showing that the stem cell population in the skin also undergoes aging, and the number of stem cells declines as a function of donor age and during aging of the skin equivalents in vitro [31].
Modulators of Aging Skin Cells The Hayflick system of cellular aging in culture is primarily a model for the study of slow and progressive accumulation of damage resulting in the arrest of cells in a nonproliferative state [1]. This system has been proved to be very useful for testing various physical, chemical, and biological conditions for their harmful or beneficial effects, and for understanding other aspects of cellular aging with implications in the origin of age-related diseases. For example, irradiation, severe oxidative stress by UV, hydrogen peroxide, or dicarbonyls, and gene transfection have been used to induce a sudden and rapid increase in molecular damage, resulting in premature appearance of the senescent phenotype [32–34]. On the other hand, insertion of catalytically active component of the telomerase gene can completely bypass the Hayflick limit in many cell types including skin cells, and such cells can proliferate indefinitely with or without becoming transformed [35, 36]. Similarly, normal diploid cells can be transformed and immortalized by chemical carcinogens, irradiation, and viral genes. Such approaches are helpful for unravelling the molecular details of cell cycle regulation in normal cells and its dysregulation in cancer cells [36]. The Hayflick system of cellular aging in culture has also been very useful for testing various natural and synthetic molecules as potential anti-aging compounds for the skin. Some of the well-tested examples are cytokinins kinetin and zeatin [37, 38], a dipeptide carnosine [39, 40], and extracts from medicinal plants and some algae [41]. Several of these tests have resulted in the successful development, production, and marketing of various products with pharmaceutical, cosmeceutical, and nutritional applications [42–45]. Another use of the model system of cellular aging in culture has been to test the principle of mild
Aging of Skin Cells in Culture
stress-induced beneficial and anti-aging effects, which is the phenomenon of hormesis [46]. For example, human skin fibroblasts and keratinocytes exposed to repeated mild heat stress (41 C, 1 h, twice a week) show several hormetic effects, such as improved protein degradation pathways, higher levels of chaperones, increased resistance to other stresses, improved differentiation, and increased proliferative lifespan [7, 46–48]. Such studies can form the basis of testing novel hormetic agents, including potential hormetins of natural or synthetic origin, for improved skin care during aging [7, 46–48].
Conclusion In conclusion, it may be reemphasized that the present understanding of the cellular and molecular basis of aging of the skin owes a lot to the use of the Hayflick system of aging of skin cells in culture. Most importantly, studies performed by using this model system have demonstrated that aging of cells is characterized by the accumulation of damage in various molecules, which results in the failure of maintenance and repair systems. Detailed genomic, proteomic, and metabolomic studies using this system can further identify the interacting networks of regulatory pathways, which may be accessible to modulation for the maintenance of the structural and functional integrity of the skin.
Cross-references > The
Use of Reconstructed Skin to Create New In Vitro Models of Skin Aging with Special Emphasis on the Flexibility of Reconstructed Skin
References 1. Rattan SIS. Cellular senescence in vitro. In: Encyclopedia of Life Sciences. 2008. doi: 10.1002/9780470015902.a0002567.pub2. 2. Norsgaard H, Clark BFC, Rattan SIS. Distinction between differentiation and senescence and the absence of increased apoptosis in human keratinocytes undergoing cellular aging in vitro. Exp Gerontol. 1996;31:563–570. 3. Yaar M, Gilchrest BA. Ageing and photoageing of keratinocytes and melanocytes. Clin Exp Dermatol. 2001;26:583–591. 4. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445:843–850. 5. Berge U, Behrens J, Rattan SIS. Sugar-induced premature aging and altered differentiation in human epidermal keratinocytes. Ann N Y Acad Sci. 2007;1100:524–529. 6. Berge U, Kristensen P, Rattan SIS. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci. 2006;1067:332–336.
50
7. Berge U, Kristensen P, Rattan SIS. Hormetic modulation of differentiation of normal human epidermal keratinocytes undergoing replicative senescence in vitro. Exp Gerontol. 2008;43:658–662. 8. Cristofalo VJ, Lorenzini A, Allen RG, Torres C, Tresini M. Replicative senescence: a critical review. Mech Age Dev. 2004;125:827–848. 9. Packer L, Fuehr K. Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature. 1977;267:423–425. 10. Chen Q, Fischer A, Reagan JD, Yan L-J, Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA. 1995;92:4337–4341. 11. Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol. 2003;48:1–19. 12. Knott A, et al. Deregulation of versican and elastin binding protein in solar elastosis. Biogerontology. 2009;10:181–190. 13. Holliday R. Understanding Ageing. Cambridge: Cambridge University Press, 1995, pp. 207. 14. Rattan SIS. Ageing – a biological perspective. Molec Aspects Med. 1995;16:439–508. 15. Marcotte R, Wang E. Replicative senescence revisited. J Gerontol Biol Sci. 2002;57A:B257–B269. 16. Macieira-Coelho A. Ups and downs of aging studies in vitro: the crooked path of science. Gerontology. 2000;46:55–63. 17. Lezhava T. Human chromosomes and aging: from 80 to 114 years. New York: Nova Sciience Publishers, 2006. 18. Stroikin Y, Dalen H, Brunk UT, Terman A. Testing the ‘‘garbage’’ accumulation theory of aging. mitotic acitivity protects cells from death induced by inhibition of autophagy. Biogerontology. 2005; 6:39–47. 19. Borlon C, et al. Expression profiling of senescent-associated genes in human dermis from young and old donors. Proof-of-concept study. Biogerontology. 2008;9:197–208. 20. Molinari J, Ruszova E, Velebny V, Robert L. Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts. Biogerontology. 2008;9:177–182. 21. Xie L, Pandey R, Xu B, Tsaprailis G, Chen QM. Genomic and proteomic profiling of oxdiative stress response in human diploid fibroblasts. Biogerontology. 2009;10:125–151. 22. Krtolica A, Parrinello S, Lockett S, Desprez P-Y, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001;98: 12072–12077. 23. Parrinello S, Coppe JP, Krtolica A, Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci. 2005;118:485–496. 24. Campisi J. Senescent cells, tumor suppression, and orgnismal aging: good citizens, bad neighbors. Cell. 2005;120:513–522. 25. Blagosklonny MV, Campisi J. Cancer and aging: more puzzles, more promises? Cell Cycle. 2008;7:2615–2618. 26. Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–9367. 27. Hornsby PJ. Cellular senescence and tissue aging in vivo. J Gerontol Biol Sci. 2002;57A:B251–B256. 28. Yang NC, Hu ML. The limitations and validities of senescence associated-b-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp Gerontol. 2005;40:813–819. 29. Rubin H. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol. 2002;20:675–681. 30. Giangreco A, Qin M, Pintar JE, Watt FM. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell. 2008; 7:250–259.
491
492
50
Aging of Skin Cells in Culture
31. Youn SW, et al. Cellular senescence induced loss of stem cell proportion in the skin in vitro. J Dermatol Sci. 2005;35:113–123. 32. Toussaint O, et al. Stress-induced premature senescence as alternative toxicological method for testing the long-term effects of molecules under development in the industry. Biogerontology. 2000;1:179–183. 33. Sejersen H, Rattan SIS. Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts. Biogerontology. 2009;10:203–211. 34. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593–602. 35. Simonsen JL, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20:592–596. 36. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130:223–233. 37. Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun. 1994;201:665–672. 38. Rattan SIS, Sodagam L. Gerontomodulatory and youth-preserving effects of zeatin on human skin fibroblasts undergoing aging in vitro. Rejuven Res. 2005;8:46–57. 39. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res. 1994;212:167–175.
40. McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999;34:35–45. 41. Nizard C, et al. Algae extract protection effect on oxidized protein level in human stratum corneum. Ann N Y Acad Sci. 2004; 1019:219–222. 42. Glaser DA. Anti-aging products and cosmeceuticals. Facial Plast Surg Clin N Am. 2004;12:363–372. 43. Rattan SIS. N6-furfuryladenine (kinetin) as a potential anti-aging molecule. J Anti-Aging Med. 2002;5:113–116. 44. Chiu PC, Chan CC, Lin HM, Chiu HC. The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol. 2007;6:247–253. 45. McCullough JL, Weinstein GD. Clinical study of safety and efficacy of using topical kinetin 0.1% (Kinerase) to treat photodamaged skin. Cosmet Dermatol. 2002;15:29–32. 46. Rattan SIS. Hormesis in aging. Ageing Res Rev. 2008;7:63–78. 47. Rattan SIS, Ali RE. Hormetic prevention of molecular damage during cellular aging of human skin fibroblasts and keratinocytes. Ann N Y Acad Sci. 2007;1100:424–430. 48. Rattan SIS. Hormetic modulation of aging in human cells. In: Le Bourg E, Rattan SIS (eds) Mild Stress and Healthy Aging: Applying Hormesis in Aging Research and Interventions. Dordrecht: Springer, 2008, pp. 81–96.
Metabolism
29 Alterations of Energy Metabolism in Cutaneous Aging Thomas Blatt . Horst Wenck . Klaus-Peter Wittern
Introduction Aging is understood as the result of a complex interaction of biological processes that are caused by both environmental processes (extrinsic aging) and genetic processes (intrinsic aging). Research into the biology of aging has provided detailed insight into the molecular mechanisms of age-related changes in organs, tissues, and cells. Most information relating to intrinsic aging processes comes from tissues other than the skin. This is in part due to the fact that clinically manifest diseases such as Type2 diabetes or neurodegenerative disease are often correlated with aging of cells. In part it is also due to the fact that substantial amounts of primary cells and organelles for biochemical analyses can be more easily isolated from other organs such as muscle, brain, or liver, as compared with skin. Nevertheless, intrinsic aging is based on general biological processes that apply more or less to all proliferating cells and terminally differentiated cells as well. Therefore, general intrinsic aging processes seen in a liver cell, muscle cell, or neuron can be expected also to apply more or less to skin cells. In fact, most of the aging processes identified and studied with other cells could also be confirmed with keratinocytes or dermal fibroblasts, even though some downstream details may be different. Extrinsic aging processes have been intensively studied in the skin though. This applies especially to a process called photoaging, which is induced by the skin’s most dominant stressor – UV light. In contrast to skin, UV light is an irrelevant stressor to other tissues. Researchers have developed a battery of slightly invasive or non-invasive biophysical measurement procedures to study UV-induced stress and aging-related damage in situ even in small skin samples. Furthermore, many in vitro methods are available to study photoaging based on cultured cells or threedimensional cultured skin models. Besides UV light, there are many other extrinsic stressors, encompassing, for example, environmental chemicals, nutritional conditions, or even hormonal imbalances which may induce extrinsic aging of the skin and other organs as well.
This overview will focus on aspects of energy metabolism in cutaneous aging. These aspects are especially important since human skin tissue, being exposed to a plethora of endogenous and environmental stress factors, is highly dependent on energy supply in order to combat cellular deregulation and/or to repair damage. As detailed below, cellular energy levels decline during intrinsic and extrinsic aging as well, and consequently the capacity of the skin to counteract environmental stress declines with aging. Decreased compensation of environmental stress and insufficient repair, in turn, accelerate skin aging, which consequently leads to further decline of cellular energy levels in the skin. Breaking this feedback loop by sustaining cellular energy levels in the skin is thought to decelerate, stop, or even reverse intrinsic and extrinsic skin aging, with compounded interest over time.
Phenomenology of Energetic Factors Associated with Skin Aging The energy demand of skin cells is supplied by two major primary sources – mitochondrial oxidative phosphorylation and glycolysis. In addition to these major primary sources, skin cells may also utilize a major secondary energy store for situations of acute high energy demand – the creatine/phosphocreatine system. As detailed below, all three major energy sources are affected by intrinsic and extrinsic skin aging and offer potential entry points for intervention strategies to decelerate the aging process.
Aging Effects on Mitochondrial Function The mitochondria, as small oxidative power-plants in the cells, play a pivotal role in energy supply. Beyond energy production, mitochondria can perform other pivotal cellular functions such as regulation of programmed cellular death (apoptosis). These organelles contain their own genetic material, mitochondrial DNA (mtDNA), which
M. A. Farage, K. W. Miller, H. I. Maibach (eds.), Textbook of Aging Skin, DOI 10.1007/978-3-540-89656-2_29, # Springer-Verlag Berlin Heidelberg 2010
296
29
Alterations of Energy Metabolism in Cutaneous Aging
is maternally inherited. Although much smaller than the nuclear genome, mtDNA is equally important, as it has been shown to play a crucial role in aging, as discussed in detail in the section Genetic Damage to Mitochondria of this overview. This central organelle of energy metabolism and control of cell death is supposed to be a target for aging and a promoter of aging as well [1]. Within living cells, mitochondria are observed as small sausage-shaped organelles, longer snake-like tubules, branched reticula, extended filaments and networks or clusters that are connected via intermitochondrial junctions. Mitochondrial morphology is regulated in many cultured eukaryotic cells by fusion and fission, and a tightly controlled balance between fission and fusion events is supposed to ensure normal mitochondrial ultrastructure as well as mitochondrial and cellular functions. Mitochondria of old endothelial cells show a significant and equal decrease of both fusion and fission activity [2], indicating that these processes are sensitive to aging and are likely to contribute to the accumulation of damaged mitochondria during aging [3]. Aging of cells is also associated with aberrations of mitochondrial morphology and ultrastructure. Typical changes of mitochondrial ultrastructure during aging, as can be seen by electron microscopy in cultured fibroblasts, are loss of branched mitochondria in old cells, enlargement of mitochondria, matrix vacuolization, shortened cristae, and loss of dense granules [4]. Furthermore, cystic blebs are evident in mitochondria of some cells with an apparent increase in old cells. These blebs appear to be due to weakening of the inner membrane, allowing dilatation of the outer membrane which otherwise appears intact. Similar ultrastructural changes of mitochondria as seen in aged cells are also seen in cultivated skin fibroblasts of patients with point mutations in mitochondrial DNA (mtDNA) affecting the energy metabolism of the organelles. The changes encompass partially swollen mitochondria with unusual and sparse cristae, heterogeneity of cristae in size and shapes or their absence, as well as almost complete absence of branched mitochondria [5]. Furthermore, similar changes in mitochondrial ultrastructure as seen in aged fibroblasts are also seen in photoaged keratinocytes chronically exposed to low doses of UV-B irradiation [6]. Thus, ultrastructural changes of mitochondria in intrinsically aged cells are similar to those seen in mitochondria from skin cells damaged by intrinsic genetic defects or damaged by exogenous stressors leading to photoaging. Since morphological features typical of mitochondria from aged cells can also be induced in mitochondria from otherwise normal cultured primary skin fibroblasts by inhibition of energy
metabolism with drugs targeting the respiratory chain [7], changes of the mitochondrial ultrastructure can be hypothesized to be a cause and consequence of altered mitochondrial energy metabolism as well. The central function of the mitochondrial network in the cell is the production of Adenosintriphosphate (ATP) by transfer of electrons from digested food to carrier molecules such as Nicotinamide adenine dinucleotide (NAD+) and flavin adenine dinucleotide (FAD+), thus generating NADH and FADH, and subsequent delivery of the electrons to the respiratory Oxidative phosphorylation generates mitochondrial ATP by means of five multiple subunit enzyme complexes (I through V) plus the adenine nucleotide translocator (ANT), all localized within the mitochondrial inner membrane. Complexes I–IV constitute the electron transport chain. Reduced NADH is oxidized by Complex I (NADH dehydrogenase), and succinate is oxidized by Complex II (succinate dehydrogenase); the electrons are transferred to ubiquinone (Coenzyme Q10) to yield ubiquinol. The electrons from ubiquinol are transferred to Complex III (ubiquinol:cytochrome c oxidoreductase), then to cytochrome c, then to Complex IV (cytochrome c oxidase), and finally to oxygen. The energy released is used to pump protons out of the mitochondrial inner membrane through Complexes I, III, and IV, and the resulting electrochemical gradient is exploited by Complex V (ATP synthase) to condense Adenosindiphosphate (ADP) and inorganic phosphate to form ATP. Both ATP and ADP are exchanged across the mitochondrial inner membrane by ANT. The five protein complexes of the electron transport chain work as an integrated system, with mitochondrial DNA (mtDNA) encoding 13 of the proteins and nuclear DNA encoding approximately 60. Formation of these complexes is a complicated procedure based on the coordinated transport and assembly of components from two different genomes and compartments [8]. As an organism ages, either by extrinsic or intrinsic aging, there is a significant decline in mitochondrial function and cellular energy balance [9, 10]. This applies especially to mitochondrial membrane potential which is key to mitochondrial function [11]. Assessment methods to monitor the mitochondrial respiration rate and membrane potential, even on a single intact cell level are discussed in the section Energetic effects of Creatine of this overview. Decrease of mitochondrial function during aging has been described as a general feature in many in vitro systems. These descriptions encompass the loss of mitochondrial membrane potential of old and postmitotic human umbilical vein endothelial cells [2], or lower
Alterations of Energy Metabolism in Cutaneous Aging
respiration rates of spleen lymphocytes isolated from from old mice as compared with lymphocytes from young mice [12], just to mention a few. In fact, the general decline of mitochondrial respiratory functions with age has also been described in human studies, for example in hepatocytes investigated in a study enrolling subjects of 31–76 years old, where a significant negative correlation between age and respiratory control and ADP/O ratios was observed [13]. Decline in skeletal muscle mitochondrial respiratory chain function has also been investigated in isolated intact skeletal muscle mitochondria in a study enrolling subjects aged 16–92 years. State 3 (activated) mitochondrial respiration rates showed a significant negative correlation between respiration rate and age. A similar trend was seen for respiratory enzyme activities assayed in muscle homogenate [14]. These findings demonstrate a substantial fall in mitochondrial function in aging muscle and liver cells, and suggest that a fall in mitochondrial oxidative capacity and membrane potential in aging cells may be an important general contributor to the aging process. Loss of mitochondrial membrane potential has also been reported in human dermal fibroblasts aged in vitro by serial passage [15]. Furthermore, a marked agingrelated decline in efficiency of oxidative phosphorylation was observed in human skin fibroblasts isolated from a large group of subjects ranging in age between 20 weeks fetal and 103 years [16]. In the latter study, the analysis of endogenous respiration rate revealed a significant decrease in the age range from 40 to 90 years, and a tendency to uncoupling in the samples from subjects above 60 years. These findings clearly pointed to a dramatic mitochondrial dysfunction, which would lead to a decrease in ATP synthesis rate in skin fibroblasts with increasing age. The impact of intrinsic aging on the mitochondrial oxidative capacity and mitochondrial membrane potential of skin cells is furthermore supported by a number of indirect studies discussed in this review, addressing the effects of aging on the generation of reactive oxygen species (ROS) in skin cells from young and old donors, or the effect of energy enhancers. Besides intrinsic aging effects on the mitochondrial capacity of skin cells, a substantial decline of the mitochondrial membrane potential can be observed following UV irradiation of keratinocytes in vitro, which is the dominant stressor leading to photoaging of cells [17, 18]. A decline of mitochondrial membrane potential after UV irradiation has also been reported in situ using suction blisters taken from irradiated and non-irradiated skin areas of healthy old volunteers with an average age of 65.2 years [17].
29
Aging Effects on Anaerobic Energy Pathways The loss of mitochondrial function represents an inherent part in modern theories trying to explain the cutaneous aging process. The number of damaged mitochondria increases with aging, and as a consequence an impaired mitochondrial ATP synthesis can be observed. To assure survival of a cell, any decrease in mitochondrial energy production due to impaired mitochondrial function has to lead to compensatory actions in cellular metabolism which result in higher energy production via non-mitochondrial pathways such as glycolysis. This goes along with reports from several in vitro studies demonstrating a higher glucose uptake and lactate production at advanced cellular age in fibroblasts [19, 10]. As a speacial feature of the skin, atmospheric oxygen may be directly taken up by the human epidermis, and in theory, the flux of oxygen from the environment should be sufficient to fully cover its oxygen demand [20]. A rather surprising hypothesis, stimulated by a study from Ronquist et al. [21], is that human epidermis works to a substantial extent in an anaerobic manner. In cell culture, keratinocytes contain more lactate than do most other cell types. Their lactate production in vitro is vigorous and independent of oxygen and most of it is released to the medium. During autoincubation of the epidermis under starved conditions, energy charge values are low and comparable with those reported for smooth muscle. Moreover, the overwhelming majority of the keratinocytic mitochondria have an appearance markedly deviating from those in other cells such as Langerhans cells, melanocytes and fibroblasts, and, above all, are characterized by an enormous reduction of the inner membrane. Ronquist concludes from these findings that epidermal energy metabolism is predominantly anaerobic in spite of the formal presence of mitochondria and sufficient oxygen. According to not yet published data generated in at the authors’ institution, significant age-dependent differences in mitochondrial function can be observed in keratinocytes isolated from skin biopsies of young and old donors. The data suggest that energy metabolism shifts to a predominantly non-mitochondrial pathway and is therefore functionally anaerobic with advancing age. Primary keratinocytes derived from old donors show a higher glucose uptake compared to the cells obtained from a young donor panel, and the increased lactate production in keratinocytes from the old age group clearly indicates a suboptimal utilization of glucose and a shift in metabolism towards an increased glycolysis. The data generated so far show no differences in mitochondrial
297
298
29
Alterations of Energy Metabolism in Cutaneous Aging
content and structure during aging in skin keratinocytes, indicating that the number of mitochondria does not change, but rather their function. This decline of mitochondrial function may explain the observed age-associated glycolytic activity as some kind of compensatory counterregulation. Simulation of mitochondrial dysfunction by inhibition of ATP synthase in keratinocytes from young donors leads to a comparable rise in glucose uptake and lactate production as seen in the basic, unstressed state of keratinocytes from the old age group. In fact, the energy metabolism of keratinocytes is a subject of controversy, and it is unclear why keratinocytes express a metabolic status that is, as compared with fibroblasts or endothelial cells, partially shifted to an anaerobic status. It was found that keratinocytes respire as much oxygen as fibroblasts, even though maximal activities of the respiratory chain complexes are two- to fivefold lower, whereas expression levels of respiratory chain proteins are similar. Congruent with this, superoxide anion levels are much higher in keratinocytes, and keratinocytes display higher lipid peroxidation levels and a lower reduced glutathione/oxidized glutathione ratio, indicating enhanced oxidative stress [22]. Thus, it seems that keratinocytes actively use the mitochondrial respiratory chain not only for adenosine 5’ triphosphate synthesis but also for the accumulation of superoxide anions, even at the expense of mitochondrial functional capacity. The reason for this behaviour of keratinocytes is not clear, but it may indicate that superoxide-driven processes might be a prerequisite for keratinocyte differentiation, even though the lack of energy supply via oxidative phosphorylation has to be compensated via glycolysis then.
Aging Effects on Extramitochondrial Energy Stores Precise coupling of spatially separated intracellular ATPproducing and ATP-consuming processes is fundamental to the bioenergetics of living organisms, ensuring a failsafe operation of the energetic system over a broad range of cellular functional activities, thereby securing the cellular economy and energetic homeostasis under stress [23]. Beside the mitochondrial energy supply and glycolysis as primary sources for energy, cells also have a secondary energy storage system named the creatine/phosphocreatine (Cr/PCr) pathway. This is also established in the human skin and is responsible for an extremely fast energy supply in situations of high temporal energy demand when ATP is used up faster than can be produced from primary sources [24, 25, 17], or when energy supply from
primary sources is temporarily interrupted, such as in situations of short term hypoxia or anoxia [26]. The free energy of ATP, which itself cannot be stored efficiently, is stored and transported in the form of PCr from sub-cellular sites of energy production, e.g., mitochondria, to places of high energy requirements, where creatine kinase (CK) activity can rapidly replenish cellular ATP in situ [27, 28, 29]. Predominant isoforms of CK consist of cytosolic mm-CK (muscle-type), mainly found in muscle cells, as well as cytosolic bb-CK (braintype) and ubiquitous mitochondrial mt-CK, with the last two mainly located in the brain but also present in skin [30, 31]. Creatine kinases catalyze the following reversible reaction: Mg ATP þ Cr $ PCr þ Mg ADP þ Hþ : The mt-CKs form octamers assembled from four dimers each, but only the octameric form can interact with both inner and outer mitochondrial membranes through the adenine nucleotide translocator (ANT) and the voltage-dependent anion channel (VDAC). The mt-CK activity couples the oxidative phosphorylation to mitochondrial PCr production by catalyzing the conversion of Cr to PCr at expenses of the intramitochondrially produced ATP. The PCr is exported to the cytosol, whereas the produced ADP is pumped back to the mitochondrial matrix via ANT. Cells attain their physiological levels of creatine, either by biosynthesis from the amino acids arginine, glycine, and methionine in the kidney, liver, and pancreas of vertebrates including humans, and/or alternatively by ingestion of meat and fish. Creatine is transported via the blood circulation and is taken up into cells by the Na- and Cl-dependent creatine transporter (CRT) protein [32, 33]. Once inside a cell, creatine can be stored at high concentrations (e.g., 40 mM for muscle cells). In skin, oxidative damage of cellular and extracellular components activates intrinsic repair mechanisms, which necessarily require ATP for full functionality. The PCr/CK system together with the recently discovered epidermal creatine transporter (CRT) [30] provides human skin with an important tool to cope efficiently with such conditions of high energy demand. In fact, both creatine kinase subtypes, bb-CK and mt-CK, as well as CRT, are expressed in human skin [17], showing high levels in the epidermis but less in the dermis, with the highest enzyme activity found in keratinocytes, which are generally shifted to a more anaerobic state of metabolism, as discussed in the section Aging Effects on Anaerobic Energy Pathways. Results from experiments using skeletal muscle and heart muscle clearly show that both PCr amount [34, 35, 36], and CK activity decrease with age [37, 35].
Alterations of Energy Metabolism in Cutaneous Aging
Also in skin, a reduction in the cellular concentration of creatine can be determined from the age of about 30 [38], paralleled by a slightly reduced CK activity in skin cells from older donors [17]. This decline in skin CK activity may be caused by the generation of ROS during cutaneous aging. This is supported by the fact that CK, specifically mt-CK, is a primary target for ROS, especially peroxynitrite [39]. Moreover, cutaneous cells may show signs of a declining creatine level, probably caused by a stress and age-related decline of dermal vascularization [40].
Mechanisms of Skin Aging Related to Energy Metabolism Mitochondrial Impairment by Its Own Oxidation By-products Free reactive oxygen species (ROS) are generated in the skin by several different processes [41], with exogenous stress following UV-irradiation being the most dominant generator of ROS in UV-exposed skin. Other important contributions include proteins within the plasma membrane, such as the growing family of NADPH oxidases. Furthermore, generation of H2O2 as a by-product of fatty acid degradation in peroxisomes has to be taken into account as an endogenous source of ROS. The same holds for the generation of ROS by oxidative burst of phagocytes during inflammatory reactions, as well as the activity of various cytosolic enzymes such as cyclooxygenases. Although all these sources contribute to the overall oxidative burden of a cell, the vast majority of cellular ROS (estimated at approximately 90%) which is generated in cells independently of UV-stress can be traced back to the mitochondria as by-products of impaired mitochondrial respiration [42], and oxidants generated by mitochondria are supposed to be the major source of the oxidative lesions that accumulate with age [43]. The continuous threat of oxidant damage to the cell, tissue, and organism as a whole is underscored by the existence of an impressive array of cellular defenses that have evolved to battle these reactive oxidants [44]. The cell is equipped with a variety of defence mechanisms to remove ROS. Superoxide dismutases convert superoxide into hydrogen peroxide, which in turn can be transformed into water by catalase or glutathione peroxidase. The cell also contains nonenzymatic scavengers such as ascorbate, pyruvate, flavenoids, carotenoids and glutathione which may inactivate potentially damaging ROS. However, these defenses are not perfect and, consequently, cellular macromolecules become oxidatively damaged.
29
Relevant to mitochondrial function is the efficiency of electron movement through the electron transport chain and its coupling to oxidative phosphorylation to produce ATP. The coupling efficiency can be measured experimentally by determining ADP/O ratio, and by determination whether the mitochondria are in State 3 or State 4, whereby State 3 represents a condition where the rate of oxidative phosphorylation is not limited by ADP concentration, and State 4 a condition where the level of ADP limits oxidative phosphorylation. State 4 is associated with a reduced respiratory chain, leading to an ‘‘electron jam’’ and increased formation of ROS byproducts. When the rate of electron flow is slow, electrons tend to accumulate in the respiratory chain, and electrons escaping from the somewhat ‘‘leaky’’ electron transport chain (ETC) can reduce oxygen to form the highly reactive free radical superoxide anion (O2●), which, in turn, can be further reduced to hydroxyl radical (OH●) and hydrogen peroxide (H2O2). Furthermore, the superoxide anion can initiate the oxidation of sulphite or nitric oxide, resulting in ROS such as sulphur pentoxy anion or peroxynitrite. Overall, mitochondrial ROS generation is high during resting respiration, but when electrons flow quickly through the respiratory chain reducing O2 to water, the rate of ROS production is usually lower. It has been estimated that about 1012 O2 molecules are processed by each cell daily, and that the leakage of partially reduced oxygen molecules is about 2%, yielding about 2 1010 O2● and H2O2 molecules per cell per day [45]. In addition to the toxic electron transport chain reactions of the inner mitochondrial membrane, the mitochondrial outer membrane enzyme monoamine oxidase catalyzes the oxidative deamination of biogenic amines and is a quantitatively large source of H2O2 that contributes to a further increase in the steady state concentrations of reactive species within both the mitochondrial matrix and cytosol [46]. High ROS concentrations, resulting from either increased production or decreased detoxification, can cause oxidative damage to various cellular components, ultimately leading to cell death [47]. Beyond damage to mitochondria, which will be discussed in detail below, age-related features often associated with excess ROS are accumulation of oxidized intracellular proteins with age [48], the decrease of fluidity of cellular membranes with age [49], or even malfunctioning of the connective tissue remodeling process due to increased activity of extracellular matrix-degrading metalloproteinases [50], just to mention a few. Toxic reactions exerted by ROS, and imbalances in the production and removal of ROS, significantly contribute to the aging process and are the basis of the ‘‘The Free Radical Theory of Aging’’ [51], postulating that the
299
300
29
Alterations of Energy Metabolism in Cutaneous Aging
production of intracellular reactive oxygen species is the major determinant of life span [42]. The hypothesis that rate of intracellular ROS production is associated with the rate of aging was tested by Sohal [52], comparing the rate of H2O2 generation by mitochondria in houseflies. The rate of mitochondrial H2O2 release was found to be associated with remaining life expectancy or the physiological age of flies. At the same chronological age, mitochondria from flies with a shorter remaining life expectancy had a markedly higher rate of H2O2 generation than those with a longer life expectancy. In another experimental model of aging – the senescenceaccelerated mouse (SAM) – animals exhibit a shortened life span (about 18 months) as compared with normal mice, as well as early manifestation of various signs of senescence including changes in physical activity, skin, and spinal curvature. In the SAM the respiratory control ratio and the ATP/O – an index of ATP synthesis – decreases more rapidly as compared with the unaffected wild-type mice. Furthermore, uncoupled respiration in liver mitochondria is markedly decreased with aging in SAM [53]. Cultured dermal fibroblasts from SAM produce more ROS within the mitochondria than do cells from wild-type control mice, coinciding with an increase in the mass of the mitochondria, degenerative mitochondrial morphology with longer culture periods, and lower membrane potential as compared with the controls [54]. Another study supporting the hypothesis that rate of intracellular ROS production is associated with the rate of aging used genetically modified mice with impaired mtDNA repair function. Secondary to the impaired mtDNA repair function all such mice exhibit a significant reduction in respiratory chain activity and ATP generation in postmitotic tissue such as heart, as well as a significantly shortened life span and the appearance of a number of age-related phenotypes, including hair loss, kyphosis, and reduced fertility [55]. These findings suggest that damaged mitochondria, which produce an excess of ROS, can accelerate the aging process in a kind of feedback loop. In fact, the mitochondria seem to be highly susceptible to harm exerted by ROS, including those produced by themselves, and increasing levels of oxidative damage in various compartments of the mitochondrium can be observed during cellular aging. Damages to mitochondrial DNA (mtDNA) – which contributes a substantial part of the proteins of the respiratory chain – isolated from rat liver or various human brain regions are at least tenfold higher than those of nuclear DNA. These higher levels of oxidative damage and mutation in mtDNA have been ascribed to location of the DNA near the inner mitochondrial
membrane sites where oxidants are formed. The extent of damage and mutation of mtDNA may be further aggravated by lack of protective histones, and lack of DNA repair activity in mitochondria. Oxidative lesions in mtDNA accumulate as a function of age, which has been well described for human diaphragm muscle [56], human brain [57]), and rat liver [58]. As in the case of oxidative damage to DNA, an ageassociated increase in oxidative damage to mitochondrial protein is also observed [59]. The accumulation of oxidized dysfunctional protein with reactive carbonyl groups can lead to inter- and intramolecular cross-links with protein amino groups and may cause loss of biochemical and physiological function in mitochondria. Thus the age-related accumulation of protein oxidation products in mitochondria may also lead to loss of energy production and increased production of oxidants. Increased oxidants may also contribute to alterations in mitochondrial membrane fluidity and phospholipid composition that occur during aging. These in turn can affect the ability of mitochondria to transport substrates and to generate sufficient proton motive force to meet cellular energy demands. With regard to lipids, part of the increased sensitivity of mitochondria to oxidants appears to be due to peculiarities in membrane lipid composition [60] which is characterized by the presence of cardiolipin. Cardiolipin serves as an insulator and stabilizes the activity of protein complexes important to the electron transport chain, and it also ‘‘glues’’ them together. Because cardiolipin plays a pivotal role in facilitating the activities of key mitochondrial inner membrane enzymes, it would be expected that changes that increase its susceptibility to oxidative damage would be deleterious to normal mitochondrial function [43]. Cardiolipin is solely synthesized in the mitochondria, and is typically present in the membranes of mitochondria, mostly in the inner membrane, which consists roughly 20% of its lipids. Cardiolipin aquires an increasing percentage of polyunsaturated fatty acids with increasing age of an organism (substitution 18:2 to 22:4 and 22:5), which renders it even more susceptible to oxidative damage. In fact, mitochondrial cardiolipin content has been reported to decrease with age in a number of tissues, including heart, liver, nonsynaptic brain mitochondria, and epithelial cells [61, 62, 63, 64], presumably due to oxidative damage. The decrease of cardiolipin with age is associated with a decrease in State 3/State 4 ratio. This loss of cardiolipin by increased susceptibility to oxidation could play a critically important role in the agerelated decrements in mitochondrial function. In addition to the established role of the mitochondria in energy metabolism, regulation of cell death has emerged
Alterations of Energy Metabolism in Cutaneous Aging
as a second major function of these organelles. This seems also to be intimately linked to their generation of ROS [65]. Mitochondrial regulation of apoptosis occurs by mechanisms, which have been conserved through evolution, involving the release of cytochrome c into the cytoplasm which may be initiated by the oxidation of cardiolipin. Oxidation of cardiolipin, which occurs at higher rates in aged cells, reduces cytochrome c binding to mitochondrial inner membranes and increases the level of soluble cytochrome c in the intermembrane space. Subsequent release of the hemoprotein into the cytoplasm, which starts the apoptotic machinery via activation of caspases, occurs by pore formation mediated by pro-apoptotic Bcl-2 family proteins, or opening of mitochondrial permeability transition pores (MPTP). Various factors enhance the likelihood of MPTP opening, among them are dissipation of the difference in voltage between the inside and outside of mitochondrial membranes (known as permeability transition), or the presence of free radicals, both typical features of mitochondria in aged cells. ROS are also known as signaling molecules under subtoxic conditions which may activate cytoplasmic signal transduction pathways that are related to growth, differentiation, senescence, transformation and tissue degradation [66, 67, 68]. Hydrogen peroxide, for example, has been shown in different cultured cell lines to induce either apoptosis at high concentrations, or features of senescence at subtoxic concentrations [69], with cellular senescence being defined as the loss of proliferative capacity of primary cell lines, characterized by cell cycle arrest, reduced DNA synthesis, increased cell size, granularity and size heterogeneity [70, 71]. Senescent cells enter a terminally nondividing state in which they can stay for long periods before dying. Thus, in the case of stress-induced premature senescence, ROS are considered important intermediates contributing to the phenotype. The data of Zwerschke et al. [10] suggest the occurrence of significant metabolic imbalances in human fibroblasts rendered senescent by exposition to ROS. There is a drastic deregulation of the carbohydrate metabolism in senescent cells, characterized by an imbalance of glycolytic enzyme activities and the failure to maintain ATP levels. This leads to an up-regulation of adenylate kinase activity and the levels of AMP, which acts as a growth-suppressive signal that induces premature senescence. The activities of several glycolytic enzymes are strongly up-regulated. Moreover, the function of the malate–aspartate shuttle is reduced in senescent cells, preventing the transport of hydrogen into the mitochondria, where it could be used for ATP production. Instead, senescent cells activate LDH and take up pyruvate to get rid of hydrogen. Thus
29
ATP-consuming steps of glycolysis are enhanced, whereas the ATP-producing steps are inhibited, and this leads to a severe reduction of the intracellular concentration of both ATP and GTP. Senescent keratinocytes and fibroblasts were also described by Campisi [72] to accumulate with age in human skin, likely due to the impact of increased endogenous oxidative stress in aged skin.
Genetic Damage to Mitochondria The mitochondrial genome is very small and economically packed, and the expression of the whole genome is essential for the maintenance of mitochondrial bioenergetic function. Thus, even small genetic alterations may have tremendous effects on mitochondrial function. In the past decade, more than 100 mtDNA mutations have been found in patients with mitochondrial disease, and some of them also occur in aging human tissues [73]. Thus, it may be hypothesized that accumulation of mitochondrial DNA deletions may be an important factor in intrinsic aging. At higher age, several independently acquired types of mtDNA mutations, accumulating clonally in certain cells, can even be found in different tissues of the same subject [74]. The incidence and abundance of mutant mtDNAs are increased with age, and much more than for nuclear DNA mutations [75, 76]. Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissues derived from young adult and senescent animals have revealed that about 1% of the native mtDNA population in adult liver and about 5% in senescent liver having deleted/inserted segments [77]. In humans it was found that normal heart muscle and brain from adult human individuals contain low, though substantial levels of a specific mitochondrial DNA deletion, previously found only in patients affected with certain types of neuromuscular disease. This deletion was not observed in fetal heart or brain [78]. In a further human study focussing on the prevalence of mtDNA deletions in tumorous and surrounding healthy tissue, mtDNA mutations were found to be abundant in margin tissue specimens from older patients and their number correlated with the patient age. Significantly fewer deletions were detected in the tumours than the margins, and the tumours often had no deletions [79], implying a potential selection for full-length mtDNA or perhaps a protective role for mtDNA deletions in the process of tumourigenesis. Concerning photoaging, also photoaged skin is characterized at the molecular level by increased amounts of large-scale deletions of the mitochondrial genome such as
301
302
29
Alterations of Energy Metabolism in Cutaneous Aging
the 4,977 bp common deletion encompassing deletion of four genes for subunits of complex I, one gene for complex IV, two genes for complex V, and several genes for mitochondrial tRNAs [80, 81]. The common deletion can be generated in dermal fibroblasts through repetitive ultraviolet UV-A irradiation [82]. For example, in a human study, previously unirradiated skin of 52 normal human individuals was repetitively exposed to physiological doses of UV-A light, and repetitive UV exposure led to an approximately 40% increase in the levels of the common deletion in skin tissue. Nine individuals were examined up to 16 mo after cessation of UV exposure and some showed accumulation up to 32-fold [83]. In another human study focussing on extrinsic photoaging, several types of mtDNA length mutations including the common 4,977 bp deletion were investigated in normal human skin tissues. It was found that the incidences of these deletions and tandem duplications of mtDNA in sun-exposed skin were all significantly higher than those in non-exposed skin [84]. Moreover, these mutations started to appear in the third decade of life, and the age at which the mutations could be detected in sun-exposed skin was substantially younger than in non-exposed skin. In another human study focussing on mtDNA aberrations in skin tissue, the frequency of a so-called T414G mutation within the control region of mtDNA, has been demonstrated to accumulate in both chronologically and photoaged skin using cultured dermal fibroblasts from donors of different age [85]. Thus, there is a strong correlation of extrinsic and intrinsic cellular aging with the accumulation of aberrations of mtDNA, and increasing evidence suggests that, due to a negative feedback loop, damaged mtDNA is a cause and consequence of aging as well. The causative role of mtDNA mutations and resulting mitochondrial dysfunction for intrinsic and extrinsic aging has been demonstrated in several experimental models and human studies. Premature aging has, for example, been reported in knock-in mice expressing a defective mitochondrial DNA polymerase. These knock-in mice develop an mtDNA mutator phenotype with a threefold to fivefold increase in the levels of point mutations, as well as increased amounts of deleted mtDNA, associated with reduced lifespan and premature onset of aging-related phenotypes such as weight loss, reduced subcutaneous fat, alopecia (hair loss), kyphosis (curvature of the spine), osteoporosis, anaemia, reduced fertility and heart enlargement [55]. The results thus provide a causative link between mtDNA mutations and aging phenotypes in mammals. It is plausible that the accumulation of mtDNA mutations leads to decreased gene expression, resulting in a decline in
oxidative phosphorylation, and inefficient electron transport, which consequently increases the generation of ROS [86]. A direct link between the amount of mtDNA aberrations and oxidative stress has been demonstrated using a series of the cybrids harboring varying proportions of mtDNA with the common 4,977 bp deletion. The population doubling time was longer for the cybrids containing higher proportions of 4,977 bp-deleted mtDNA. In addition, the respiratory function was decreased with the increase of the portion of aberrant mtDNA in the cybrids. The results also showed that the specific contents of typical cellular oxidation products stemming from ROS in cybrids harboring >65% of the aberrant mtDNA were significantly increased as compared with those of the cybrids containing undetectable mutant mtDNA [80, 87]. In a study on human fibroblasts, gradual largescale deletion of the mtDNA from unirradiated human skin fibroblasts was found to induce a gene expression profile reminiscent of photoaged skin. The modified cells exhibited an altered gene expression profile resulting from intracellular, mitochondria-derived oxidative stress, dominated by high expression of matrix metalloproteinase-1 (MMP-1) which is known to be expressed in response to oxidative stress 95]. Vice versa, the increase in ROS production is a likely promotor for additional mtDNA damage and accumulation of mtDNA mutations. The causative role of oxidative stress for the increased frequency of mitochondrial DNA aberrations has been demonstrated in a variety of experimental models and in human studies. For example, oxidative damage elicited by imbalance of free radical scavenging enzymes and its association with large-scale mtDNA deletions in aging human skin has been suggested using skin tissue derived from donors of different age. In subjects above the age of 60 years, elevated oxidative stress was caused by an imbalance between the production and removal of ROS and free radicals, and was paralleled by an increase of the proportion of mtDNA with the 4,977 bp deletion [88]. The causative role of singlet oxygen in mediating UV-A induced generation of the photoagingassociated mitochondrial common deletion has been demonstrated in a pivotal study by Berneburg et al. [89]. Normal human fibroblasts were repetitively exposed to sublethal doses of UVA radiation and assayed for the common deletion. There was a time- and dose-dependent generation of the common deletion, attributable to the generation of singlet oxygen, since the common deletion was diminished when irradiating in the presence of singlet oxygen quenchers, but increased when enhancing singlet oxygen half-life by deuterium oxide. The induction of the
Alterations of Energy Metabolism in Cutaneous Aging
common deletion by UVA irradiation was mimicked by treatment of unirradiated cells with singlet oxygen produced by the thermodecomposition of an endoperoxide. These studies provide direct evidence for the involvement of reactive oxygen species in the generation of agingassociated mtDNA lesions in human cells.
Side Effects of Anaerobic Energy Pathways High glycolytic fluxes and glucose accumulation may be a last resort when oxidative energy capacity of mitochondria declines during aging, but they are also sources of endogenous damage by themselves. In fact, both aging and diabetes are characterized by the formation of socalled advanced glycation endproducts (AGEs), though due to different reasons. Most glycolytic intermediates favour the formation of (AGEs) via reactive carbonyl groups, that are able to modify protein amino groups in the cytosol based on the Maillard reaction. This reaction is termed glycation or non-enzymatic glycosylation. AGEs constitute a heterogeneous group of structures, whereby N’-(carboxymethyl)lysine (CML) adducts are the most prevalent AGEs present in vivo. Methylglyoxal, glyoxal and other autooxidated derivatives of sugars induce AGEs that negatively affect essential features of skin cells and extracellular matrix proteins. It has been reported that AGE formation results in a loss of contractile capacity and cytoskeleton integrity in human skin fibroblasts, which possibly affects tissue cohesion and leads to visible effects of skin aging. Vimentin was identified as a major target in skin glycation besides other longlived proteins such as fibronectin, laminin, collagen, and elastin [90]. Strikingly, the accumulation of modified vimentin can be found in skin fibroblasts of elderly donors in vivo, bringing AGE modifications in skin into strong relationship with loss of organ contractile functions associated with aging. It is also reported that the intracellular concentration of the glycating agents – such as highly reactive methylglyoxyal, which is formed from dihydroxyacetone and glyceraldehyde-3-phosphates, and rapidly glycates proteins – damages mitochondria [91], and AGEs may even induce apoptosis by enhancement of expression of pro-apoptotic genes and stimulation of apoptosis through cytoplasmic and mitochondrial pathways [92]. Furthermore, intracellular AGEs induce oxidative stress, activate NF-kB and heme oxygenase, produce lipid peroxidation products, and cross-link proteins [93].
29
Monitoring Methods for Energetic Processes in Skin Cells Monitoring of Mitochondrial and Glycolytic Activity in Skin There is no direct method available to measure mitochondrial or glycolytic activity in skin in situ. In any case, dermal cells have to be isolated from skin biopsies or suction blisters, or cultured dermal cell lines have to be employed. Assessment of the mitochondrial membrane potential is then possible through the availability of redistribution potentiometric radioactive compounds such as tetraphenylphosphonium bromide or redistribution potentiometric dyes such as rhodamine 123 (R123), or tetramethylrhodamine methyl ester (TMRM). These substances are lipophilic cations accumulated by mitochondria in proportion to the membrane potential (DC). Whereas the use of tetraphenylphosphonium bromide requires isolation of the mitochondria for uptale analysis [94], the dyes may be used also with living intact cells. Upon accumulation in the cytoplasm, R123 and TMRM exhibit a red shift in both their absorption and fluorescence emission spectra. The fluorescence